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INTRODUCTION
We make decisions all the time, almost unconsciously, relying on past experience and
present observations. However, our experience might be insufficient and our obser-
vations imperfect, which introduces uncertainty. For instance, we may be unaware
of some factors that would influence our decision had we known them. Therefore to
make the right decision we somehow need to take into account the uncertainty in
the information we have.
This thesis is about knowledge representation under uncertainty, applied to prob-
lems in biomedicine. Throughout the years knowledge representation has been a
topic of artificial intelligence research. Here we present our take on part of the
problem, focussing our efforts on challenges in the context of clinical medicine. The
question we will ask ourselves is how we can represent knowledge about processes
that are uncertain – for all kinds of reasons which we will detail later – in such a way
that we understand what happens and can perhaps predict what will occur next.
1.1 medical knowledge and decision support
The problem of knowledge representation under uncertainty is a general one and
interesting in its own right. We will place emphasis on applications in biomedicine,
which share many properties with general knowledge representation tasks but may
involve other, for example ethical, considerations. Artificial intelligence research has
also in the past often focussed on the problems of knowledge representation, uncer-
tainty and decision making within medicine. Arguably the most famous application
is mycin, a system advising on treatment of infectious diseases [88]. Basically, de-
cision support systems somehow contain a description of a particular domain and,
given observations, can suggest a possible course of action by reasoning with the
domain knowledge and the observations. The details of how this is achieved have
differed considerably through the years however.
Knowledge representation techniques
Logic has been a tool to structure knowledge dating back to ancient times, with
the European roots attributed to Aristotle. The formal language that it is now
is a powerful tool for representation and reasoning. It is therefore not surprising
that logic is still used as a representation language for decision support systems.
However, in logic a proposition is either true or false, which is too crisp a distinction
in the real world where we have to deal with gaps in our knowledge and other kinds of
uncertainty. mycin uses a large set of rules, which is in essence a logic representation,
with certainty factors to represent uncertainty [88]. Various alternatives to deal with
uncertainty have been developed, but suffice it to say that probability theory is now
mostly accepted as a sound way to represent uncertainty ([18] makes a case for
probability theory compared to other representations like certainty factors).
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Probability theory is a consistent manner to characterise random phenomena –
although the colloquial meaning of the word ‘random’ is often associated with a
uniform distribution implying equal probability for each outcome, we here mean
random in the technical sense of a process involving chance. Probability theory was
originally developed as a way to describe games of chance, with early work in the
16th and 17th century by Gerolamo Cardano, Pierre de Fermat, Blaise Pascal and
Christiaan Huygens. However, it turned out that probability is useful in a much
wider context than rolling dice, as it can be used in general to describe uncertainty.
There are two main views on the interpretation of probability theory, called the
frequentist and Bayesian view, which differ mainly in whether a probability should
be seen as a relative frequency of an outcome in a repeatable experiment – rolling
dice is a typical example – or as a subjective degree of believe in a given outcome –
e.g. the probability that you will read all of this thesis. The work by Pierre-Simon
Laplace at the start of the 19th century is considered important in the development
of probability theory and the Bayesian perspective in particular. Since then many
powerful statistical and machine learning methods have been developed based on
both frequentist and Bayesian probability theory.
Models for decision support
Irrespective of whether we choose to use logic, statistics or some other approach,
we are interested in models that somehow represent part of reality. Typically, a
model tries to capture the important aspects of a problem, in order to obtain a
better understanding of the underlying process, to reason about it and make predic-
tions about future behaviour. Deciding which factors are important is not a trivial
task, especially when not all factors are readily observable. An application domain
for which this property is often true is clinical medicine. Many clinical problems
exhibit the kind of complexity that asks for smart models to capture the relevant
information. It is therefore not surprising that much research in statistics and in
artificial intelligence has focussed on trying to solve diverse clinical tasks ranging
from diagnosis to prognostics. Recently, technological advancement has lead to new
initiatives extending medical informatics and artificial intelligence applications to
web-based and mobile platforms. As a result new opportunities arise, but at the
same time many of the challenges of knowledge representation remain.
It turns out that even with the well-developed theory of logic and of probability,
building a successful decision support system is an endeavour in which knowledge
representation is one of the difficult problems that has to be tackled. In general this
requires insight in the domain and relevant data. Adherents to pure data driven
approaches rely on what the data can tell them, mostly under the assumption that
finding correlations is sufficient for all practical purposes. Insight in the domain is
then gleaned from the data only. Indeed, statistics provides powerful tools and these
will also be used in the work described here. Nonetheless it is arguable that a causal
understanding of the domain as an expert might provide has merit beyond what can
be said on the basis of correlation. When it comes to ascertaining causality, con-
trolled experimentation is key, but often not every relevant factor can be controlled.
In this context research that tries to capture causality in probabilistic models is of
interest [76, 89]. The resulting models do not usually allow inference however, which
makes them unsuitable for practical systems. In our opinion both data and (causal)
expert knowledge tell part of the story, and insight in the domain is an important
part of making sure a decision support system does the right thing; at the same time
statistical information can provide quantified information and offers the opportunity
for knowledge discovery by finding new relations in the data.
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The characteristics of processes and data – obtained from these processes – that
will receive particular attention here are uncertainty and time. Uncertainty arises in
data as a result of limited observability, measurement errors, and missing values. At
a more abstract level uncertainty may mean that the process is not fully understood.
It may be that not all factors influencing a process are known, or it may be unclear
how variables interact. To give a clinical example, the cause of a disease may be
the interaction of a particular kind of bacteria with some physiological system, but
is usually also influenced by environmental factors. Which factors play a role in
the disease and how different factors interact will be a source of uncertainty in a
description of the disease process. The second aspect, time, is important because we
are often interested in making predictions, which means we have to understand the
dynamics of a process, how future states depend on the present and possibly past
states. Clinically, if we can predict disease progress, we can anticipate and adjust
treatment.
Chronic disease management with probabilistic models
In this thesis we will be focussing on the issues just described in the context of
chronic diseases, where especially time is a pertinent characteristic as chronic diseases
are by definition persistent. The disease that will feature throughout is chronic
obstructive pulmonary disease – which will often be abbreviated to COPD. This
chronic lung disease provides a concrete example of the challenges that in general
play a role in chronic disease management. One of the aspects of chronic disease
management is patient monitoring and the interpretation of the data resulting from
monitoring. As in the general case, uncertainty arises as a result of measurement
errors, incomplete knowledge of the underlying disease process or the inability to
measure certain aspects because of costs, both monetary as well as in terms of
patient well-being or simply convenience. The time aspect is a direct consequence
of monitoring patients for a prolonged period, resulting in longitudinal data, which
impacts how we can and should interpret these data. The chronic nature of the
disease naturally leads to such a situation.
To represent disease processes we use a class of probabilistic models called Bayesian
networks, which in essence are factorised representations of joint probability distri-
butions. Bayesian networks are a particular type of probabilistic graphical mod-
els, which represent relations between random variables in a graph. In the case of
Bayesian networks this is a directed graph which has the interesting property of facil-
itating a causal interpretation, where a direct causal influence can be represented in
the graph as an arc. Although it is not true in general that a Bayesian network has a
causal interpretation, in a clinical context it is useful to work with causal models as
it makes it easier to understand what the model means, without requiring a complete
technical understanding. The causal interpretation also facilitates hand-crafting a
model in cooperation with an expert, which can be augmented with data to estimate
the parameters.
The progressive nature of chronic diseases and the temporal data that result from
monitoring imply that it is necessary to take time into account in our models. Dy-
namic Bayesian networks are an extension of Bayesian networks for discrete time
processes, where the graph indicates relations between variables either as atemporal
using arcs as before or as temporal arcs to represent influences over time. This means
that the evolution of a process can be modelled in detail, which in turn can be used
to make predictions. In Chapter 2 we will consider these models in detail.
Alternative techniques exist that might have been used instead of (dynamic)
Bayesian networks. For example continuous time Bayesian networks [72] could have
been used to model the temporal process. However, discreet models are generally
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easier to interpret. Interpretability also provides a motivation for the choice to start
with a discreet hand-crafted model without explicit time information. Dynamic
Bayesian networks then form a natural generalisation, as they are in some sense just
a static model that is repeated over time, whereas continuous time requires a change
in representation to a distribution that can model time, for example an exponential
distribution. Another option would have been partially observable Markov decision
processes. Our choice for Bayesian networks was motivated by the desire to first
capture the nature of the disease process which does not yet involve decisions. It
may however be useful to reconsider partially observable Markov decision processes
to extend the disease model with decisions. We aimed to solve the problem of COPD
support in a practical manner, trying to develop a solution that can be applied in
the current health care environment. As a consequence decisions on what techniques
were used have not only been made on theoretical grounds but have also been in-
fluenced by considerations of practicality, for example the availability of software
implementations.
1.2 on ehealth
Computer assisted medicine has long been a topic of research in artificial intelligence
and later in medical informatics. One aspect of this broad field of research is what
is sometimes referred to as telehealth, or, telemedicine. One of the reasons for re-
search in remote healthcare is that it is seen as a way of possible cost reduction,
yet without sacrificing quality of care, which is one of the most significant current
challenges of healthcare. Examples of measures that try to achieve these aims in-
clude reduction of the number of face-to-face consultations in out-patient clinics and
prevention by detecting people at risk at an early stage and by providing guidance
to prevent costly hospital admission. These last points have become a topic of much
research under the denomination of eHealth (electronic health) and mHealth (mo-
bile health). Modern names for variations on the same general concept of facilitating
health care irrespective of location by means of technology. Concepts that are also
often mentioned in this context are patient empowerment and self-management, as
it is thought that eHealth solutions will enable patients to be more involved with
and responsible for their own health.
A very short history
Figure 1.1 offers a visual summary of the development of the field. In general we see
greater patient involvement combined with new technological advances.
A surprising, very early example of telehealth is the work by the Dutch physiologist
and Nobel prize winner Willem Einthoven, the developer of the electrocardiograph.
In 1905 he transmitted, via telephone wire, electric cardiac signals of a patient from
the hospital to his laboratory 1.5 km away to demonstrate the power of his ideas. The
next phase in telehealth was due to the development of the television in the 1950s,
which allowed a patient’s condition to be visualised at a distance. Telemedicine is
a term introduced in the 1970s to indicate the distance management of a patient’s
condition, and thus includes a treatment component.
From the mid-1990s on, when internet access and usage became widespread and
turned into the primary method for telecommunication, eHealth emerged as a prom-
ising field for better and more efficient healthcare delivery using web-enabled services.
The internet-based foundation of eHealth has been reflected in the majority of 51
definitions of eHealth, reviewed in [73]. In comparison to telehealth, eHealth is a
broader term and encompasses not only health services but also health information,
education and research. Evidence for the subsequent rapid growth of eHealth sys-
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Figure 1.1: Timeline development and general definitions of telemedicine, eHealth and
mHealth.
tems and tools is the development of a large body of systems to monitor patients’
condition, usually in the home environment, and enabling earlier diagnosis and more
effective treatment.
Many of the eHealth systems that are currently in use for patient monitoring are
limited to transmitting data to a physician or nurse for manual interpretation (see
e.g. [79] for a review of COPD telehealth). Alternatively, simple threshold detec-
tion is used to generate alerts. A more comprehensive view on different patient
characteristics is not yet common. It therefore appears worthwhile to study auto-
matic interpretation of monitoring data, taking multiple clinical factors into account,
represented in a disease model.
Now, before going into the challenges of chronic disease management and monit-
oring in particular, we first introduce the chronic disease that will be the main focus
of the clinical part of our research.
1.3 chronic obstructive pulmonary disease
Throughout this thesis we will consider specific examples of patient monitoring and
data interpretation in the context of chronic obstructive pulmonary disease. COPD
is a highly prevalent lung disease, that causes morbidity and mortality at significant
rates worldwide. According to the World Health Organisation [110], currently around
64 million people suffer from COPD. Prospects are that this number is yet to rise,
which makes it an important target for health care research.
COPD is caused mainly by inspiration of (tobacco) smoke, both actively or pass-
ively, and by exposure to severe air pollution. It is characterised by a combination
of chronic bronchitis – airway inflammation – and emphysema – destructive enlarge-
ment of airspaces – leading to airflow limitation that is not fully reversible. It is a
generally progressive disease that is currently not curable, but largely preventable
and with proper treatment, manageable [104]. The main symptoms are a result of
the chronic inflammation and airway obstruction and include dyspnea – difficulty
11
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Figure 1.2: Abstract representation of patients monitoring data characteristics.
with breathing – sputum producing cough and wheezing breath. Because of re-
duced lung capacity patients also often suffer from fatigue and are sometimes unable
to perform day-to-day activities due to shortness of breath. Clinical signs include
reduced lung volume – usually measured by the forced expiratory volume in one
second (FEV1) – blood oxygen saturation level and body temperature – as indicator
of airway infection induced fever.
The chronic and progressive nature of the disease make a case for monitoring
patients. This is especially relevant for the group of patients that have frequent
exacerbations – acute events of worsening of symptoms. Exacerbations play an
important role in the disease progression, have significant impact on patient well-
being and determine for a large part COPD related health-care costs [108]. Infection
with respiratory viruses and airway bacteria is one of the main underlying causes
of inflammatory reactions in the lungs resulting in the increase in symptoms of an
exacerbation. Monitoring for early detection of exacerbations is useful as prompt
treatment appears to lead to improved recovery and better health status [109]. In
addition, if hospital admission can be prevented this benefits patients and reduces
health-care cost.
1.4 patient monitoring data and reasoning
The following situation sketch gives an idea of the general clinical case of chronic
disease care and the challenges that arise, both theoretically and practically. In
Figure 1.2 a graph is shown with time on the horizontal axis and on the vertical
axis an abstract measure of health. This is a typical situation in chronic disease
management, where one tries to maintain patient health and react appropriately to
deterioration of health. The grey shaded area on the right indicates an episode of
health status decrease that requires intervention. The nature of monitoring data
results in a number of challenges.
• Measurement uncertainty
Data may contain measurement errors, or uncertainty may arise from lack of
knowledge about the exact relation between observable properties and the un-
derlying causal mechanism (depicted as vertical error bars on the data points).
• Data sparsity
It is often difficult to obtain sufficient data due to costs or inconvenience to
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the patient. Additionally, data may not be available at crucial moments (note
the lack of data points at the start of the shaded area).
• Irregular data acquisition
Taking measurements may not always be possible at regular intervals, which
may introduce time related confounding factors and complicates modelling the
process through time (illustrated by the dashed lines indicating time between
measurements).
• Temporal indeterminacy
The exact time of the measurement may be unknown. This can be caused by
a delay between measurement and registration or by failing to remember when
exactly something occurred, when asked about a past event (depicted by the
horizontal error bar).
• Heterogeneity
Clinical data are often of a diverse character. Some of the values will be
discreet, others continuous. Ranging from subjective symptom data to lab
results, they are not easily comparable. A related problem is that some of the
relevant variables may change on very different time scales.
To properly take these properties of the data into account, we need different
modelling techniques. Some of these aspects will be studied in more detail and
possible solutions will be developed.
1.5 outline of this thesis
In this thesis we report on the results of the Aerial project, in which a system has
been developed for COPD-exacerbation management. In addition more theoretical
work on representing uncertain temporal processes is presented. We now give an
overview of the chapters in this thesis and summarise their contributions.
Chapter 2: Preliminaries
In the next chapter a brief overview is given of some necessary technical preliminaries
on probability theory and probabilistic graphical models.
Chapter 3: An autonomous mobile system for the management of COPD
In this chapter the disease management system for COPD is described in detail. It
is shown how mHealth can be used to help COPD patients gain insight in their
disease through the use of disease models for automatic data interpretation. The
main contributions of this chapter are the identification of system requirements for
monitoring COPD patients at home, and the development of a prototype system
that satisfies these constraints. Our objective was to develop an mHealth solution
that enables self-management by means of decision support, requiring a means of
data acquisition that is sufficiently reliable and usable in an uncontrolled environ-
ment; and data interpretation that can handle uncertain and sometimes missing time
series information. The system implements data acquisition through a smartphone
application to gather subjective information and sensors for objective information.
Automatic data interpretation is performed by a Bayesian network that allows estim-
ating the probability of a COPD-exacerbation given the observations. The model
was constructed through knowledge elicitation from a pulmonologist. This model
does not yet take the temporal aspect into account, however this is addressed in
13
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Chapter 5. To our knowledge, a mobile system capable of automatic data inter-
pretation is a novel contribution to chronic disease management and COPD care in
particular. This chapter is based on [97]. My contribution consisted of the data
analysis and writing the paper.
Chapter 4: Automatic COPD-exacerbation prediction: findings from
a home-monitoring pilot study
In Chapter 4 our monitoring system is studied in a pilot study with COPD patients
from the target population of patients with frequent exacerbations. We showed that
the system is usable for COPD patients and that it records the required information
to assess patient health status. Based on the data that was gathered, the exacer-
bation prediction model turned out to predict, with high accuracy, gradual onset
exacerbations and detects rapid onset exacerbations at an early stage. This chapter
is based on [100]. My contribution includes a large part of running the pilot studies
and writing the paper.
Chapter 5: Learning Bayesian networks for clinical time series analysis
In this chapter an algorithm to learn a Bayesian network from a limited amount
of time series data that contain missing values is described. The relatively low fre-
quency of exacerbation events is the main cause of the limited availability of data.
The algorithm is applied to data gathered in the pilot study described in Chapter 4.
The contribution of Chapter 5 is a detailed study of temporal Bayesian networks
for exacerbation prediction, in comparison to static models. The result of structure
learning is compared to a temporal variant of naive Bayes and to the expert-opinion
based models constructed earlier. Also studied are techniques to overcome the prob-
lems due to the limited availability of data. This lead to dynamic Bayesian networks
learned via structural expectation maximisation and model averaged variants over
bootstrapped time series. Using dynamic Bayesian networks learned from sparse
data for clinical monitoring-data interpretation is a novel approach that appears to
work well according to a validation performed on an independent data set. This
chapter is based on [101]. My contribution was the data analysis and the main part
of writing the paper.
Chapter 6: Probabilistic reasoning with temporal indeterminacy
In this chapter it is studied how temporal indeterminacy can be represented within
the framework of Bayesian networks. Different assumptions on properties of inde-
terminacy are explored and an example in COPD monitoring is given. Although a
related problem of the discrepancy between measurement time and registration has
been studied for temporal databases, we here focused on modelling the temporal
uncertainty probabilistically. We showed that Bayesian networks can be used for a
representation at two temporal granularities, abstracting observations at a precise
granularity to a coarser granularity; and modelling different temporal patterns going
from a coarse granularity to a more precise granularity. This chapter is based on
[99]. My contribution consisted of theoretical development and writing the paper.
Chapter 7: A probabilistic logic of qualitative time
The main contribution of Chapter 7 is a general logic-based language capable of
expressing structural relations between events, probabilistic relations that capture
uncertainty and temporal aspects through the use of qualitative relations based on
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Allen’s algebra [4]. This probabilistic logic of qualitative time allows us to reason
about processes with uncertainty that evolve over time, of which the temporal in-
formation can only be specified partially. Clinically, this situation occurs frequently,
since the complexities of clinical situations often result in partial observability which
also manifests itself in not knowing the precise timing of events. We showed that
we can describe the COPD monitoring process within our language and that it gen-
eralises other frameworks like Temporal Nodes Bayesian Networks. This chapter is
based on [98]. My contribution includes theoretical development and writing the
paper.
Chapter 8: Discussion and conclusion
Finally, we discuss the main findings of this thesis in a more general context and
conclude with an outlook on the future.
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2
PREL IMINARIES
In this chapter we give a brief overview of some of the theoretical background of the
formalisms used in this thesis. In particular we describe the basics of probability
theory and probabilistic graphical models. As we could easily fill a book trying to
provide comprehensive preliminaries, we will assume some mathematical background
and limit ourselves to introducing some important concepts. References to more
comprehensive sources will be given in the text below.
2.1 probability theory
Probabilities are a standard way to formally describe uncertainties, viewed either
from a traditional statistical perspective as samples of some experiment that have
particular outcomes with some relative frequency; or from the Bayesian viewpoint of
degrees of belief of obtaining a particular outcome. Both interpretations have their
use in certain situations and we will use them somewhat interchangeably through-
out this thesis, although if pressed to take a stance a preference for a Bayesian
interpretation would surface.
We give a short overview of some formal concepts that will prove useful later on,
for a complete treatment see e.g. [41].
Definition 2.1. Let Ω be the sample space containing all possible outcomes of the
experiment; F , a set of subsets of Ω, the event space; and P a function P : F →
[0, 1], such that:
• P (∅) = 0;
• P (Ω) = 1;
• For any countably infinite selection of disjoint events e1, e2, . . . ∈ F
P
( ∞⋃
i=1
ei
)
=
∞∑
i=1
P (ei),
then the tuple 〈Ω,F ,P 〉 is called a probability space.
The last property is called countable additivity which simplifies to finite additivity
for discrete spaces:
P
( n⋃
i=1
ei
)
=
n∑
i=1
P (ei).
Usually it is more convenient to work with random variables than it is to work
directly with probability spaces.
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Definition 2.2. A random variable is a function X : Ω→ R, such that
{ω ∈ Ω : X(ω) ≤ x} ∈ F for each x ∈ R. The probability distribution of a random
variable is the function F : R → [0, 1] given by F (x) = P (X ≤ x). The following
distinction can be made:
discrete random variable A random variable which takes on a finite number
of values, for which the probability mass function is defined as the function
f : R→ [0, 1] given by f (x) = P (X = x);
continuous random variable A random variable for which F (x) =∫ x
−∞ f (u)du, with f (u) the probability density function.
As we deal mainly with discrete variables in this thesis, the following definitions will
be given for discrete variables and the similar definitions for continuous variables are
omitted.
For multiple random variables, the distributions can be combined in a joint prob-
ability distribution.
Definition 2.3. For a vector of random variables X = (X1,X2, . . . ,Xn) the joint
probability function is defined as f : Rn → [0, 1] given by f (x) = P (X = x) =
P (X1 = x1,X2 = x2, . . . ,Xn = xn).
The marginal probability distribution gives the probability of a single element from
X disregarding the other variables; and is defined as
P (Xi = xi) =
∑
x1,...,xi−1,xi+1,...,xn
P (x1, . . . ,xi, . . . ,xn). (2.1)
The probability of an event given knowledge of a related event is called the con-
ditional probability, which is defined in terms of joint and marginal probabilities for
disjoint sets of variable X,Y :
P (X = x | Y = y) = P (x | y) = P (x, y)
P (y)
, (2.2)
for P (y) > 0. Often it is useful to write the joint probability in terms of conditional
probabilities, which also shows the symmetry of x and y:
P (x, y) = P (x | y)P (y) = P (y | x)P (x). (2.3)
This decomposition of the joint probability can be performed recursively, which is
known as the chain rule of probability:
P (x1,x2, . . . ,xn) =
n∏
i=1
P (xi | xi+1, . . . ,xn). (2.4)
By rearranging terms in Equation 2.3 we obtain Bayes’ rule:
P (x | y) = P (y | x)P (x)
P (y)
, (2.5)
after the 18th century mathematician Thomas Bayes. Bayes’ rule, also called Bayes’
theorem, can be explained by taking x to be a hypothesis and y observed data per-
taining to the hypothesis; the theorem states that the probability of the hypothesis
given the data is equal to the likelihood of the hypothesis P (y | x) times the prior
belief in the hypothesis P (x) normalised by the evidence, the probability of the data,
P (y).
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2.2 probabilistic graphical models
Probabilistic graphical models graphically represent (conditional) independence re-
lations between variables. Two sets of variables X,Y are said to be conditionally
independent given Z, denoted X ⊥⊥P Y | Z, if
P (X | Y ,Z) = P (X | Z).
Bayesian networks
In this thesis we will focus mainly on a specific class of models called Bayesian
networks [75].
Definition 2.4. A Bayesian network is a pair BN = 〈G,P 〉, with G a directed
acyclic graph and P a probability distribution. The graph G = 〈V ,A〉 consists of
a set of vertices V , corresponding one-to-one with random variables X, and arcs
A ⊆ V × V representing relations between the variables. Let X ∈ V be a variable
and pa(X) the parents of X in G. The distribution P is specified by a conditional
probability distribution for each X ∈ V , of the type P (X | pa(X)).
A Bayesian network represents the joint distribution over a set of random variables
X, which are represented by the vertices in the graph G. An important feature of the
graphical representation of a Bayesian network is that the graph is an independency
map (I-map) which means that the independences implied by the graph also hold in
P (X). That is,
X ⊥⊥G Y | Z ⇒ X ⊥⊥P Y | Z,
where in a directed graphX ⊥⊥G Y | Z can be established with the graphical criterion
d-separation (see e.g. [75]). As the graph implies conditional independences, the joint
probability can be factored according to the graph, as follows:
P (X1,X2, . . . ,Xn) =
n∏
i=1
P (Xi | pa(Xi)), (2.6)
where the Xi ∈ X denote the random variables represented in the graph G.
Dynamic Bayesian networks
A dynamic Bayesian network [28, 69] is an extension of a Bayesian network to a
distribution over a sequence of random variables, which is particularly well suited
to representing time. A dynamic Bayesian network, DBN henceforth, represents a
Markov process:
X1 → X2 → · · · → Xn → · · ·
where Xt represents a random variable at a particular moment in time t. A hidden
Markov model, an often used model for such a sequence, is a special case of a DBN.
The joint distribution can be decomposed using the chain rule, writing X1:T for
X1, . . . ,Xt, . . . ,XT :
P (X1:T ) = P (XT | X1:T−1)P (X1:T−1).
In general a DBN is a factorisation of a probability distribution, like its atemporal
counterpart. That is in the sequence above, each Xt can be represented as a BN
that factorises the probability distribution over the values of the random variable
Xt. This BN is called a time slice and relations between time slices can be modelled
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by introducing arcs in the graph between random variables in different time slices.
A DBN factorisation can then be written as:
P (X1:T ) =
∏
t
∏
i
P (Xt,i | pa(Xt,i))
where i indexes variables within a time slice and pa(X) denotes the parents of X in
the graph.
A common assumption is that there is only a limited time frame that influences
the current state of the process. Assuming a nth-order Markov process we obtain:
P (X1:T ) = P (XT | XT−1:T−n)P (XT−1:T−n)
When only limited data is available, it is common to make the most restrictive
version of the Markov assumption, that is first-order, such that the future state of
the process only depends on the present:
P (Xt+1 | X1:t) = P (Xt+1 | Xt).
Hence all parents of a variable X will be in the same time slice or in the previous
time slice. When we now also assume the process is stationary, that is P (Xt,i |
pa(Xt,i)) = p for all t, we obtain a two-slice DBN consisting of an initial network
BN0 and a transition network BN→. A process through time can now be modelled
by a sequence of repetitions of transition networks.
2.3 model learning
Bayesian networks can be constructed by hand on the basis of domain knowledge.
Causal knowledge can be used to structure the graph while the parameters can be
estimated from facts available in the literature or directly by a domain expert. This
is however a time consuming process, and depending on the size of the domain may
or may not be feasible. The model reported in Chapter 3 is constructed with expert
knowledge. The alternative is a statistical approach to the problem: learning a model
from data. There are multiple ways in which data can be used in model construction:
parameter estimation in a model with predetermined graph structure; full model
learning of both structure and parameters. Here we give a brief overview of some
notions related to model learning, Chapter 5 provides a fairly detailed description
in the context of Bayesian networks.
2.3.1 Parameter learning
The essence of learning parameters is finding the maximum likelihood estimate, or
the Bayesian equivalent of finding the posterior distribution over the parameters.
Given data D the maximum likelihood estimate of parameters θ is:
θˆ = argmax
θ
P (D; θ). (2.7)
The maximum likelihood parameters are those parameters that best describe the
data. For example, if we take a binary random variable X and sample N identically
and independently distributed data points, the maximum likelihood estimate of the
parameter θ of the Bernoulli distribution f (k; θ) = θk(1− θ)1−k is the expectation,
1
N
∑N
i=1 I(X = 1).
Maximum likelihood estimates work well when large amounts of data are available.
In practice we may not have sufficient data, in which case maximum likelihood can
be unreliable. For example, the estimate of the bias of a coin that is in fact fair θ = 12
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from three tosses that happen to land heads is θ = 1. Although this can be alleviated
with smoothing to obtain θ = 3+13+2 = 0.8 where we used Laplace smoothing, also
known as add-one smoothing, a Bayesian approach allows one to incorporate prior
knowledge explicitly. In this case we could assume that in fact the coin is fair. The
Bayesian parameter estimate is given by:
P (θ | D) = P (D | θ)P (θ)
P (D)
, (2.8)
by Bayes’ rule, where P (D | θ) is the likelihood and P (θ) the prior distribution over
the parameters.
The Bayesian perspective has the advantage that we can start from a sensible dis-
tribution on the basis of expert knowledge or from a uniform prior when no specific
information is available. As Equation (2.8) shows the result of Bayesian parameter
estimation is a distribution over the parameters instead of a point estimate, essen-
tially modelling the uncertainty in the estimate. Sometimes a point estimate is also
used in the Bayesian case; the maximum a posteriori estimate is maxP (θ | D),
which is different from the maximum likelihood estimate as it is weighted by the
prior distribution.
One of the problems with learning parameters from data is missing data values,
which often occur in practice. If values are missing for reasons independent from what
we are measuring this is called missing completely at random (MCAR). In this case
the estimate is unbiased if we compute it from the available data. Unfortunately
missing values are seldom MCAR, instead the missingness is correlated with the
values of other variables, which is called missing at random (MAR). If it depends
on the value of the variable itself whether it is missing this is called not missing at
random (NMAR), which introduces a bias in the estimate. Most learning algorithms
assume data is missing at random, which is not always warranted, but works fairly
well in practice.
The process of filling in missing values is called imputation. A simple approach
is replacing a missing value with its mean, which is unbiased for a single variable.
In general for multivariate estimation the correlations of the missing values with
other variables should be taken into account to obtain reliable estimates. One ap-
proach is multiple imputation, where different data sets are generated with some
(nondeterministic) imputation method and the final result is averaged over the data
sets. The expectation maximisation algorithm [31] is an iterative procedure to es-
timate parameters from data with MAR-values. In the expectation step the current
estimate of the parameters is used to compute the posterior probability over the miss-
ing values. The probabilities are interpreted as fractional counts when computing
the sufficient statistics and subsequently the maximisation step finds new paramet-
ers based on the sufficient statistics. This is repeated until the estimates converge.
See also Chapter 5.
2.3.2 Structure learning
A Bayesian network structure implies certain dependences and independences between
variables. There are two main approaches to the problem of learning network struc-
tures: constraint based methods and score based methods. Constraint based meth-
ods try to directly test whether variables are independent with a series of statistical
independence tests. This works well if the data satisfies the criteria of the test. Espe-
cially for small data samples criteria like normality may not hold in which case score
based methods might be preferable. Structure scoring relies on some measure over
network structures and a Bayesian approach then leads to the probabilistic score
P (G | D) ∝ P (D | G)P (G),
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which is the posterior probability of the graph structureG given the dataD. Comput-
ing the likelihood term P (D | G) requires learning the parameters. As the number of
possible graph structures grows exponentially with the number of variables, it is for
most realistic domains not possible to search exhaustively. Instead a greedy search
is used that adds, removes or reverses the direction of an arc in each step, choosing
the operation that improves the score the most.
Greedy search procedures have the disadvantage that finding the optimal solution
is not guaranteed, although restarting the search from different initial configurations
helps cover the search space. In general it depends on the kind of problem and
amount of data whether the optimal network can be found. Structure learning
from data with missing values is a particularly difficult task because to estimate the
missing values correlations have to be taken into account. In Chapter 5 we address
some of these issues. A detailed account of learning Bayesian networks from data is
given in [57].
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AN AUTONOMOUS MOBILE SYSTEM FOR THE
MANAGEMENT OF COPD
3.1 introduction
Increasing demands on health-care and continuous pressure from health-care author-
ities and insurance companies to reduce costs while maintaining quality of care has
created a situation in which automation of particular parts of the patient’s care pro-
cess has attracted attention. Especially the provision of computer-aided assistance
in the management of the patient’s diseases is an attractive option. In the context of
chronic diseases, patients are continuously at risk of deterioration of health, requiring
regular medical checkups and monitoring of their health status by the treating med-
ical doctor. Providing computer-aided support to the patient can relieve work-load
of health-care workers, while helping patients self-manage their disease. However,
the provision of computer-aided support to patients poses questions with respect
to whether or not patients are able to profit from the support, how the patient
data needed for that purpose can be collected and interpreted, and which technical
infrastructure is most effective.
The idea to offer computer-aided support to patients at a distance from the treat-
ing hospital or practice is not new. Remote care facilitated by telecommunication
technology has existed for some time already under different names such as: ‘tele-
health’, ‘telemedicine’ and more recently ‘eHealth’ (electronic health) and ‘mHealth’
(mobile health). The exact scope and definition of all these terms varies, as exempli-
fied by the review of Oh et al. [73] that identifies 51 definitions of the term ‘eHealth’.
Although different definitions will place different emphases we can summarise the
definitions as facilitating health care irrespective of location by means of technology.
Practically speaking this means that information and communication technology as-
sists in disease management, patient-doctor communication, patient education or
any other application that promotes health.
The research described in this paper aimed at developing methods for computer-
aided assistance, including event detection, alerting, monitoring and treatment ad-
vice, as part of chronic disease management at a distance from the hospital. Pa-
tients with diseases such as diabetes mellitus, chronic obstructive pulmonary disease
(COPD), asthma and heart failure can benefit from assistance. We have applied
it here to assist COPD patients, but the general framework is applicable to many
other health-care situations. For COPD we collect data on respiratory symptoms,
measure lung function and interpret these data by a probabilistic model to assess
the risk of a clinically relevant worsening of symptoms due to an exacerbation.
The main challenge addressed by the research was to develop a computer-aided
disease management framework that allows finding a proper balance between self-
management by the patient and support in various forms by health-care workers.
This depends on the patient’s demands and wishes, the disease being managed and
the requirements of health-care workers. One of the implications of the resulting
requirements was that disease-related patient data had to be interpreted automatic-
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ally as part of the patient’s self-management support. The system had to be capable
of delivering autonomous assistance in disease management without being intrusive.
Hence we decided for data monitoring and interpretation directly on a smartphone.
Thus, the smartphone became the device of choice, enabling instant feedback to the
patient. To cover the whole spectrum from complete self-management to distance
support by health-care workers, collected patient data can also be relayed to health-
care providers through a central server for both disease management configuration
and inspection.
Use of a smartphone makes it possible to forego the need for a personal computer
(PC) with internet connectivity. This has the advantage that whereas most people
are used to responding to phone alerts, sending reminders via email or a website
may have little effect on the patient’s behaviour. This is also very much in the spirit
of health care that is no longer tied to a particular location.
If we compare this to usual care we see that patients have regular but fairly
sporadic contact with their physician unless there is an acute reason for an unsched-
uled visit. Our system is capable of advising patients to take measures at an earlier
stage than usual and enables easier communication between patients and health-care
providers. Although parts of what the system provides has been used before in the
context of eHealth or decision-support systems meant for health-care workers as user,
the idea to place both healthcare users and workers on an equal footing by offering
patients sophisticated, mobile decision support is new. The more common eHealth
systems are mainly focussed on sending small sets of measurements from the patient
to health-care providers, who still have to interpret these findings [67]. In the sys-
tem described below, clinical knowledge is incorporated by means of a probabilistic
graphical model in the smartphone, making it possible to provide relevant clinical
advice automatically, to assist in patient self-management.
The following questions are explored in the rest of the paper. It is investigated
in what way patients can be empowered with disease management assistance to pre-
vent exacerbations of COPD. Another relevant question is whether it is feasible to
automatically interpret monitoring data by probabilistic models to detect clinically
relevant events. This question is explored by means of statistical model validation
methods. As a prerequisite we examine choices with respect to the important fea-
tures of the disease management system in terms of hardware and software. Finally,
the usability of the system was investigated with the help of COPD patients. Sum-
marising, we report on a system for COPD exacerbation management, that has the
novel feature of including automatic data interpretation by a probabilistic risk model,
enabling autonomous operation to support patient self-management.
In the next section, we start with some background on the clinical problem ad-
dressed in the research. Then the architecture of the disease management system is
described in Section 3.3, focussing on its design and technical capabilities. Further-
more we report on a pilot study that investigates technical and clinical feasibility
with a number of patients. The probabilistic model that is used for data interpret-
ation is explained and evaluated in Section 3.5. Then in Section 3.6 we compare
our system with telemonitoring requirements laid out by Peirce et al. [78] and with
existing work on COPD telehealth, followed by a general discussion in Section 3.7.
3.2 chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, or COPD for short, is a chronic lung disease
with high impact on patient well-being and with considerable health-care related
costs [104]. Exacerbations – acute events of worsening of COPD-related health status
– are important events in the progression of COPD, such that monitoring patients
in a home setting to detect exacerbation onset may be warranted [66]. In this paper
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we focus on disease management and specifically on detecting and managing the
occurrence of exacerbations of COPD at an early stage. We aim to decrease the
impact of COPD on the patient’s quality of life, and prevent unscheduled doctor
visits and hospitalisation due to exacerbations.
Chronic obstructive pulmonary disease is estimated to affect some 64 million
people worldwide [110] and is one of the major chronic diseases in terms of both
morbidity and mortality. COPD affects the respiratory system, decreasing lung capa-
city and obstructing airways, thus interfering with normal breathing. Patients often
suffer from a combination of emphysema and chronic bronchitis, causing shortness
of breath and therefore reducing their capability of performing day-to-day activities.
The main cause of COPD is prolonged exposure to tobacco smoke; other causes
include severe air pollution. COPD is currently not curable, but treatment does re-
duce the burden considerably. For further information on COPD see e.g. the Global
Initiative for Chronic Obstructive Lung Disease (GOLD) [40].
An important aspect of COPD which is particularly relevant in the present context
is the progressive nature of the disease. Specifically exacerbations have a profound
impact on the patient’s well-being and on health-care costs [104]. These exacerba-
tions are mainly caused by airway infections resulting in symptom worsening [108].
Important to note is also that patients with frequent exacerbations usually have
faster disease progression, which makes exacerbation prevention a particularly relev-
ant goal. Additionally, a faster treatment response to exacerbations leads to better
recovery [109]. We can distinguish different clinical approaches to defining exacer-
bations. Due to limited observability it is not feasible to give a practical definition
in terms of pathophysiology, hence exacerbations are usually defined as an increase
in symptoms; in terms of use of medication; or in terms of unscheduled health care
use. We will return to this point in Section 3.5.
The state of the respiratory system is observable via symptoms including dyspnea
(breathlessness), productive cough, wheezing breath and decreased activity due to
breathlessness. Besides these symptoms a number of physiological signs are relevant,
in particular the forced expiratory volume in 1 second (FEV1) and blood oxygen
saturation. FEV1 measures airway obstruction by testing to what extend the pa-
tient can overcome obstructive and restrictive resistance during forced exhalation.
A number of other indicators of deterioration exist, like blood oxygen pressure, in-
flammatory proteins and white blood-cell counts. However, measuring these factors
requires hospital-grade equipment and incurs considerable inconvenience for the pa-
tient. Blood oxygen pressure can be observed by proxy with a pulse-oximeter that
measures blood oxygen saturation.
3.3 remote disease management
The long term nature of COPD and associated exacerbation risk require that any
system, deployed in a home-care setting, takes into account not only efficacy, but
also usability as important factors in the design. This section describes the current
system design, the choices we made and some of the issues that arose during the
development and implementation.
3.3.1 System overview
general architecture In Figure 3.1 a graphical representation of the gen-
eral idea behind our disease management setup is shown. The system consists of
a smartphone as the main component taking care of communication and computa-
tion. Sensors are used to obtain objective information on the patient’s health status,
transmitted wirelessly to the smartphone. Questionnaire data is collected from the
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Figure 3.1: Schematic of the system setup.
patient on the smartphone. A web-based system allows scheduling tasks and collect-
ing patient data centrally. The web-centre receives the data from the smartphone
and provides data access for health-care workers. Patient data are interpreted in
the smartphone by means of a disease-specific probabilistic model that incorporates
clinical variables considered relevant by a clinical specialist.
the copd-specific system The system we used for COPD management is
a specific instantiation of the general system just described. For COPD we were
interested in measuring lung function and blood-oxygen levels to complement the
recorded clinical symptoms. To do so we employed a sensor interface that took care
of the Bluetooth communication and to which a micro-spirometer and pulse-oximeter
were connected.
Before going into more detail on the various components let us first describe the
monitoring process. At regular intervals, adjustable in frequency and in time of the
day, the patient gets an automatic reminder for data entry from the smartphone.
The patient is presented with a simple touch-interface to answer a set of questions
about COPD symptoms and is subsequently asked to perform a spirometry test and
pulse-oximeter measurement. The results of the measurements are transmitted to
the phone, and entered in a Bayesian network model to determine the probability of
an exacerbation. In addition, the data is synchronised with the web-centre, which
allows the responsible health-care workers to examine the patient data; depending
on the situation this may be a nurse specialised in lung diseases, general practitioner
or pulmonologist. If necessary, the patient can be advised to take action, based on
the model’s prediction.
Monitoring patients for relapse or a new occurrence of exacerbation provides valu-
able additional information compared to usual care, as exacerbations are often un-
derreported, with patients only contacting their physician when the exacerbation is
already quite severe. For the population of patients with regular exacerbations, this
intervention provides a means for the patients themselves and for health-care profes-
sionals to stay better informed on the patient’s health status and to act accordingly.
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3.3.2 Design considerations
We now discuss a number of design issues that are relevant for automatic disease
management. Although we focus on the requirements for our COPD system, these
points also have more general value for similar systems.
population Chronic disease management is by its very nature a long term effort,
which makes it particularly important to find a careful balance between costs and
benefits. The intrusiveness of monitoring systems and costs, both monetary and in
terms of patient time investment, require a precise definition of the target population.
We argue that those that stand to gain the most from our COPD system are the
patients with moderate to severe COPD and frequent exacerbations (more than 2
per year). These patients suffer greatly from the consequences of exacerbations,
hence providing regular data to detect exacerbations in an early stage will in general
be more acceptable. The most appropriate time to start the intervention would
be directly after emergency treatment, because at that time the goal of preventing
hospitalisation is clearly relevant for the patient. To increase the chance of success in
general, psychological factors associated with intervention acceptance and technology
acceptance in particular should be taken into account when introducing a disease
management system.
security The system can operate autonomously in which case no data is trans-
mitted. If data is communicated to health-care providers, all data transmission from
the smartphone to the server is encrypted (HTTPS) to protect the privacy sensitive
nature of the data. Also access-rights to the data in the web-centre are controlled
and patients should give prior consent. Since these are general issues when working
with patient data, we will not focus on them here, but they remain important.
usability & instruction Ease of use is a critical requirement for any system
that has to be used on a regular basis for a prolonged period of time. Since the
interval between exacerbations is usually in the order of months, one should take
care to reduce patient effort to a minimum, lest patients would stop entering data
due to it being inconvenient. The patient population is relatively old on average –
possibly not very experienced with the kind of technology offered – hence to facilitate
understanding the system provides the ability to do practice runs. Nurses will have
a supportive role in training patients. Specifically, at the start of the monitoring
process, the nurse will enter the relevant information in the web-centre and instruct
the patient on the use of the smartphone and sensors. A practice run serves to check
whether the process has been understood and also provides baseline measurement
values. In addition to the verbal instructions, the patient receives a written step-by-
step instruction for reference. Our initial tests showed that a written instruction may
be insufficient and therefore visual instructions, for example with screen captures of
the phone, should be provided as well. As nurses are often just as pressed for time
as physicians and also cannot be expected to be experts on the technicalities of the
system, we provided a support phone-number for both patients and the nurses to
assist in resolving any problems they might have. When introducing technology,
especially to older patients, instruction by example appears to be preferable to only
written instructions.
data collection rate Depending on the health status of the individual pa-
tient the rate of data acquisition can be varied, which can be automated based on
the acquired data and the model. As long as a patient has low risk of an exacerba-
tion, monitoring can take place on a weekly basis, keeping the time investment at a
minimum. If a patient is at risk according to model predictions, the system check-in
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can be scheduled daily to ensure the possible exacerbation is detected and acted
upon appropriately. A week between registrations may however be too long as an in-
fection can develop in a matter of days, which means that unscheduled registrations
are also an important part of the monitoring process. To facilitate self-management,
it is important that the patient is in control of the registration schedule and can
initiate registrations in addition to the predefined schedule. In this way patients can
check their probability of exacerbation (appropriately visualised) when they feel they
might be at risk. Eventually, this would hopefully lead to patients who no longer
need our supporting technology, instead being able to decide by themselves when to
contact their physician. The system, thus, has a dual role, providing information
to the patient and health-care workers and helping the patient assess their COPD
related health status, for better control over their disease.
sensor data reliability One of the critical points in the current system is the
lung function measurement, which provides objective data to augment the subjective
symptom data. Whereas oximetry is a simple manoeuvre clipping the sensor on
your finger and waiting for a few seconds, spirometry is harder to perform well. In
a home-care setting there is a risk of obtaining little useful data. Although patients
that would use our system are diagnosed with COPD and therefore have to perform
regular spirometry tests, it remains of paramount importance to properly instruct
the patient at the start of the intervention. To adhere to the spirometry standards
the FEV1 measurement is performed thrice and the best value is used. For the sake of
usability we do not continue until three successful measurements have been made, as
this would raise the bar unrealistically high. A reduction of the problem comes from
the fact that we only take FEV1 into account which is easier and far less strenuous
for the patient than measuring forced vital capacity (FVC), as is customary in lung
function testing, and requires complete exhalation. In general, the reliability of all
data that is gathered should be considered. Sensors can provide objective data only
when they are sufficiently reliable.
feedback A further consideration is the kind of advice that the system should
provide based on the model prediction of exacerbation risk. Typical advice would
be to contact the physician, but a useful next step would be to advise, for example,
to increase the dosage of bronchodilator drugs, corticosteroids or to start with anti-
biotics. The exact implementation of different kinds of advice should be decided in
cooperation with clinicians, in accordance with clinical guidelines. We return to this
point in Section 3.7.
3.3.3 Hardware components of the disease management system
Smartphone
Currently our system runs on an HTC Desire smartphone as an application in the
Android OS. In principle any Android phone with Bluetooth capability should suffice,
which makes the platform fairly general. If available the fast 3.5G HSDPA connection
was used, but due to the use of asynchronous communication and the relatively
limited amounts of data being transmitted, data can also be transmitted to the
central server when only a slower 2G GPRS connection can be realised. Recall that
the self-management part of system also functions without any server connectivity
at all.
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Figure 3.2: The monitoring kit consisting of a smartphone, sensor interface and sensors.
Sensor interface
The phone communicates with the sensors via a Mobi, a Bluetooth-capable mul-
tichannel sensor-interface, from Twente Medical Systems International. In our case
a Nonin pulse-oximeter and a custom micro-spirometer were connected to the Mobi.
An important advantage of using the Mobi sensor interface is the availability of the
communication-protocol specification, enabling us to integrate the sensor readings
seamlessly into the Android application. Most of the other micro-spirometers on the
market do not allow this, which makes them unsuitable for easy deployment in a
home setting. The monitoring kit is shown in Figure 3.2.
Pulse-oximeter
The pulse-oximeter used in this study was a Nonin Medical 8000AA, which is an
industry standard pulse-oximeter. SpO2 accuracy is 70-100% ±2 digits.
Spirometer
We used custom-made pneumotachograph micro-spirometer prototypes by Twente
Medical Systems International. These spirometers were newly developed to interact
with the Mobi sensor interface and have the advantage of providing raw data such
that analysing the spirometer readings is possible without requiring external software.
This enables tight integration with our application, which is difficult or impossible
with most commercial spirometers on the market.
Measuring raw spirometric data requires that we do some signal processing. The
raw data signal is processed on the smartphone to obtain FEV1 values, i.e. forced
expiratory volume in 1 second. In Figure 3.3 a schematic spirometric flow-curve is
shown. The shaded area is the FEV1, which is computed from the raw data by first
determining the peak of the curve, then finding the lowest point in the half second
prior to the peak and integrating the flow during one second from there.
3.3.4 The Aerial application
As the project in which the intervention was developed was called Aerial, the smart-
phone application inherited the same name. Android applications are written in
Dalvik, a programming language that uses Java syntax, but is compiled to run on
the Android OS without the Java Virtual Machine. The application provides the
following functionality: a timed alarm to signal the registration, with on-screen but-
tons to delay the start of the registration; a touch-screen interface for the question-
naire, which consists of 8 yes/no questions (see Table 3.1); on-screen instructions for
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Figure 3.3: Schematic depiction of a spirometric flow-curve. Shaded area indicates FEV1.
Since the last registration, did you have dyspnea worse than usual?
Since the last registration, did you have more sputum than usual?
Since the last registration, did you have sputum of a different colour than usual?
Since the last registration, did you cough more than usual?
Since the last registration, did you have more wheezing breath than usual?
Since the last registration, were you limited in performing day-to-day activities due to COPD?
Since the last registration, did you have a feeling of malaise?
Since the last registration, did you have a fever?
Table 3.1: Monitoring questionnaire. All on-screen text was in Dutch and has been trans-
lated to English for ease of exposition.
performing the measurements and Bluetooth communication with the Mobi sensor-
interface to receive the measured data; processing of the spirometry data to compute
the forced expiratory volume in 1 second (FEV1); computation of the probability of
an exacerbation based on the observed data (see also the section on the Bayesian
network and model implementation below); asynchronously transmission of the ob-
served data to the server over a secured data connection. In Figure 3.4 screen
captures are shown of the alarm screen and of the question about cough.
3.3.5 Risk model
The main component of our system is the probabilistic risk model. Based on the
data that is gathered, the model can compute the probability of an exacerbation.
The model we use is a Bayesian network [75, 57]; Section 3.5 is devoted to the
description of the development and evaluation of this model. The Bayesian network
has been implemented using the lightweight reasoning engine EBayes [24]. Since
EBayes is written in Java the model inference could easily be integrated in the
Android application. Due to the relatively small size of the Bayesian network and
the processing power of modern smartphones, the inference does not have to be
deferred to a server but can be performed on site. This has the advantage that even
when mobile phone network coverage is suboptimal the application can still provide
a probability estimate and accompanying advice. Recall that this capability is also
in line with our aim of patient empowerment as mentioned in the introduction.
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Figure 3.4: Screen captures of the application start screen at registration time and the
question about cough.
Figure 3.5: A screen capture of the patient administration web-interface.
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3.3.6 Web-centre
The web-centre is the administration web-application that was built using the work-
flow management system iTasks [61]. The workflow system implements advanced fea-
tures to generate and coordinate tasks and provides a generic (web)interface. Since
the data management involved with patient monitoring is suitable to be represented
as a workflow, iTasks provides a simple and effective way to construct the web-centre.
In Figure 3.5 an impression of the web-centre is shown. Shielded by a secure login
and different levels of access rights, the web-centre provides a workflow to enrol
patients in the system as follows: first a user account is made with a registration
number as identifier; the regular registration schedule is established in consultation
with the patient; and a monitoring kit is assigned to the patient; then a practice
registration can be performed (registrations are scheduled on the server; the smart-
phone regularly polls for new messages from the server but can also be forced to
synchronise manually), of which the measurement results can be saved as baseline
values; finally a start date and time for the registration schedule can be chosen. In
addition, the web-centre has basic administration functionality to manage users and
monitoring kit assignment as needed in research projects. Importantly, all the data
received from the phone can be made available for inspection by the relevant health-
care workers, thereby offering a means to stay apprised of the patient’s health staus
that is not available in usual care.
3.4 technical feasibility and usability pilot study
Normally, there is a long way to go between the development of a prototype system
and its actual use within a health-care setting. The involvement of patients in the
development of a system is of crucial importance to improve a system based on their
feedback and to ensure that the system meets the requirements.
We performed a system evaluation with a limited number of stable COPD patients
recruited from the University Centre for Chronic Disease Dekkerswald in Groesbeek,
the Netherlands, mainly to ensure that they were able to use the system effectively.
We tested the monitoring equipment and data entry procedures with help of the
patients and also studied the usability of the system from a patient’s point of view.
3.4.1 Methods
For this study 5 stable patients were recruited by a convenience sample from the
lung rehabilitation program who gave informed consent to participate in the study.
Using three exacerbation monitoring kits (as described in Section 3.3) patients were
monitored for a duration of 9 days, starting in January 2011. Patients were contacted
daily during this time to answer a set of questions and perform spirometry and
oximetry measurement. The answers were entered as evidence into the Bayesian
network model to determine the probability of occurrence of an exacerbation. These
predictions have not been used for patient advice yet, as further model validation
is required. Patients were asked to report malfunctioning which together with the
received data and server-logs could be used to verify system performance. At the end
of the monitoring period a semi-structured evaluation interview was held – both with
the patient and with the health-care staff involved – to obtain qualitative feedback
on the usability of the system. In the interview we established whether or not the
patients understood the procedure and the questions and whether they found the
phone-interface sufficiently usable. Also, we checked anomalous data we received (if
any) and asked for suggestions for improvement. The evaluation results of the first
2 patients were used to improve the system before starting with the second group.
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As this was a technical feasibility test, the clinical data obtained were only used to
check for errors in the application or obvious model inaccuracies.
3.4.2 Results
The pilot study allowed us to identify some problems in the server-side software,
for example with respect to adequately recovering from connection errors, which
could be amended relatively easily. After these amendments, the system functioned
adequately at the technical level. With respect to usability, some problems became
apparent at an early stage, such as the response buttons being placed too close
together for comfortable use and an unclearly worded question resulting in confusion.
In the evaluation interviews that were carried out with the patients the consensus
was that the system could be useful to gain insight in the disease, was easy to use
and not found to be intrusive. In particular patients indicated that they would be
willing to use such a system in a home-care setting, which will need to be verified
more rigorously in the next research stage. Thus, the patients’ impression of the
system after using it was quite positive and made us confident that the current
system offers a suitable basis for moving toward a commercial product.
3.5 a probabilistic model for the detection of copd exacerbation
The conclusion reached above, that the system was suitably functioning from a
technical point of view, leaves the question unanswered whether it is also sufficiently
accurate for predicting exacerbations, the ultimate aim of the development of the
system. This question is addressed below.
3.5.1 Bayesian networks
For the data interpretation to detect exacerbations we use a Bayesian network
[75], i.e. a probabilistic graphical model represented as a pair BN = (G,P ). Here,
G = (V ,A) is a directed acyclic graph consisting of vertices V , corresponding one-to-
one to random variables of interest, and arcs A ⊆ V × V , representing dependencies
between variables. Furthermore, P is the quantitative part, denoting a joint probabil-
ity distribution, specified in terms of a family of conditional probability distributions
of the form P (V | pa(V )), that is the probability that V takes on a specific value
given the values of its parent variables. The network represents the joint distribution
over the random variables, which can be factored according to the independences
represented in the graph, resulting in:
P (V1,V2, . . . ,Vn) =
n∏
i=1
P (Vi | pa(Vi)),
where Vi ∈ V is the representation of a random variable in the graph G. Probabilities
of interest can be computed from this joint probability. In this case we are mainly
interested in the probability of an exacerbation given the evidence obtained from
monitoring.
Although other probabilistic models, such as based on logistic regression or arti-
ficial neural networks, could have been used for detecting exacerbations in patients,
Bayesian networks appeared to be the most suitable method for our research. The
main reason is their inherent flexibility, as it is possible to develop Bayesian networks
from expert knowledge only, whereas learning of parameters and structure from data
is also an option [63]. This is a necessary feature because of the ironic situation that
although COPD is a very common disorder, there is currently not much patient data
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available from which probabilistic models can be learned. This is caused by the early
stage in which much of the eHealth research still is; few researchers have tried to
monitor sufficient number of parameters of a sufficient number of patients at home
in a sufficiently frequent way, e.g. more than once every week.
Bayesian networks also support reasoning about individual patients: although the
model describes general relations between the variables of interest, all predictions
are personalised by entering patient-specific data. The model is thus capable of
making predictions for individual situations, and can provide ‘what-if’-predictions
by entering virtual evidence. Furthermore Bayesian networks are able to provide
probability estimates given partial patient data.
3.5.2 A Bayesian network for COPD
For our COPD models, the main outcome variable is exacerbation, focussing on a
symptom based definition. But the nature of a Bayesian network allows us to easily
inspect probabilities for any variable. The network contains two hidden variables,
namely infection and lung function which cannot be observed directly, but whose
values can be derived based on indirect measures, such as body temperature for infec-
tion and the forced expiratory volume in 1 second (FEV1) for lung function. Other
important variables are the symptoms that one might expect a patient to report, such
as dyspnea (breathlessness), sputum volume and purulence, cough, wheeze, general
malaise, fever, and whether performing daily activities is difficult due to COPD. Ad-
ditionally, the clinical signs FEV1 and blood oxygen saturation (SpO2) are included.
Other signs and lab results are not included as these are generally not available in
a home-care setting. All variables except for FEV1 are binary and either encode
presence or absence, or normal or abnormal states, which should be interpreted in
comparison to the individual patient’s baseline values. As FEV1 is an important,
objective measure it has 5 states: ‘Normal’; -10%; -20%; -30%; <-30%; this division
is based on expert opinion but would perhaps be represented more naturally as a
continuous variable (as volume is clearly continuous), which requires appropriate
continuous data.
Expert knowledge model
The goal of using expert opinion to construct the model was to obtain an under-
standable clinically justifiable model, in the absence of sufficient data that would
allow learning the structure from the data. The contrast with a purely data driven
approach lies in the fact that we can ask the expert for causal influences, instead
of correlations obtained from data via statistical methods. We can therefore argue
for the validity of the structure of the Bayesian network in causal terms, of course,
without supposing that a Bayesian network is a causal network. We were interested
primarily in the probability of an exacerbation, which is a clinically relevant event
that is mediated by a number of physiological processes and influenced by envir-
onmental factors. We cannot hope to take into account every relevant factor, but
it is clear that the symptoms of an exacerbation are a consequence of reduced lung
function. Unobserved processes that constitute either normal or abnormal lung func-
tioning can be represented by hidden variables. The measurements SpO2 and FEV1
are objective, but not sufficient to fully characterise lung function. The symptoms
dyspnea and wheeze are direct consequences of reduced lung function. Whether pa-
tients are capable of performing daily activities also depends on whether the lungs
are capable of providing sufficient oxygen. Next in the causal view are possible
causes of reduced lung function. The most prevalent cause of an exacerbation is a
lower airway infection, which is in itself a combination of unobservable processes,
modelled by the variable infection. The presence of an infection is then the cause of
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Figure 3.6: Expert opinion based Bayesian network with prior, marginal probabilities
shown (top probability is Normal state). A = activity, C = cough, D =
dyspnea, E = exacerbation, F = FEV1, I = infection, LF = lung function, M
= malaise, S = SpO2, SP = sputum purulence, SV = sputum volume, T =
temperature and W = Wheeze.
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further symptoms like fever, general malaise and sputum production, the latter in
turn causing cough to clear the sputum accumulation in the airways.
The resulting expert-opinion based COPD-exacerbation prediction model is de-
picted in Figure 3.6. The Bayesian network has been constructed in close coopera-
tion with two pulmonologists (lung specialists) of the Radboud University Nijmegen
Medical Centre. The relevant variables that are related to the occurence of ex-
acerbations were identified by the domain experts and supported by recent clinical
literature (e.g. [108]). As a second step the dependence relations between the vari-
ables were elicited from the domain experts, resulting in the qualitative part of the
model. Subsequently, probabilities were estimated. As this is a fairly difficult task
for clinicians not used to the abstract representation in terms of conditional probab-
ilities, we started off by asking them to provide qualitative constraints of the type
‘Is P (X = true | pa(X) = x) <, = or > P (X = false | pa(X) = x)’ (expressed in
words). Based on these constraints an initial network was constructed to give some
insight in how, approximately, the resulting Bayesian networks would look. We then
went over different test cases to adjust the probabilities until the expert thought the
resulting predictions were acceptable. The entire process has – in a different context
– been previously described in [62].
Parameters from data
We have used two data sets to learn parameters and to validate the model. We
started with a data set from an earlier project on detecting exacerbations at the
Radboud University Medical Centre [12]. We will refer to this data set with A. This
set consists of questionnaire answers of 86 Dutch COPD patients, 54 of whom had
an exacerbation during the study. The data has been acquired biweekly during 2006-
2007 via automatic telephone interviews, resulting in time series data with a total
of 1922 data entries, of which 162 entries provided exacerbation data according to
a symptom based definition of exacerbation. Later we will study the influence on
the results by different definitions of an exacerbation. Data was only available for
a subset of the variables in the model, specifically: exacerbation, dyspnea, sputum
volume and purulence, wheeze, cough, and activity.
As a comparison we also validated the predictions on an unrelated data set [51],
that provides time series of COPD-exacerbation related variables. We refer to this
data set with B. This data set is used solely for external validation, so no model
parameters were learned from this set. As the data is used for testing our model
retrospectively, the set of variables is incomplete. However, it should give some
indication of the generalisability of the results. The data consists of time series from
13 patients of the London COPD cohort who had an exacerbation, with a total of
2849 data entries, of which 406 were during an exacerbation. In contrast to the Dutch
data set, these data were collected on a daily basis. The data contains values for the
variables dyspnea, sputum volume and purulence, wheeze, cough, temperature, and
SpO2.
Parameter estimation proceeded as follows. Since not all data sets include all
variables of interest, parameters were learned for those variables for which data was
available. The usual approach to learning parameters from data entails computing
a maximum likelihood estimate of the parameters, let us call them θ, for the given
data D:
argmax
θ
P (D | θ),
or from a Bayesian perspective, the maximum a posteriori (MAP) estimate:
argmax
θ
P (θ | D) = argmax
θ
P (D | θ)P (θ)/P (D)
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by Bayes’ rule. Note that the denominator P (D) is constant when maximising the
expression for the parameter θ and therefore irrelevant. For complete data this can
be computed easily when assuming that the data is independent and identically
distributed (i.i.d.-assumption), but when data is incomplete – as it almost always
will be in a clinical context – this should somehow be taken into account. We used
the expectation-maximisation algorithm, popularised by Dempster, Laird and Rubin
[31], which iteratively adjusts the parameters by alternating between estimating
values for the missing data given the current parameters and using the completed
dataset to compute new maximum likelihood parameters. Although this does not
guarantee that the optimal parameters are found, Dempster et al. proved that the
procedure improves the likelihood at each iteration, resulting in a local maximum of
the likelihood function.
Comparison between expert and data models
We developed exacerbation predictions models both on the basis of expert opinion
and from data. One would hope and expect that these models at least have some
similarity. Although the parameters will usually not be the same we can make a
qualitative comparison using the constraints we elicited from the expert. As de-
scribed above we asked the expert to order the values of the random variables based
on which would be more likely given the values of the parent variables. We would
expect that the parameters learned from data would follow the same patterns.
For most of the variables for which we had data, the ordering constraints were met,
except for the symptom variables sputum purulence and activity and the outcome
variable exacerbation, which warranted more detailed inspection. For sputum pur-
ulence (SP) the qualitative constraints were that the conditional probabilities given
infection were ordered as follows: P (SP = normal | I = false) > P (SP = abnormal |
I = false) and P (SP = abnormal | I = true) > P (SP = normal | I = true). Analog-
ous constraints were established for activity given lung function. When we look at the
parameters learned from the data we can see that in both these cases the direction of
the effect is correct and the probabilities are close to meeting the constraints. For in-
stance the parameters for sputum purulence are P (SP = abnormal | I = false) = 0.02
and P (SP = abnormal | I = true) = 0.43, indicating that the probability in-
creases considerably with the presence of an infection, but not quite enough to reach
the limit of 50% which would reverse the ordering. The threshold of 50% follows
from the qualitative constraints, because if for a binary variable X the probability
P (X = 0) < P (X = 1) then by definition P (X = 1) > 0.5. Something similar holds
for activity. For the exacerbation variable the situation is a bit different in the sense
that the distance to the threshold of 50% is larger, but the difference between the
probability of an exacerbation given normal lung function or abnormal lung function
is large. It appears that the qualitative constraint was too strict and there are more
situations with decreased lung function that are not an exacerbation. However as the
evaluation that follows will show, the difference between the probabilities for normal
and abnormal lung function is sufficiently large to result in enough discriminative
power.
3.5.3 Model evaluation
To gain some insight in model accuracy we can study the behaviour personalised with
patient data. In the network of Figure 3.6 prior probabilities were shown, but by
entering observations we can personalise the probability estimates to be consistent
with a particular patient status. Table 3.2 contains the probabilities of some key
variables, given different evidence situations. The causal nature of the model ensures
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Dyspnea Sputumpurulence Cough SpO2 Exacerbation
No evidence 0.38 0.14 0.37 0.16 0.11
Cough 0.43 0.20 1 0.20 0.17
Cough, Wheeze 0.68 0.45 1 0.41 0.46
Dyspnea, SpO2 1 0.51 0.53 1 0.55
Dyspnea, Sputum volume, 1 0.67 0.80 0.60 0.71
FEV1 (-20%)
Table 3.2: Model behaviour for different evidence situations. First column indicates which
variables are observed to be abnormal. Other columns show probability of being
abnormal (e.g. symptom is present).
that the probability of an exacerbation increases when more symptoms are reported
or signs measured.
roc-analysis To understand how the model behaves in general we performed an
ROC-analysis, using 10-fold cross-validation with data set A, on the sub-model for
which data was available to compare the expert opinion probabilities with learned
parameters. That is, the variables in the set {exacerbation, dyspnea, sputum volume,
sputum purulence, cough, wheeze, activity}. Prediction are obtained for each data
point by inserting evidence into the network and inferring the resulting probability of
an exacerbation. Concretely this first means that the observed variables are clamped
to the observed value (and thus have probability 1). Second, the probability of an
exacerbation is computed given the observations (using standard Bayesian network
inference algorithms, see e.g. [75]). In Figure 3.8 the resulting ROC-curves are
shown for both the data and expert model, conveying that the predictions can indeed
distinguish the exacerbation cases. For the data model we find a mean area under
the curve (AUC) of 0.93; and for expert model a mean AUC of 0.97.
Since the construction of our model we have obtained the data set (B) from Hurst
et al. [51] described above. It is worthwhile to compare the results on this data set
with the data set we used originally. To do so we looked at the subset of variables
in B that intersect with the original data, that is {exacerbation,dyspnea,sputum
volume,sputum purulence,cough,wheeze}. We then computed the model predictions
for exacerbation given the observations on these variables and again performed an
ROC-analysis. The area under the curve for these predictions was AUC = 0.87.
As is common in ROC-analysis, we computed the optimal cut-off probability p∗ by
means of the point on the ROC curve closest to the (0, 1) coordinates:
p∗ = argmin
p
((1− tprp)2 + fpr2p)
where ‘tprp’ and ‘fprp’ are the true (false) positive rate that depend of the chosen
threshold value p. The optimal cut-off value gives a general, problem-independent
balance between true positive and false positive rates. Table 3.3 shows a comparison
of the prediction results of the cross-validation model on the original and the new
data in terms of AUC and the true (false) positive rate and accuracy at cut-off p∗
(computed separately for each data set). As a further interesting evaluation we took
the model learned from A and decided upon a cut-off probability which we then
applied to the data from B. Hence we used the new data as if we did not have the
correct labels, in the sense that we did not compute the optimal cut-off point. Since
the A model was learned via cross-validation we first computed p∗ for each of the
cross-validation runs and compared two options, either taking the mean cut-off of
the cross-validation runs pAmean; or the max cut-off probability pAmax (row 5 and
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Data set AUC TPR FPR ACC
A 0.93 1 0.16 0.85
ADrug 0.81 0.79 0.3 0.72
AContact 0.85 0.87 0.3 0.72
B 0.87 0.88 0.20 0.81
B pAmean - 1 1 0.14
B pAmax - 0.88 0.20 0.81
Table 3.3: Exacerbation detection performance for different data sets and definitions of
exacerbation (see text for details).
6 in Table 3.3). Note that using the mean is too aggressive a cut-off as it results
in all data being classified as an exacerbation. This can be explained by the class
imbalance in the data, as misclassifying only a few data points has a relatively large
influence on the performance measures. The optimal cut-off point is in some sense
overfitted to the training data. Using the max cut-off however, we see that the
performance is the same as for the optimal value for data set B. This sensitivity to
the precise cut-off point will likely decrease when we obtain more data (especially
positive examples).
definitions of exacerbation When using data to learn parameters it is im-
portant to note that clinically there are different definitions for when a worsening of
COPD-related health status should be considered an exacerbation. The article by
Bischoff et al. [12] that describes the study data we use here, also acknowledges this
point by distinguishing exacerbations defined in terms of symptoms; drug prescrip-
tions; and health care contact. In Figure 3.7 the counts are shown for data points
according to the following definitions:
symptom-definition Presence for at least 2 days of at least the major symptoms
dyspnea, sputum volume increase and sputum purulence.
drug-definition Start of a course of corticosteroids or antibiotics.
contact-definition Unscheduled contact with health care workers due to worsen-
ing of COPD.
Interestingly enough there are many data points for which these definitions do not
agree, which will of course influence model accuracy. Hence it is worthwhile to study
the effect of using other definitions on predictions. Row 2 and 3 of Table 3.3 show
the performance statistics of using the drug or contact definition with the model
learned with the symptom definition. As expected this results in a considerable drop
in performance, as the definitions capture different aspects of exacerbations.
More interesting is the performance of the expert opinion model as this is based on
the experience and clinical gaze of the pulmonologist instead of a technical definition.
The result, using the same indicators as before, is shown in Table 3.4. Interestingly
enough we observe the same pattern here as with the learned parameters, in the sense
that the symptom based definition performs considerably better than the event based
definitions. A possible explanation is that drug use and health care contact data are
based on self reporting which may have introduced noise (both over-reporting and
under-reporting could have occurred due to for example misremembering). Since the
symptom-based definition is derived from more variables it is less likely that someone
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Figure 3.7: Venn diagram of data-point counts for different definitions of exacerbation in
data set A.
Definition AUC TPR FPR ACC
Symptom 0.97 1 0.10 0.91
Drug 0.82 0.75 0.24 0.75
Contact 0.85 0.83 0.25 0.76
Table 3.4: Performance of the expert model for different definitions of exacerbation.
would mistakenly remember multiple symptoms. Another explanation might be that
by explicitly constructing a model of symptoms we primed our expert to focus on the
symptomatic part of exacerbations. Perhaps this balance would have been different
had we included medication in the model. This is a topic for further investigation.
These results indicate that we can reliably detect exacerbations as they are hap-
pening, which is a practically useful result. The final trade-off between true and
false positives should be based on more data, taking into account what definition of
exacerbation is most useful for disease management. Compared to usual care it is
an improvement even if we catch only some of the exacerbations that are now detec-
ted too late. Ultimately, the more difficult task of predicting exacerbations still lies
ahead, as currently we lack sufficient data to model the temporal progression. In
further testing of the system we also plan to gather the necessary data to construct
a temporal model, which requires trend analysis of time courses of symptoms and
signs leading up to an exacerbation.
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Figure 3.8: ROC-curves, cross-validation results (dashed lines) and average (bold).
3.6 related work
3.6.1 Telemonitoring requirements
In a recent study by Peirce et al. [78] an extensive analysis of current telemonitor-
ing practice was performed. Based on this analysis a set of requirement questions
was identified that should be answered to obtain an effective telemonitoring system.
Although we think that out system is more general than purely monitoring, it still
appears useful to consider these questions and try to answer them for our system.
Why monitor? Early detection of deterioration leads to improved outcomes for pa-
tients. Who to monitor? In general deciding on the target population is important
for the success of an intervention. For our COPD system we target those patients
that suffer from frequent exacerbations (more than 2 per year), which is a clearly
defined group that stands to gain from timely intervention on exacerbations. How
to monitor? Our system uses a combination of objective and subjective data, while
trying to maintain a minimal effort requirement for patients. What to monitor? The
variables in our model have been identified in cooperation with clinicians and the
value of each variable is determined statistically from data to ensure we take into
account the most relevant parameters. That is, we started out from clinical require-
ments, not from technological ones. However to obtain a usable system, in practice
some concessions had to be made to what is possible technically and cost-wise. How
to detect deterioration early? This is an important point that forms the basis of our
current research. Now that we have a system that can detect exacerbations, the next
step is modelling temporal progression in order to observe trends that allow us to
predict an approaching exacerbation. Although Peirce et al. labelled early detection
as a shortcoming of many systems, it is one of the main reasons for the development
of our system. How to display information appropriately? We have tried to keep the
user interface as simple as possible to accommodate our users who may not be pro-
ficient with modern smartphones. The presentation of the feedback based on model
predictions is still a topic of further research. However as was recognised by Peirce
et al. a combination of a simple feedback mechanism (say a smiley face, traffic light
or some kind of simple colour coding scheme) with a more in depth analysis of the
data (e.g. trend graphs for symptoms and measurements) will likely turn out useful.
Patients can then choose the level of detail with which they are comfortable. Who to
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notify? How to respond? Alert notifications are an important part of the practical
embedding of a telemonitoring system in day-to-day care. We think that both the
patient and their health care providers should stay part of the decision process, even
if data interpretation is automated as it is here. Therefore, patients keep the initiat-
ive in contacting their physician, but the system can provide advice on when to do
so. How to store data? It depends on the local health care structure whether integ-
ration with GP or hospital information systems is desirable. From the perspective
of patient-empowerment/self-management, it is useful that our system can also be
employed stand alone, leaving access rights with the patient. Summarising, our sys-
tem is already well-equipped with respect to these telemonitoring requirements, yet
refinements can also be identified by further attention to answering these questions.
3.6.2 Related telemonitoring systems
Monitoring COPD-patients has been a topic of interest for some time now, but the
level of automation is usually limited. Basically we can distinguish two types of
earlier work, telemonitoring where technology only provides a means of communica-
tion between patient and physician; and systems that have some kind of automated
alerting or data interpretation. Systems of the first kind have for example been re-
ported by [64], where pulse-oximetry data was send to the hospital via a telephone
line and analysed by hand; [107], where a nurse set up a teleconference with a physi-
cian; and [106], where patients with respiratory failure were monitored by telephone.
The system reported in [74] is more similar to ours in the sense that both question-
naire answers and measurements are acquired and alerts are sent when readings fell
outside the previously established normal range. Also in [94] a monitoring system
is reported that checks symptoms by means of a questionnaire and automatically
checks for deviant answers. These studies all focus on general COPD care, whereas
we focus on early detection of exacerbations. Also, by employing a Bayesian network
we are able to perform more automatic data interpretation. Recently, an exacerba-
tion risk alert-call system has been tested, based on weather forecasts, which was
reported to be effective in predicting risk periods [44]. Another recent study on
predicting exacerbations found that breathing frequency is a good predictor [111].
Currently their approach is limited because breathing frequency was measured via
a home oxygen-therapy system. If a convenient way to monitor breathing frequency
could be found, this would be a possible extension of our current system. For further
references, see also the review of home care for COPD by Polisena et al. [79] and
the telehealthcare review by McLean et al. [67].
3.7 discussion
We aimed to develop a clinically useful system to assist in patient management and
in this paper have described the progress towards that goal. In this section we discuss
limitations of the current implementation, lessons learned from the development, and
we look at future work, extensions and possible generalisations.
The current version of our system has some limitations in the implementation
that are a consequence of an iterative design process. We envision an autonomous
system capable of disease management, but it is necessary to first construct and test
the various components. Currently our probabilistic model functions as a classifier
labelling the monitoring data as an exacerbation with some probability. We have
shown that we can do this reliably, also on new data. To further assist in disease
management we would like to infer the probability of health states ahead of time.
In general chronic disease management can benefit from focussing on the analysis
42
3.8 conclusion
of trends in time series. We are currently working on a temporal Bayesian network
that extends the current model to take time into account.
Currently, we provide the patient with information about the likelihood of an
exacerbation as a minimal kind of support. A logical next step is to analyse in more
detail what kind of advice would be beneficial. In order to do so we will also take
into account more background information about the patient, most notably current
therapy plans. Patient feedback can then be extended to include adjusting therapy.
So while the system we have now is mainly an alerting system – which is already an
improvement compared to usual care – it will be extended to more specific advice.
Clinical guidelines and input from clinicians is indispensable in formulating the right
advice. Also more in general, for a decision support system to become successful it
is important to have the cooperation of both patients and clinicians. As users of the
system they will be able to comment on usability and suggest improvements.
These extensions are part of the route to a system that is capable of both autonom-
ous functioning and more traditional alerting. Besides the improvements mentioned
already, future work will include a larger evaluation on prospective data of model
performance leading up to a randomised trial to evaluate the efficacy of the interven-
tion. The current work however provided us with valuable insights about usability,
by asking patients for feedback; allowed us to test the technical aspects of monitor-
ing; and ensured that detecting exacerbations was possible. These findings form a
good basis for the extended evaluation that is now being planned.
3.8 conclusion
We have described the results of the development of a novel autonomous mobile
assistance system for disease management, in particular focussed on COPD. The
system described in this paper uses probabilistic reasoning to automatically inter-
pret patient specific data to assist patients in managing COPD exacerbations. Initial
testing shows that applying the system is technically feasible and patients are capable
and willing to use the system. The model is well-founded on expert knowledge, liter-
ature and data, providing effective exacerbation detection. We have thus produced
and evaluated on a pilot scale an advanced system architecture for home manage-
ment of COPD exacerbations, with promising results. Future work will involve a
more extensive test in a home-care setting, finally leading to a system capable of
exacerbation detection in an early stage such that COPD exacerbation impact can
be reduced and patients can self-manage their disease.
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AUTOMATIC COPD-EXACERBATION PREDICT ION :
F IND INGS FROM A HOME-MONITORING P ILOT STUDY
4.1 introduction
Exacerbations of chronic obstructive pulmonary disease (COPD) cause considerable
patient suffering [71] and regularly lead to hospital admission, resulting in significant
health-care costs [108]. Prevention of exacerbations thus is a worthwhile goal, as has
also been stated in global clinical COPD guidelines [40]. This is further supported by
the finding that earlier treatment of exacerbations seems to lead to better outcomes
[109]. It is therefore not surprising that mobile health (mHealth) is seen as a prom-
ising approach to improve COPD home-care and self-management. Our research
fits within the general trend in health-care to develop eHealth solutions intended to
improve care while reducing costs by means of computerised support systems. With
our system we aim to reduce the impact of exacerbations on patient’s well-being and
the burden these acute events put on the health-care system. The main advantage
of mobile monitoring is improved information provision, as the monitoring system
can keep patients informed about their own health status and present data to health
care professionals, which are not available in usual care, to keep them updated about
their patients’ health status. Moreover the system can assist in self-management by
automatically giving the patient appropriate advice based on the monitoring data,
which is usually not the case in existing telehealth solutions for COPD [67].
In the current article we report on a pilot study of a mobile COPD monitoring
system for the detection of exacerbations at an early stage. A probabilistic model
is used for automatic data interpretation. Data was gathered in the patient’s home
environment by means of a smartphone-based system that included a spirometer
and pulse-oximeter. Predictions are based on the combined data from the sensors
and the information on respiratory symptoms and signs acquired through an on-
screen questionnaire on the smartphone display. The current system is a prototype
and not yet optimal with respect to usability. A detailed description of the system
can be found elsewhere [97]. An earlier version of the model has been developed
in cooperation with pulmonologists from the Radboud University Medical Centre
Nijmegen, using data from the TEXAS study [12] and validated using data from a
subset of the London COPD cohort [51]. However, in the TEXAS study registrations
took place biweekly, which is too infrequent for our current purposes. Also, not all
variables that are part of our model were available in either data set. We now
gathered new data with our home-monitoring system to assess the performance of
the interpretation model for exacerbation detection and to assess whether the target
population of elderly patients with COPD would be capable and willing to use such a
system at home. We report on the monitoring data and model predictions of typical
patients with COPD who either developed an exacerbation or recovered from an
exacerbation.
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Since the last registration, did you have dyspnea worse than usual?
Since the last registration, did you have more sputum than usual?
Since the last registration, did you have sputum of a different colour than usual?
Since the last registration, did you cough more than usual?
Since the last registration, did you have more wheezing breath than usual?
Since the last registration, were you limited in performing day-to-day activities due to COPD?
Since the last registration, did you have a feeling of malaise?
Since the last registration, did you have a fever?
Table 4.1: Questionnaire items (translated from Dutch).
4.2 methods
4.2.1 Study design
In this prospective observational pilot study patients with a confirmed diagnosis of
COPD were instructed to use the monitoring system consisting of a smarthphone, a
pneumotachograph micro-spirometer (Twente Medical Systems international, Olden-
zaal, the Netherlands) and a pulse-oximeter (Nonin Medical, Amsterdam, the Nether-
lands) for a duration of four weeks. Measurements took place daily, at a prearranged
time of the patient’s preference, initiated by an automatic alert from the smartphone.
The registration consisted of a questionnaire, answered via the smartphone’s touch-
screen, of 8 binary queries on whether patient’s symptoms were worse than normal
(Table 4.1). The questions are derived from questions used in the TEXAS study
[12], which in turn were based on the Anthonisen criteria [5]. In addition to the
questionnaire FEV1 (Forced Expiratory Volume in 1 second) and SpO2 (Saturation
of hemoglobin with Oxygen as measured by pulse-oximetry) were measured. Pa-
tients were instructed by a nurse on how to use the system and how to perform the
spirometry. The results of the sensor measurements were wirelessly transmitted by
a Bluetooth interface to the smartphone. Data was automatically synchronised to a
central server via a secured connection.
The system is capable of data interpretation by means of an advanced probabilistic
model, which can compute the probability of an imminent or regressing exacerba-
tion based on current data as provided by the patient. The model allows us to
detect exacerbations automatically and based on the model prediction the system
can provide direct feedback to the patient via the smartphone and to care providers
via the secured web-interface. For this study we decided not to provide automatic
advice to the participants based on the data, as the model is still in the process of
being validated.
At the end of the four week period, patients were asked to fill in the System
Usability Scale (SUS) [16], to assess usability of the home monitoring system. The
SUS is a questionnaire consisting of 10 Likert scale items and is an often used reliable
indicator of overall usability [9]. We used a version that was translated to Dutch.
Three questions were added on the use of sensors and the smartphone touchscreen
to obtain specific usability information for our system. The questionnaire with the
additional questions will be referred to as the ‘extended scale’.
Permission for the study was given by a medical ethics committee (CMO Arnhem-
Nijmegen, the Netherlands; approval number 2011/242).
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4.2.2 Study population
Ten patients with COPD were recruited from hospitals and general practices in the
eastern part of the Netherlands. All participants gave written informed consent. In-
clusion criteria were moderate to severe airflow obstruction (i.e. GOLD grades II or
III) and sufficient cognitive capability to operate the monitoring system. We aimed
to include two subgroups of patients: patients that were currently stable, but had
experienced exacerbations in the past, and patients that consulted a physician be-
cause of a current exacerbation. Analysis of the first subgroup provided information
on stable patients, who are ‘at risk’ for developing an exacerbation and might de-
velop an exacerbation during the monitoring period; analysis of the second subgroup
provided information on exacerbation recovery and possibly relapse.
4.2.3 Data analysis
The responses to the respiratory symptoms questionnaire were summarised into a
single symptom score by counting the number of positive responses (i.e. indicating
worse than normal). For FEV1 the best result of three attempts was taken as the
real value except where this resulted in implausible values (FEV1 > 6L), which were
considered measurement errors.
A dynamic Bayesian network model [69] was used for the model predictions. A
dynamic Bayesian network models an uncertain process over time, which allows us
to predict the value of a variable given observations of other variables. Here we use
the network as a classifier that gives the probability of an exacerbation as output.
Bayesian networks are robust against missing values, imputing them with the condi-
tional distribution given the other observations or the prior distribution if there are
no other observations. Predictor variables included in the model were the following:
dyspnea, sputum volume, sputum purulence, cough, wheeze, activity, general mal-
aise, fever, SpO2 and FEV1. The outcome variable of the model was exacerbation.
However, in general, Bayesian networks are not limited to computing an outcome
from predictors but also allow computing arbitrary probabilities of variables in the
model given observations. For example, it is possible to compute the probability of
observing certain signs given the observed symptoms. Details of the model will be
published elsewhere [101].
Exacerbations were defined according to a slight adaptation of the symptom-based
definition used by Bischoff et al. [12]: “A change for at least two consecutive days in
two or more major symptoms (dyspnea, sputum purulence and sputum volume) or
any one major symptom plus any one or more minor symptoms”, where we defined
minor symptoms as any symptom that was measured and was not a major symp-
tom. The optimal parameters of the model were computed using this definition
as ‘ground truth’, i.e. data records that satisfied the definition were considered an
exacerbation for the purpose of estimating model parameters. The prediction probab-
ility threshold for exacerbations was computed via a receiver operating characteristic
(ROC)-analysis [112]. Exacerbation events are predicted based on the observations
from the last two days and are reported as the probability of the event for the next
day. The situation is illustrated in Figure 4.1.
Time course plots were produced to compare the symptom scores to the model
predictions and visually assess model performance over time. For each day during the
monitoring period the symptom score is plotted together with the model prediction
for the same day, which is based on the data from the previous day. The model
prediction is the conditional probability of an exacerbation given the findings P (E =
yes | findings).
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Figure 4.1: Part of the network model used for exacerbation predictions. Each time point
represents a day. Variables shown are D = Dyspnea; T = Temperature; F =
FEV1 and E = Exacerbation. Shaded nodes indicate observations. The pre-
diction shown is the probability when the presented observations are deviant
from normal.
Patient’s usability scores were computed following the standard procedure for the
SUS, which results in a normalised score in the range 0-100 (higher is better). For the
extended scale, scores were recomputed including the extra items and normalised to
the same score range. Interpretation of the scores follows the analysis by Bangor et
al. [9] to correct for score bias. The minimal score at which the system is considered
acceptable is 70.
4.3 results
4.3.1 Study population
The ten patients with COPD that were enrolled had the following characteristics:
7 male and 3 female, between 53 and 76 years of age (mean (SD): 65.6 (6.8)) and
FEV1 % predicted < 80%. Five patients were recruited while stable. One patient
(from the stable group) withdrew participation due to perceived difficulty in using
the system, caused mainly by a technical malfunction. The service interruption also
caused missing values for other patients. In total 189 registrations were collected.
Nine patients experienced an exacerbation according to the definition, with a total
combined duration of 60 days.
4.3.2 Model predictions
The dynamic Bayesian network model predicts the onset of an exacerbation on the
next day based on the current observations. The optimal discrimination threshold
computed from the ROC-curve as the point closest to the perfect prediction point is
P (E = yes | findings) = 33.7%. Data points with prediction probability higher than
this threshold are considered an exacerbation. With this threshold the classification
accuracy of the model predictions over all data records is 81% (bootstrapped 95%
CI: 0.72 – 0.87), with a false positive rate of 14% (bootstrapped 95% CI: 0.07 – 0.33).
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Figure 4.2: Time courses of monitoring data. Diamonds indicate symptom scores (left
y-axis), circles prediction probabilities (right y-axis). The horizontal line de-
lineates the classification probability threshold. Note that predictions are
based on the observations from the two previous days.
4.3.3 Time course analysis
In Figure 4.2 time courses are shown that illustrate the performance of the model
using symptom scores as a comparison measure. Three typical time courses are depic-
ted: a stable patient that had a short increase in respiratory symptoms at the end of
the time course; a patient with a prolonged increase in respiratory symptoms, indic-
ating an exacerbation; and a patient that starts out with some symptoms, returns to
a stable state and develops a sudden onset exacerbation. Predictions show a strong
correlation with symptom scores, as expected. Sudden onset exacerbations are diffi-
cult to predict as can be seen in the first and third time course. A day-in-advance
prediction will result in a false negative prediction and in these cases we should aim
for early detection instead of prediction. In the first time course we observe a false
negative prediction on the first day of the exacerbation, where the symptoms just
reach the criteria for an exacerbation but FEV1 is not affected. The second time
course shows a more gradual onset, although due to the inclusion process of patients
with current exacerbations the data is left censored. The model correctly classifies
the start of the exacerbation and probabilities remain high during the course of the
exacerbation, indicating correct predictions. Analysis of the third time course shows
again that predicting sudden onset exacerbations is infeasible, however in this case
the classification is correct on the first day of the exacerbation and the following
days.
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4.3.4 System usability
Eight patients completed the extended SUS questionnaire. The mean (SD) of the
SUS scores was 67.2 (13.3), which according to Bangor et al. [9] is borderline accept-
able. The extended score was 68.5 (12.9), which is not significantly different from
the standard scale, suggesting that the smartphone touchscreen and the sensors did
not adversely affect usability. It therefore appears that the system is reasonably
usable for this group of relatively old patients, but improvements are possible.
4.4 discussion
Using an mHealth solution to assist in exacerbation management at home appears
useful to limit the impact of exacerbations on patient health and potentially reduces
health care costs by preventing use of acute care, out-of-hours medical services and
hospital admissions. In this pilot study we tested the performance of an exacerba-
tion prediction model to automatically interpret monitoring data with the aim to
detect (relapse of) an exacerbation early. Model performance appears sufficient to
assist in self-management, but more extensive research is required to establish this
conclusively before the model can be applied to support patient care.
In a recent study a distinction was made between two exacerbation onset types [1].
Gradual onset and sudden onset exacerbations were identified, and in our data this
divide is also visible. To successfully predict exacerbations it is important to take
the type of exacerbation into account. Gradual onset exacerbation can be predicted
more easily since there are measurable changes before exacerbation onset. For this
type of exacerbation it is of interest to study in more detail the time course of the
prodromal stage to see whether the dynamic Bayesian network can be optimised to
predict this type of exacerbation. For sudden onset exacerbations, timely detection
is more important but the sudden increase of multiple symptoms should be relatively
straightforward to detect. The expert model may be useful to do so. The patient can
also play an active role in this case by initiating a registration when their symptoms
increase.
Our system captures relevant information to predict or detect exacerbations at an
early stage which is a marked improvement over usual care where this information
is usually not available, at least not from a mobile system and accompanied by
automatic data interpretation [94]. Moreover, our initial usability test suggests that
patients would be able and willing to use our home monitoring system. That the
SUS score only reaches a borderline level of acceptability might be explained by the
fact that the system used for this pilot study was a prototype lacking some polish
and suffered from some technical malfunctions during the study period. These issues
can be resolved and we expect that future versions of the system will have improved
usability.
In our opinion, automatic interpretation of mobile monitoring data has great po-
tential to detect at an early stage (relapse of) exacerbations in patients with COPD
and improve self-management support, especially if combined with automatic feed-
back to the patient. The current model appears a useful step on the route towards
an intervention that can be applied as a part of regular COPD patient care. This
study was limited by the number of patients that was included. However, as proof
of concept that automatic interpretation of monitoring data at home is possible, it
provides sufficient support to warrant a follow-up study. In a validation study that
is currently in preparation a larger group of patients from an in-patient pulmonary
rehabilitation program will be monitored to obtain the required data to validate our
dynamic Bayesian network.
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5
LEARNING BAYES IAN NETWORKS FOR TIME SER IES
ANALYS I S
5.1 introduction
Clinical data often takes the form of time series, which, when interpreting all the
variables concerned in their mutual context, offer a description of the progression of
a disease over time. While insight into the evolution of a disease is an important as-
pect of the management of any disease, whether acute or chronic, for patients with a
chronic disease the evolution is of even more importance, as often the disease will not
disappear. In this context it is in particular important to be able to detect when the
disease becomes worse, i.e. to detect and possibly prevent exacerbations. For any
chronic disease it is therefore of clinical interest to study the interaction between
different variables, ranging from signs and symptoms to environmental factors, in
terms of both static and temporal relationships. If we can capture this knowledge in
a model, predictions regarding health status made by means of such models can be
used to assist in chronic disease management, for example by advising on therapy
adjustment. Furthermore, disease models are of paramount importance for epidemi-
ological purposes, for example for survival analysis, as well as for cost-effectiveness
analysis and policy planning.
A complication that arises when analysing clinical time series is that it is often hard
to obtain sufficient data, for example because the event of interest is relatively low
frequency or because taking measurements is costly, time consuming or inconvenient
for the patient. In addition, the reality of gathering clinical data is that observations
are made at irregular time intervals and the data will contain missing values. Patients
will sometimes forget to provide data, or omit some evidence for unknown reasons.
Also measuring devices may sometimes fail or readings may not be recorded. These
observations pose a challenging research question, which we seek to answer in this
paper, namely, whether we can learn useful predictive models from clinical data with
the combined characteristics of missing values and limited availability.
The research methods we propose draw their inspiration from various existing
methods, which have proven to be successful in general machine learning applications.
However the combination of methods has not been applied to clinical time series
analysis. Temporal Bayesian networks are our main tools to reason about causal
and temporal processes in a probabilistic manner. They provide interpretable and
versatile models to describe time series data and can be used to classify states and
make predictions about future states. To learn network structures in the presence of
missing observations we make use of the structural expectation-maximisation (EM)
algorithm [35], which iteratively completes the data and performs a search for the
best network structure to explain the data. Here we employ a variant of structural
EM, with a different approach to filling in values for the missing data. Finally,
to tackle the problem of data sparsity, we consider bootstrap methods originally
developed in statistics [32]. In the context of Bayesian networks these methods have
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been applied to the analysis of micro-array data and we extend them here to the
learning of temporal models from clinical time series.
To provide a concrete clinical context for this research, we focus on chronic ob-
structive pulmonary disease (COPD) as an application area. This disease has many
characteristics that are typical for any chronic disease, although symptoms and signs
will be mostly different from those other diseases. COPD is a major chronic disease
in terms of morbidity and mortality; it affects the respiratory system, decreasing
lung capacity and obstructing airways, thus interfering with normal breathing. An
important aspect of COPD which is particularly relevant in the present context is
the progressive nature of the disease. Specifically episodes of acute deterioration
have a profound impact on patient well-being and on health-care costs [104]. These
exacerbations are mainly caused by airway infections resulting in symptom worsen-
ing [108]. Important to note is also that patients with frequent exacerbations usually
have faster disease progression, which makes exacerbation prevention a particularly
relevant goal. Additionally, a faster treatment response to exacerbations leads to
better recovery [109].
The main contributions of the paper are as follows:
• We formulate an algorithm to learn temporal probabilistic models from limited
clinical time series with missing values. The main novelty of the algorithm lies
in combining learning of dynamic Bayesian networks from clinical data using
structural EM with block bootstrapping for small data samples.
• We propose a variant of our learning algorithm based on naive Bayes networks,
which has the attractive properties of reduced computational complexity, thus
easy construction, while offering good prediction performance.
• The proposed learning algorithms are used to build predictive models of COPD
patient’s health status, focussing on day to day progress of signs and symptoms
that can rapidly change during exacerbation events. These predictive models
are novel in the context of COPD as they can handle both the dynamic nature
and uncertainty inherent in the disease progression. As such, these models can
be embedded within clinical or home-based applications for chronic disease
management.
• We evaluate the learning procedure on COPD synthetic and patient data and
show that it is effective in terms of structure discovery of interesting variable re-
lationships, interpretability and prediction performance of the models learned.
• The results from this research demonstrate important clinical implications not
only for the prediction of COPD exacerbations but also for the clinical relev-
ance of the methods proposed for chronic disease management applications in
general.
5.2 related research
5.2.1 Clinical time series analysis
Data analysis is a typical statistics topic that plays a crucial role in medicine. Sur-
vival analysis [85] is a good example of time series analysis, but the standard tech-
nique of Cox-regression is however less flexible than Bayesian network techniques.
Our work is more closely related to the research in [102], which argues for using
dynamic Bayesian networks for prognostic models in medicine. Variants of dynamic
Bayesian networks have also been used to model temporal dynamics of organ failure
in patients in intensive care units (ICU) [77], although there no structure learning
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was used. Further, a Bayesian network has been developed on the basis of electronic
health record data to predict the onset of COPD in asthma patients, however, tem-
poral information was not explicitly taken into account [49]. In the specific context
of long term disease management for COPD, related research has focussed on fa-
cilitating remote communication [67, 79] and automatic data interpretation is still
uncommon. In [10] a telehealth system is described that has been applied to COPD
and contains a decision support component. However, currently the decision support
is limited to rule based detection of abnormal values and trend detection. Automatic
interpretation of monitoring data using machine learning while taking time and un-
certainty into account therefore appears to be a useful contribution to the area of
chronic disease management.
5.2.2 Modelling techniques
Early work on using Bayesian networks for prediction includes dynamic network
models [26], with e.g. a clinical application to predicting sleep apnea [25]. We use
and extend techniques for learning Bayesian networks from data with missing values
[35] and learning from small samples using bootstrapping [37]. These methods are
used extensively in bioinformatics [56], but application to the domain of clinical time
series analysis constitutes a new and interesting challenge. The bootstrap methods
used for small data samples are related to what is known as bagging in the machine
learning literature [14], but are usually applied to learning decision trees instead of
Bayesian networks. Our augmented temporal naive Bayes model is an extension of
the TAN classifier from [36] to a prediction model that takes time dependencies into
account. Other approaches to learning dynamic Bayesian networks include using
steady state information [59] and introducing hidden variables to model process
changes [95].
5.3 the aerial project: mobile copd management
The methods we developed and use in this paper were needed as part of a research
project, called Aerial, aimed at the detection of worsening in patients with COPD,
i.e. exacerbations. Here we briefly describe the system and the design of the study
to sketch the practical clinical context of the work.
5.3.1 A system that supports self-management
In order to facilitate self-management of COPD by patients we developed a system
with the capability to gather patient-specific information, to interpret the gathered
data automatically and to offer feedback and advice to the patient. The general
architecture of the Aerial system is shown in Figure 5.1. The system consists of a
smartphone as the main component taking care of communication and computation.
Questionnaire data is collected from the patient on the smartphone, which also
communicates wirelessly with the sensors used to obtain objective information on the
patient’s health status. A web-based system allows scheduling tasks and collecting
patient data centrally. The web-centre receives the data from the smartphone and
provides data access for health-care workers. Patient data are interpreted in the
smartphone by means of a disease-specific probabilistic model, different variants of
which are studied in this paper. A more comprehensive description of the system
can be found elsewhere [96, 97].
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Figure 5.1: Schematic of the system setup.
5.3.2 Patient population and data gathering
The aim of the study was to investigate the prerequisites to facilitate self-management
of COPD-patients in a home-care setting. We tested the Aerial system at home to see
whether this would result in usable data with the goal of gathering a data set from
which to learn models for COPD-exacerbation prediction. Ten participants were re-
cruited from hospitals and general practices in the Netherlands, 7 male and 3 female,
between 53 and 76 years of age (mean (sd): 65.6 (6.8)). All participants gave written
informed consent. Inclusion criteria were GOLD II or III (disease severity classific-
ation on a scale from I to IV) [40] and sufficient cognitive capability to operate the
system. There were two possible inclusion paths: stable patients, although having
had exacerbations in the past, and patients that reported to a physician because of
an exacerbation. The first path provides information on stable patients, and possibly
on exacerbation onset; the second on exacerbation recovery and possibly relapse.
Patients were monitored daily for a duration of approximately 4 weeks. Each
day they answered a set of binary questions about their symptoms and performed
spirometry and pulse-oximetry measurements. All questions were formulated such
that a ‘yes’ answer indicates a symptom worse than the baseline condition for that
patient. The set of recorded variables consists of the symptoms dyspnea (D), sputum
volume (SV), sputum purulence (SP), cough (C), wheeze (W), temperature (T),
malaise (M) and activity (A); plus the measurements SpO2 (SO) (blood oxygen
saturation) and FEV1 (F) (forced expiratory volume in 1 second). Exacerbations
(E) were defined using a clinical symptom-based definition (see e.g. [12]). A total of
189 data records were collected, which when regularised by adding missing values for
days that were not recorded resulted in a data set of 250 records. Of these records
60 were during an exacerbation. Missing data was partly a consequence of technical
issues and partly due to patients omitting data for unknown reasons.
5.4 probabilistic models for temporal data analysis
As the research aim was to develop models that were able to interpret temporal
clinical data, in particular revealing the progression of COPD including its stochastic
variation, especially probabilistic models were considered to be attractive for that
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purpose. Probabilistic models can express temporal trends and handle missing values
when data of a specific patients must be interpreted. The successful use of dynamic
Bayesian networks in the context of micro-array analysis [56], where sparsity of data
is also a problem, made us wonder whether similar methods might also be successfully
applied to clinical problems.
We start with a brief summary of basic methods used in the research, leading up
to a method to learn models from sparse clinical time series data.
5.4.1 Dynamic Bayesian networks
A Bayesian network [23, 75], is a probabilistic graphical model represented as a pair
BN = (G,P ). Here, G = (V ,A) is a directed acyclic graph consisting of vertices V ,
corresponding one-to-one to random variables of interest, and A ⊆ V × V are arcs,
representing dependencies between variables. Furthermore, P is a joint probability
distribution defined by a family of conditional probability distributions of the form
P (V | pa(V )), that is, the probability that V takes on a specific value given the
values of its parent variables, pa(V ). The network represents the joint distribution
over the random variables, which can be factored according to the dependences
represented in the graph, resulting in:
P (V1,V2, . . . ,Vn) =
n∏
i=1
P (Vi | pa(Vi)),
where Vi ∈ V is the representation of a random variable in the graph G. Any
probability of interest can be computed from this joint probability distribution.
A dynamic Bayesian network [28, 69], DBN for short, is an extension of a Bayesian
network to a distribution over a sequence of random variables. It is particularly well
suited to represent a Markov process
X1 → X2 → · · · → Xt → · · ·
where Xt represents a random variable at a particular moment in time t. The joint
distribution can be decomposed using the chain rule, writing X1:T for X1, . . . ,Xt,
. . . ,XT :
P (X1:T ) = P (XT | X1:T−1)P (X1:T−1).
In general a DBN is a factorisation of a probability distribution, like its atemporal
counterpart. In addition, each Xt can be represented as a BN. This BN is called a
time slice and relations between time slices can be modelled by introducing arcs in
the graph between random variables in different time slices. A DBN factorisation
can then be written as:
P (X1:T ) =
∏
t
∏
i
P (Xt,i | pa(Xt,i))
where i indexes variables within a time slice and pa(X) denotes the parents of X
in the graph. A hidden Markov model, a popular stochastic model used for pattern
recognition, is a special case of a DBN.
A common assumption is that there is only a limited time frame that influences
the current state of the process, as opposed to the complete history, which simplifies
model learning. When assuming an nth-order Markov process we obtain:
P (X1:T ) = P (XT | XT−n:T−1)P (XT−n:T−1),
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recursively. In the context of clinical data analysis, this assumption makes sense
for two reasons: first, as time passes physiological and disease processes will change
and older information will be less informative about the current state of the patient;
second, it will often not be possible to obtain reliable information about the past.
For smaller n more temporal independence is introduced and when only sparse data
is available, it is common to make the most restrictive version of the Markov as-
sumption, first-order, such that the future state of the process only depends on the
present:
P (Xt+1 | X1:t) = P (Xt+1 | Xt).
Hence, all parents of a variableX will be in the same time slice or in the previous time
slice. From a medical point of view this means that the current health status provides
the most information about the future. Given that clinical data is often sparse, an
important practical consequence of this assumption is that it simplifies the model,
and hence reduces the amount of data we need. When we now also assume that the
process is stationary, that is P (Xt,i | pa(Xt,i)) = P (Xt′,i | pa(Xt′,i)) for all t, t′, we
obtain a two-slice DBN consisting of an initial network BN0 and a transition network
BN→. A process through time can now be modelled by a sequence of repetitions of
transition networks. When modelling a chronic disease over a long period, it may
be that stationarity is not a reasonable assumption. For COPD one might argue
that it is also useful to consider separate models for the disease stages (GOLD I-IV
[40]). The COPD data we study here is, however, limited to GOLD II and III by
the inclusion criteria, and the amount of available data is too limited to make a
distinction. In general however, it appears useful to consider recent techniques to
learn non-stationary DBNs [81].
5.4.2 Model learning
Given a data set we can use machine learning techniques to learn a model from the
data. Two main tasks are usually distinguished: (i) finding a network structure, and
(ii) finding the parameters that best describe the data given a network structure.
See [57] and [68] for fairly comprehensive overviews of probabilistic learning.
Parameter learning
Parameter learning entails finding the optimal parameters θˆ for a given network
structure G, that explain the data D:
θˆ = argmax
θ
PG(D; θ).
This is the maximum likelihood estimate, parametrised by θ, which is straightforward
to compute. It may suffer from overfitting, especially for sparse data, which is
the case that we are considering here. A Bayesian approach makes explicit the
uncertainty in the parameters by taking θ to be a random variable, leading to:
PG(θ | D) = PG(D | θ)PG(θ)/PG(D),
from Bayes’ theorem, where we compute a distribution over parameters, with some
prior distribution PG(θ). Assuming independent and identically distributed data,
global and local parameter independence, the likelihood can be decomposed in local
likelihood terms according to the graph:
PG(D | θ) =
∏
D
n∏
i=1
PG(Xi = k | pa(Xi) = j, θ).
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Since we are using discrete variables in our COPD model, we use multinomial
distributions for the local likelihood terms PG(Xi = k | pa(Xi) = j, θ). The conjug-
ate prior distribution of the multinomial is a Dirichlet distribution, where conjugacy
implies that the posterior is also a Dirichlet distribution. We can interpret the
hyperparameters α of the Dirichlet distribution as pseudo-counts which leads to a
parameter estimate
θijk = PG(Xi = k | pa(Xi) = j) =
|D[k, j]|+ α[k, j]
|D[j]|+ α[j] ,
where D[k, j] (and analogously for α) is an index expression selecting the data cases
where Xi = k and pa(Xi) = j and D[j] =
∑
k
D[k, j].
Parameter estimation using likelihood decomposition properties works well for
complete data, which is unrealistic for clinical models. The expectation-maximisation
(EM) algorithm can be used to learn parameters when we have missing values [31].
Let D = 〈O,H〉 be a data set consisting of observed values O and hidden values H;
Oi,Hi indicate a single data point and τ (D) =
∑
i
τ (Oi,Hi) the sufficient statistics.
The EM algorithm iteratively adjusts the parameters in two steps:
E-step: E[τ (D)] =
∑
i
EP (Hi|Oi,θs)[τ (Oi,Hi)]
M-step: θs+1 = argmax
θ
P (D | θ)
where s is the step counter. The E-step completes the data based on the expected val-
ues for the hidden variables given the current parameters and the M-step computes
the maximum likelihood parameters based on the completed data. This algorithm
provably improves the likelihood in each step until some maximum is reached, al-
though this could very well be a local maximum [31]. EM gives us no guarantee of
finding a global maximum; however, its results are normally sufficiently good.
Structure learning
Hand-crafting a network structure is difficult and time consuming and hence it is
useful to also try to learn the network structure from data. Even for a limited
number of variables as we have in our case, the search space is of such a size that ex-
haustive search is infeasible. Alternative methods include constraint based and score
based techniques. See [2] for a comparison on a large set of hospital management
data, where constraint based methods appear to perform somewhat better. However,
an important disadvantage of constraint based methods, that rely on independence
tests, is that early errors propagate and can have large effects. Additionally, in-
dependence tests tend to be less reliable especially on small samples, for example
because distribution assumptions are not met. In [27] arguments for and against
constraint based methods are examined and a hybrid approach is proposed, which
is however not directly applicable to time series. We opt here for a standard score-
based search procedure that tests local changes to the graph, greedily maximising
the score logP (G | D), which by Bayes’ rule can be written as
logP (G | D) ∝ logP (D | G) + logP (G).
Taking a Bayesian approach the probability P (D | G) can be written as the integral
P (D | G) =
∫
θ
P (D | θ,G)f (θ | G) dθ,
with f (θ | G) a probability density function, marginalising out the parameters. For
complete data the likelihood again decomposes according to the graph and assuming
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conjugate priors there is a closed form solution for the marginal likelihood P (D | G)
(see for example [57]). A common choice for the structure prior P (G) results in the
BDe-score [47], which uses a prior such that we have score equivalence. That is,
networks that encode the same independence information will have the same score.
Unfortunately, the task becomes increasingly difficult with missing data. Finding
optimal parameters when we have missing values depends on the structure, while
structure search clearly depends on the data, including the missing values. There is
no particularly efficient solution to this problem, but we can use the same general
principle as we did to learn parameters from partially observed data. This idea
is called structural expectation maximisation [35]. In essence the structural EM
algorithm alternates between completing the data based on the current structure
and parameters and finding a model that has a better score. The same caveat
as mentioned for the EM algorithm applies here as well, structural EM does not
guarantee finding the global maximum likelihood solution. When the number of
missing values increases the search space becomes larger and we are less likely to
find a globally optimal model.
5.4.3 Small data samples
With the model learning techniques described above we can try to find models that
reasonably fit our data, even when some of the data is missing. However, as we are
learning statistical models there is a strong dependence on the amount of available
data. The more data we have the better we can learn relations. Unfortunately,
gathering data is often a difficult, time consuming process. For the COPD self-
management application the demanding logistics of studying a new system in a home-
care setting, made data collection hard. Furthermore, sometimes the model space
is so large that obtaining sufficient data to learn models directly may be infeasible.
Previous research in determining gene interaction patterns from micro-array data
[37, 56], is another example of research that stumbled across the mentioned problems.
The clinical data we study here is, however, of a different nature than micro-array
data, as signs and symptoms will clearly produce other temporal dynamics. Although
the number of variables was fairly limited in our case, we had a combination of
missing values within records and a limited number of records in total. Hence we
needed to combine the EM procedure with some technique to deal with the small
data sample.
bootstrapping The data sparsity in modelling gene data led to using boot-
strapping [32] as a way to estimate the uncertainty of relations in Bayesian networks
[37]. The idea is as follows: bootstrapping can be used as a nonparametric estimate
of a statistic of interest, for which we can take the presence of arcs in the Bayesian
network graph. The intuition behind bootstrap replications of a data set is that if
we assume a generative model, the actual data we see are just a particular realisation
which may be unrepresentative of the underlying process. Bootstrapping a number,
say m, of new realisations by resampling (with replacement) |D| samples from the
original data and learning models from those data sets, we can estimate whether an
arc a should be present in our model:
P (a) =
1
m
m∑
i=1
I(a,Gi),
where I(a,Gi) is an indicator function that is 1 when a is present in the graph
learned from bootstrap realisation i.
Since we are analysing temporal data, the situation is somewhat more difficult.
Simply resampling from the original data will discard all the ordering information,
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which is clearly undesirable. Instead we have to apply a kind of bootstrapping that
preserves the correlation between different time points. In the statistics literature
a number of methods have been developed to do so, and we opted to use fixed-
length block bootstrapping. As the name suggests this entails resampling blocks of
data points, which preserves the time relations within the block (see e.g. [60] for a
theoretical comparison of block bootstrap methods). We used the implementation
from the R-package boot [17], with a fixed block-length of 5.
From the bootstrap results we can construct a model that includes the features
(arcs) that have a high probability. Another possibility is to use model averaging,
where we compute the prediction probability on validation data Dval as the average
over the predictions of the bootstrap models
P (Dval) =
1
m
∑
i
P (Dval | Gi). (5.1)
However, each of the networks Gi has some score attached to it, so a better approx-
imation to the real probability can be obtained from the weighted average
P (Dval) =
1
m
∑
i
P (Dval | Gi)P (Gi | Di). (5.2)
5.4.4 A method to learn temporal models from small data samples with missing
values
With all the machinery described above, we can now start putting together the
method to learn models from time series. The main idea is a variant of structural
EM applied to bootstrap resampled data. The new features of this procedure are
that it combines sparse data techniques with structure learning on small samples of
time series data, which is typical for clinical data.
Algorithm 1:
1 Construct m data sets D1:m from the original data D using block
bootstrapping
2 foreach Di i ∈ {1, . . . ,m} do
3 for j = 0, 1, 2, . . . until convergence or reaching a time limit do
4 Learn parameters θj for the DBN structure Gj with EM
5 Complete the data Di by sampling from the posterior P (H | O, θj)
6 Search for a DBN structure Gj+1 on the completed data that improves
P (Gj | Di)
7 end
8 end
9 Compute the model average predictions
This algorithm generalises the bootstrap method for sparse data [37], to temporal
models. In order to learn the structure of a temporal model, we need a generalisation
of the structural EM algorithm [38]. In each iteration we learn the structure of a
two-slice network consisting of BN0 and BN→. There are however some differences
with the algorithm in [38]. In particular, we take a different approach to completing
the data. On line 5 of our algorithm, we sample values from the posterior distribu-
tion P (H | O, θj) instead of computing fractional sufficient statistics. That is we
sample values for the missing data H from the posterior given the observed values
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O and the current parameters θj . This allows us to decouple the parameter learn-
ing and the structure search. The result is a complete data set without (fractional)
expected values filled in for the missing values, which lets us use structure search
methods developed for complete data. Additionally, sampling from the posterior
P (H | O, θj) has the interesting property that it results in automatic small data
perturbations. Because structural EM is not guaranteed to find a global maximum,
the data perturbations help in starting the search from slightly different departure
points. The posterior sampling provides a way to let the search reach different parts
of the search space. In [54] some of the differences between hard-assignment, EM
(soft-assignment) and posterior assignment are studied in the context of clustering,
which is closely related to filling-in missing values.
Some remarks on implementation. The EM parameter learning is implemented
using Smile [30], and the DBN structure search from the completed data is imple-
mented in Banjo [45]. In practice, convergence of the complete procedure can be
very slow because the search space is large. Within each iteration we use the gen-
eralised EM result that it is sufficient to update the model when it has a higher
score, without having to maximise the score. Per iteration we set a time limit on the
structure search only accepting the new structure when a higher score was found.
augmented temporal naive bayes Although a full model is useful to gain
insight into the domain, for our application it is important that the performance on
predicting exacerbations is good. It therefore appears useful to emphasise this goal
during model construction. To do so we start from the concept of a naive Bayes
classifier, with exacerbation, E, as class variable. The rationale is that naive Bayes
is a good baseline classifier that can be extended with the information obtained from
structure learning. The idea of modelling dependencies between naive Bayes feature
variables has been used to construct tree augmented naive Bayes (TAN) classifiers
[36]. We here propose an augmented temporal naive Bayes classifier. The presence
of arcs from our class variable exacerbation to each of the other variables in the
same time slice is enforced, ensuring the naive Bayes structure. Structure search
can then identify dependencies between the other variables, also through time. We
retain the inner loop of Algorithm 1 to find the dependencies that best explain the
data, but instead of bootstrapping we restrict the model search space by predefining
part of the network structure. The acyclicity of the graph implies that Xt → Et
is not present, whereas we need to explicitly blacklist arcs of the type Xt → Et+1
for all X. The structure search will identify temporal dependencies but one could
argue that since we are interested in the temporal behaviour of the class variable
that we should also enforce the presence of the arc Et → Et+1. It turns out that in
this specific case of a COPD model, when the arc is not enforced, it is found by the
search procedure.
5.5 experimental setup
In the previous section we described a general method to learn dynamic Bayesian
networks from small sample time series data. Here we describe the experimental
evaluation of the methods for the clinical problem of predicting exacerbations of
COPD. The experiments serve to evaluate, first, whether the models that result from
the learning procedure are accurate; second, to explore what models can be learned
from the COPD data. For the first goal we use synthetic data from a synthetic
model, described below. The second goal can be further refined, as we are interested
in how the learned models compare to the model constructed in cooperation with a
pulmonologist; and we want to find out what the performance of these models is on
predicting exacerbation events.
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Figure 5.2: Model used to generate the synthetic data. The variables are A = activity; C
= cough; D = dyspnea; E = exacerbation; F = FEV1; M = malaise; SO =
SpO2; SP = sputum purulence; SV = sputum volume; T = temperature; W
= wheeze.
5.5.1 Data
Synthetic data
To test our model learning procedure we first study the results with synthetic data
from a known model. The model contains the same variables as the Aerial data
(Section 5.3) to stay as close as possible to the real data context. The arcs in the
model were chosen such that the relations are intuitive, but were not meant to be
clinically correct per se. Analogous to the other models both atemporal and temporal
arcs are in the model. The structure of the model is shown in Figure 5.2. The
parameters were assigned by hand, without attempting to capture the real relations.
From this model we generated four data sets of the same length as the Aerial data,
one without missing values and the others with 10%, 20% and 30% missing values
respectively. The latter is similar to the percentage of missing values in the Aerial
data. We then applied our model learning procedure to each of these data sets in
order to be able to compare the learned models to the known source model.
Aerial data
The Aerial data consists of time series from 10 patients, gathered during the pilot
study of our disease management system. The characteristics of this data set have
been described in Section 5.3 as part of sketching the background for this work. The
data set is used as the input for the learning procedure, to learn models that explain
the COPD-monitoring time series.
Validation data
An independent data set [51] was used for validation. It provides time series of
COPD-exacerbation related variables, used solely for external validation, so no model
parameters were learned from this set. As the data is used for testing our model
retrospectively, the set of variables is incomplete. The data consists of time series
from 13 patients of the London COPD cohort who had an exacerbation, with a
total of 2849 data entries, of which 406 were during an exacerbation. The data
contains values for the variables dyspnea, sputum volume and purulence, wheeze,
cough, temperature, and oxygen saturation (SpO2). We consider two variants of
this data set, the complete validation set, denoted by Dval, and a deduplicated
version Ddedup. The latter consists of the same data, but with consecutive identical
entries removed. The idea behind removing duplicates is that we are interested in
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Figure 5.3: Expert model, with added temporal identity arcs. The variables are A =
activity; C = cough; D = dyspnea; E = exacerbation; F = FEV1; I = infection;
LF = lung function; SO = SpO2; SP = sputum purulence; SV = sputum
volume; T = temperature; W = wheeze.
predicting relevant state changes instead of finding models that are often correct
by predicting that nothing changes. By removing repeating sequences we ensure
that we make predictions with data that frequently changes state. Note that we
only remove exact duplicates, so a change in the observations without a change in
exacerbation label still constitutes a change.
5.5.2 Expert model
The model constructed in cooperation with pulmonologists from the Radboud Uni-
versity Medical Centre, described in [96, 97], is used as a baseline model. This model
is static, in the sense that it does not explicitly model time effects. To make tem-
poral predictions we simply interpret the exacerbation probability as the prediction
probability at a future time point. Additionally we constructed a dynamic version
of the expert model by adding identity arcs to each variable. The graph is shown in
Figure 5.3. For the additional parameters we choose values heuristically, assuming
that remaining in the same state is more likely than switching state. It should be
noted that although we refer to this model as dynamic expert model, the pulmono-
logist was only involved in the construction of the static model and the dynamic
version should therefore be seen only as a naive extension for comparison purposes.
5.5.3 Evaluation metrics
To evaluate the models and their performance we will use standard metrics from
classification. Classification evaluation is often based on measuring true positives
(TP), cases that are correctly classified as positive; false positives, incorrectly classi-
fied as positive; and analogously for true/false negatives (TN; FN). The true positive
rate (TPR) is then defined as TP/(TP + FN) and the false positive rate (FPR) as
FP/(FP + TN). Plotting a curve of TPR-FPR for different cut-off points results
in an ROC-curve, which is often summarised in a single number by computing the
area under the curve or AUC.
We distinguish two situations: (i) the performance of network structure discovery
and (ii) the prediction performance of different models. For structure discovery, a
true positive is an arc present in both the original and learned network graph and a
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Data set TP FP FN TPR
Complete 11 4 3 11/14 ≈ 0.79
Missing 10% 9 4 5 9/14 ≈ 0.64
Missing 20% 8 3 6 8/14 ≈ 0.57
Missing 30% 4 5 10 4/14 ≈ 0.29
Table 5.1: Structural equivalence scores for models from synthetic data.
false positive is an arc not present in the original network. True and false negatives
are defined analogously. For prediction, the usual interpretations in terms of data
records is used.
To evaluate the prediction results we also compute the Brier score [15], which is
defined as 1|D|
∑|D|
i=1(pi − li)2, where p is the predicted probability and l the correct
label. A Brier score of zero indicates perfect prediction.
5.6 results
5.6.1 Synthetic data
To get a feel for the performance of the methods we used, let us first look at the
results of synthetic data from a known model (Figure 5.2). The data are similar to
the real data, so the performance of our learning methods should tell us something
about the performance on the real data. Table 5.1 shows the true positives and
false positives/negatives of the learned model arcs. The true negatives are less
interesting because the learning procedure is forced to only consider graphs with
bounded indegree. For the complete data we do not actually need the structural EM
method, but for completeness we still report the results.
Some interesting observations can be made. Looking at the true positive rate
(TPR), we see that as the percentage of missing values increases the TPR decreases,
as expected. True and false positives do not tell the whole story however. It is not in
general possible to establish the direction of arcs based only on observational data,
hence we may learn networks with arcs that are reversed. With simple scoring this
results in both a false positive and a false negative for a single reversed arc. This
occurs in the model with 10% missing values where the directions of the arcs on the
path E → SV → C are reversed and in the model with 30% missing values where
the arc E → SV is reversed. Also, failing to detect that there is both a direct and
a temporal arc D → A and D → M is not a very serious issue, because whether
these should be distinguished as separate arcs is quite sensitive to the parameters.
Furthermore, all models missed the arc F → SO, but looking at the parameters we
see that the distribution is close to uniform which makes it almost impossible to
detect the dependence from limited data.
We also computed bootstrap models for the data with 30% missing values. In
Figure 5.4 the resulting aggregated model is shown. For each bootstrap replication
we computed the best network using the procedure described above and then we
averaged over the models to compute the probability of finding the arc. Due to
the computational cost of the search procedure, bootstrapping was restricted to 9
resampled data sets. The arcs shown in the graph were found in a majority of the
bootstrap models, i.e. the probability of the arc is P (a) > 0.5. Because the scores of
the best networks are fairly close together, it makes little difference whether we use
Equation (5.1) or Equation (5.2) to compute the arc scores. Observe that there are
only a limited number of arcs with a high score, which is to be expected if there are
multiple models that explain the data reasonably well. The arcs that are found are
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Figure 5.4: Majority vote of arcs according to the bootstrap models.
correct, except for E → SO, which means 5 arcs are true positives and 1 is a false
positive. The TPR is 5/14 ≈ 0.36 which is somewhat better than the result without
bootstrapping for data with 30% missing values.
As usual, structure learning has the twofold goal of elucidating the structure of
the domain and performing density estimation. It turns out that the bootstrap
method allows us to identify important edges in the graph, which serves to fulfil
the first goal. We now turn to the goal of density estimation, for which prediction
performance can be used as a measure. In the context of COPD management,
we are primarily interested in the probability of exacerbation. We compute the
probability P (Et+1 | Ot), which is the prediction probability of an exacerbation
at time t + 1 given the observations at time t (recall that the observations were
made daily, so a single step is a day). A new data set with 30% missing values was
generated from the original synthetic model as test data. An ROC-analysis shows
that all models perform almost identically, with an area under the curve AUC =
0.63. This performance may seem low, but an ROC-analysis with the true model
that generated the data also results in an AUC of 0.63. This is a consequence of the
fact that the generating model contains limited temporal dependencies. Computing
the autocorrelations for the generated time series also clearly shows that correlations
are small. Therefore we cannot expect to make very good predictions on these
data. Inspection of autocorrelations in the real data set shows the presence of more
temporal information, so prediction performance analysis will be of more interest
there.
The analysis of synthetic data indicates that even from a small sample of time
series data we can reasonably reconstruct the network structure. As expected the
performance is sensitive to the presence of missing values, but it appears that some
amount of missing values is tolerable. These results provide sufficient confidence to
analyse the COPD-monitoring data.
5.6.2 Aerial data models
The Aerial project aims to provide disease management for COPD patients. In order
to achieve this goal we have performed a pilot study as described in Section 5.3. We
now turn to the analysis of the gathered data to see whether our learning procedure
is capable of finding relevant patterns.
Model learning and bootstrapping result
The result after 100 iterations of structural EM is shown on the left in Figure 5.5.
We will refer to the model learned from the Aerial data as Model A. It is not as easy
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Figure 5.5: Model A: Structure of the best learned network on the Aerial data (left).
Majority graph learned from the bootstrap replications of the Aerial data
(right). The variables are A = activity; C = cough; D = dyspnea; E =
exacerbation; F = FEV1; M = malaise; SO = SpO2; SP = sputum purulence;
SV = sputum volume; T = temperature; W = wheeze.
as with the synthetic data to ascertain whether this structure is correct. We can
however compare it to the structures found by the bootstrap replications. The same
procedure as used on the synthetic data leads to a majority graph of the bootstrap
replications of the Aerial data, shown on the right in Figure 5.5. Comparing the
two graphs we see that the majority bootstrap model is sparser than model A; the
arc E → C is not present in model A and the relations between the variables T ,
M and E differ in arc direction and temporal signature. All other arcs in the
majority bootstrap model are also present in model A. When we test the prediction
performance of our models in Section 5.6.3, we will call the model average over the
bootstrap models Model B.
To get some insight in which variables are good predictors according to the model,
it is informative to approach the prediction problem from the other side and look at
the probability of predictors given the event, P (Xt−δ | Et). In Table 5.2 the prob-
abilities of some observations for δ ∈ {0, 1, 2} are shown. We can see that dyspnea
is a good direct predictor, as its probability increases leading up to an exacerbation.
The variable activity denotes a decrease in daily activities and is similarly predictive.
Sputum volume and cough give less information about exacerbations over time.
Structural comparison to expert and naive Bayes models
It is informative to compare the result of the structure search to the hand-crafted
model introduced in Section 5.5.2. Although this expert model is static, we can at
least see whether the found dependencies are similar irrespective of whether arcs are
temporal. The comparison is hindered by the presence of hidden variables in the
expert model which are not present in the learned models – learning models with
hidden variables is a difficult problem, see e.g. [33] for a possible approach. As a
consequence we expect to find dependencies between symptoms that are mediated
by a hidden variable in the expert model.
Although we cannot really interpret the model in Figure 5.5 causally, it helps to
keep the clinical meaning of the variables in mind when comparing the model with
the expert model. The dependence between sputum volume and cough is found
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X P (Xt−3 | Et) P (Xt−2 | Et) P (Xt−1 | Et) P (Xt | Et)
Dyspnea 0.55 0.60 0.67 0.79
Sputum volume 0.43 0.46 0.49 0.48
Cough 0.50 0.53 0.53 0.50
Activity 0.75 0.78 0.84 0.91
Table 5.2: Probabilities of predictors given evidence of an exacerbation.
in both the expert and learned model. The learning procedure finds a dependence
between exacerbation and FEV1 which is an indicator of lung function, which is in
line with the expert model. Fever is a strong indicator of infection, which is often the
cause of an exacerbation, explaining the dependency E → T in model A, whereas
the expert models the dependence of temperature on the hidden variable infection
by the arc I → T . In the expert model activity is influenced by lung function, which
is captured by the dependence between activity, exacerbation and sputum volume
in model A. So although there are clear differences between the models, model A
appears to identify dependencies that can be explained. It should be noted however
that identifiability of relations between subjective symptoms can be a problem with
limited data, so there might exist other models that are also reasonable and perform
similarly. The advantage of Bayesian networks in this context is that they at least
provide a simple way to inspect the relations and for example check with a clinician
whether the found relations are clinically defensible.
If we compare the structure of model A to the temporal naive Bayes structure (not
shown), we see that most of the dependencies between the features remain intact.
Note that the structure of this model is restricted by both the naive Bayes arcs from
exacerbation to all the other variables and by the complexity limit in our search
procedure which bounds the number of parents to three. For the augmented naive
Bayes model five temporal arcs are found, self loops for E, A, SP and T and the arc
SP → T , all of which are also present in model A. The atemporal arc T → SV is not
present in model A and the path A→ SO → D is represented by the arc A→ D in
model A. Based on the data we have it is hard to determine directly which of these
models is correct. Therefore we now turn to the evaluation of the models in terms
of exacerbation prediction performance.
5.6.3 Prediction performance & validation
Ultimately, we are interested in prediction performance. We can use our bootstrap
replications as an alternative cross-validation, measuring performance of model A
on the bootstrap data. To do so we concatenated all the bootstrapped data and
computed the TPR, FPR and AUC for the combined data. The results with model
A are modest, with TPR = 0.76, FPR = 0.40 and AUC = 0.66. Although ideally
our model should be tested on prospective data – a project to gather validation data
is in planning – we can gain some insight in the generalisability of our results by
testing the performance on a different data set.
We performed an ROC-analysis on the validation data set Dval, that has not
been used for model learning. The ROC-curves for model A and B are shown in
Figure 5.6. Model A reaches an AUC of 0.84 with one day ahead predictions on the
validation data, which is an encouraging result. Model B, the model average over the
bootstraps, outperforms model A, obtaining an AUC of 0.90. In practice one has to
decide on a cut-off point somewhere on the ROC-curve which gives a reasonable trade
off between true and false positive rates. Our system can adapt the kind of feedback
that is given to the patient based on the probability of exacerbation, incorporating
68
5.6 results
False positive rate
Tr
u
e
 p
os
itiv
e
 r
a
te
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Figure 5.6: ROC-curve on the validation data set Dval for the Aerial model predictions
(solid); for the bootstrap averaged model (dash); and on the deduplicated
validation data Ddedup for the Aerial model (dot) and bootstrap averaged
model (dash-dot).
different cut-off points for different kinds of advice. We should be careful however
in interpreting the prediction results as consecutive time points are often the same,
positively skewing the results by predicting that nothing changes.
To test the influence of repetitions in the test data we also checked the performance
of the models on Ddedup, the deduplicated version of the data. This way we can see
how the model reacts to state changes, which is ultimately what we are trying to
detect. In Table 5.3, we summarise the results for different models: the static and
dynamic expert model, the augmented temporal naive Bayes model and model A
and B on the regular validation data and the deduplicated data. For all models we
compute the performance measures from the prediction probabilities P (Et+δ | Ot)
for δ ∈ {1, 2}.
As expected performance drops for all models on Ddedup, with the most notable
decrease in the expert models. As AUC alone is not sufficiently informative, we
also look at true and false positive rates, computed with the point on the ROC-
curve closest to (0, 1) as cut-off point. The true and false positive rates show that
although the baseline static model appears to perform on par with the temporal
models, this is only true on average over cut-off points. At the theoretically optimal
cut-off we see that detecting changes is difficult with a static model, as one would
expect. Model A and the temporal naive Bayes perform similarly in this condition,
but are outperformed by model B in terms of false positive rate without a significant
change in true positive rate. The Brier scores show a similar pattern, although
differences in scores are small.
The performance for two day ahead predictions is also shown in Table 5.3. A de-
crease in performance is expected as health status can change quickly over time. The
same caveat with respect to predicting ‘no change’ applies, so again the performance
on the deduplicated data is of more interest. In terms of AUC the performance drop
seems relatively small, however false positive rates are getting less acceptable for a
useful application. The static expert model shows some remarkable behaviour by
increasing its TPR for two day ahead predictions, but this is mostly a consequence of
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Model
Data Expert static Expert dynamic Temporal ANB Model A Model B
t+ 1 AUC TPR FPR BS AUC TPR FPR BS AUC TPR FPR BS AUC TPR FPR BS AUC TPR FPR BS
Dval 0.86 0.89 0.25 0.11 0.85 0.89 0.25 0.19 0.89 0.90 0.21 0.09 0.84 0.89 0.20 0.10 0.90 0.87 0.12 0.09
Ddedup 0.76 0.59 0.14 0.14 0.76 0.60 0.15 0.20 0.77 0.80 0.31 0.15 0.75 0.82 0.32 0.15 0.82 0.78 0.19 0.13
t+ 2
Dval 0.84 0.86 0.26 0.11 0.83 0.86 0.26 0.19 0.87 0.87 0.22 0.10 0.86 0.82 0.15 0.10 0.86 0.84 0.13 0.11
Ddedup 0.72 0.72 0.39 0.15 0.72 0.54 0.16 0.20 0.72 0.78 0.36 0.16 0.73 0.70 0.31 0.15 0.76 0.69 0.21 0.15
Table 5.3: Summary of AUC, True Positive Rate, False Positive Rate and Brier Score
for different models on the validation data set Dval and the deduplicated data
Ddedup.
finding the optimal cut-off, resulting in a higher TPR but also very high FPR. The
naive Bayes model performs best in terms of TPR, but model B remains the best
performer in terms of FPR. Hence it appears that different approaches are all capable
of making predictions with some accuracy, but that model averaging over bootstrap
models has a slight edge. This shows that bootstrapping is a useful technique to
learn clinical models from small data samples of patient monitoring data.
5.7 discussion
Chronic disease management using automatic data interpretation requires analysing
time series to make predictions. We studied time series data from a pilot study with
chronic obstructive pulmonary disease patients, with the purpose of developing a
predictive model for COPD exacerbations. In this section we discuss the impact of
our findings, limitations and future work.
There has been quite some work on telehealth and monitoring for chronic dis-
eases in general and COPD in particular [67], but automatic data interpretation
has not played an important role up to now. The methods we employed based on
developments in artificial intelligence however, offer powerful tools for automatic
interpretation. Bayesian networks are well suited to deal with data analysis in a clin-
ical context, because the models are interpretable – one can ask a clinician whether
the relations found with structure learning make clinical sense. Equally important
for use in a home-care setting is that it remains possible to make predictions when
data values are missing. Since missing values are virtually impossible to prevent com-
pletely, this is an important feature. Dynamic Bayesian networks generalise these
desirable features to time series analysis. An issue that relates to model interpretab-
ility is that the best performance is obtained by a model average, which is more
difficult to understand. Cooperation with a clinician seems advisable, to make sure
that differences in models describe possible domain features. Alternatively, augmen-
ted naive Bayes may be a better choice when a fully interpretable model is desired.
In the augmented naive Bayes model only the interpretation of the dependencies has
to be verified to be clinically valid and at least in our data the performance difference
with the model average was fairly small.
Structure learning of Bayesian networks has been studied extensively [57], but the
present challenge was combining structure learning techniques for dynamic Bayesian
networks with sparse data methods. Structural EM is in itself already a computation-
ally expensive operation and bootstrapping data sets makes it even more daunting,
which is clearly a limitation when using these methods for very large models. The
computation time for our COPD data however, although long in absolute terms
(about a day per data set on current hardware), is negligible compared to the time
investment of data acquisition. Therefore it may still be worth considering even
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for larger models. The current result also indicate that if model averaging is too
expensive, augmented temporal naive Bayes provides an alternative that is easier to
construct because the model space is restricted, but offers good performance relative
to the computational complexity.
For our COPD application our results are promising as we are able to learn models
that appear quite capable of predicting exacerbation occurrences. Nonetheless there
are limitations to the extend to which we can rely on the results of the validation.
The test data has not been gathered specifically for this purpose and does not con-
tain all the variables in our model, also the number of missing values may not be
typical for the data that needs to be analysed in the final system. Furthermore, the
decision on what is an acceptable trade-off between true and false positives is beyond
the technical scope and depends on clinical views, cost considerations and regulatory
requirements. As the project’s initial focus was on analysing the monitoring data,
background information on the patient, including current treatment, and more gen-
eral environmental factors (e.g. time of year, weather conditions) have not been
taken into account at present, but are part of future work. Whether our results gen-
eralise will be tested in a follow-up study that is currently being planned, in which a
more substantive group of patients will be monitored, extensive baseline information
will be taken into account and exacerbation events will be verified by a pulmonolog-
ist as gold standard. A confirmation of the present prediction results would then
open up the way for a practical implementation of automatic data interpretation for
COPD disease management.
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6
PROBABIL I ST IC REASONING WITH TEMPORAL
INDETERMINACY
6.1 introduction
In clinical medicine, as in many other fields, one frequently has to deal with data
that is uncertain and records temporal progression. The time aspect is often also
uncertain, which is sometimes referred to as temporal indeterminacy [22]. To build
useful predictive models we need to deal with these two kinds of uncertainty. A
typical example in clinical medicine would be diagnosis based on a patient report of
symptoms, e.g. over the last week. From a modelling perspective it may be uncertain
which symptoms occurred, and, while our knowledge of when the symptoms occurred
is constrained to last week, within that period we may not be able to be more specific.
There are many methods that support modelling processes of time; dynamic
Bayesian networks (of which hidden Markov models are a special case) are an ex-
ample [28, 69]. The problem of temporal indeterminacy and its relation to temporal
granularities has been recognised in the database community (e.g. [22]). However,
the fundamental problem of dealing with temporal indeterminacy in predictive mod-
els is mostly unsolved.
The representational power of Bayesian networks makes them a useful tool in a
clinical context to represent (causal) relations between symptoms, signs and diseases.
We have developed a decision support system for chronic obstructive pulmonary
disease (COPD), where patients are monitored at home to detect exacerbation events.
In this system a Bayesian network is used for automatic data interpretation [96].
The dynamic nature of the disease process leads naturally to the desire to employ
a model that mirrors the disease and clinical practice more closely than a static
Bayesian network. The first step is then to extend the Bayesian network to a dynamic
Bayesian network (DBN) which allows us to model dependences through time.
Temporal indeterminacy results from the harsh reality of patient monitoring in a
home environment, in the sense that it may not always be possible to obtain precise
information at the right time. We want to be capable of dealing with indeterminacy
of the kind “symptom S appeared between 2 and 4 days ago”. This problem is not
limited to monitoring, but appears often in clinical practice. We can identify similar
aggregation problems: when lots of data is available (e.g. on the intensive care unit),
aggregation as a summary is sometimes useful; a situation that occurs frequently is
that measurements are taken at different times but the clinician is interested in an
aggregated result that represents the health status of the patient over the period
the measurements were taken. These problems have been studied in the context of
temporal abstraction [87], but not in probabilistic graphical models.
We aim to develop a framework to specify temporal indeterminacy, and related
aggregation problems, probabilistically. In this paper we focus on this representa-
tional problem in the context of dynamic Bayesian networks, with the objective to
make predictive models that handle indeterminacy.
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6.2 preliminaries
6.2.1 Representing time
In order to reason about temporal indeterminacy we need a formalism to represent
time and granularity. The work on representing time in temporal databases seems
useful as a starting point [22]. We take a linearly ordered set of points (T ,≤)
as the primitive representation of a time line, where T is a subset of the natural
numbers N. A determined instant at the lowest time granularity (e.g. seconds) is a
point t ∈ T . Due to temporal indeterminacy and granularities, it may be useful to
represent an instant as a set. For example, an instant at the scale of minutes is a
single minute, but may be represented as a set of 60 seconds at a finer granularity.
Similarly, when the exact time of an instant is unknown, a set of points can be used to
represent the uncertainty in time, that is, to represent the temporal indeterminacy.
An indeterminate instant is defined as a set a ⊆ T , with the property that a is
contiguous: ∀t ∈ T : inf a ≤ t ≤ sup a ⇔ t ∈ a, using inf a and sup a to denote the
lower and upper bound of the interval of indeterminacy. Two instants a, b are called
non-overlapping if sup a < inf b or sup b < inf a.
In studies on logical representations of granularities (e.g. [11]), different time struc-
tures are allowed as granularities. This allows one to specify hierarchies of granular-
ities for example for the Gregorian calendar. Here we define a granularity G in a
more restricted sense as a partition of T , i.e. a set of subsets such that
⋃
G = T
and if g, g′ ∈ G then g ∩ g′ = ∅ or g = g′. We further consider only granularities
that are contiguous, uniform and comparable, which means that every time point
can be expressed in each granularity and time points within a granularity have the
same size (which excludes for example ‘month’). Examples of possible granularities
with these restrictions include ‘second’, ‘hour’, ‘day’ etc.
Before we go on we introduce some notation. We are often interested in events
associated with time. In particular we consider events of observing a value of a
certain variable of interest. We write Ea for an event E that occurs in a, where a is
an indeterminate instant. It is sometimes convenient to specify a certain time point
t within a. For example, to denote the probability that E occurs at t ∈ a, with a an
instant, we write P (Ea(t)). The complement event of Ea is denoted E¯a.
6.2.2 Bayesian networks
To be able to add temporal indeterminacy to temporal Bayesian networks, we first
define the usual way to explicitly incorporate time in Bayesian networks.
A dynamic Bayesian network is a pair (G,F), with G a graph G = (V,A) and F
a set of factors over random variables X corresponding to the vertices V. The set
of arcs in the graph A ⊆ V×V represents (in)dependences of the variables. For
a two-slice dynamic Bayesian network we subdivide the vertices in an initial slice
and a repeated transition slice V = V0 ∪V1:T , which implies a similar subdivision
X = X0 ∪X1:T . An arc (v,w) ∈ A with v ∈ Vt and w ∈ Vt′ , t < t′, denotes a
temporal dependence. Let pa(X) denote the parents of X ∈ X in the graph G. The
set F contains factors for each X ∈ X such that f (x,p) = P (X = x | pa(X) = p).
The joint distribution over X =
⋃T
i
Xi, factorises over the graph such that P (X) =∏
X∈X P (X | pa(X)).
To simplify the models, often only first-order Markov models are considered, which
means that the future is independent of the past given the present:
P (Xt+1 | Xt,X1:t−1) = P (Xt+1 | Xt).
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Furthermore, a usual assumption is homogeneity, also called stationarity, which
means that the probabilities are equal between time steps:
P (Xt | pa(Xt)) = P (Xt′ | pa(Xt′ )) ∀t, t′ : Xt ∈ Xt,Xt′ ∈ Xt′ .
This may be too strong an assumption for real processes, which has lead to recent
work on learning non-stationary dynamic Bayesian networks [81, 42]. We leave these
assumptions intact here, and focus only on the indeterminacy problem.
A technique often used to model the interaction between multiple variables (to
prevent an exponential growth of parameters) are causal independence models [75].
The main assumption is that different causes of an effect can be assumed to be
independent and only interact through a particular deterministic function. Here we
will use this method to model the interaction between random variables at different
time granularities.
6.3 events and granularity
We first state some properties of indeterminate events, and their consequences. Con-
sider an event Ea to be a point-like occurrence at the finest granularity under con-
sideration somewhere at a. We then have:
Ea =
∨
t∈a
Ea(t), (6.1)
i.e., event Ea is defined in terms of events at the finer granularity. Analogously, the
complement event is:
E¯a = ¬
∨
t∈a
Ea(t) =
∧
t∈a
E¯a(t). (6.2)
The following property ensures that only a single point event Ea(t) is true:
∀t, t′ ∈ a : t 6= t′ → Ea(t) ∧Ea(t′) = ⊥. (6.3)
called the single event assumption. This means that the event at coarser granu-
larity is caused by exactly one event at finer granularity. Conversely, if multiple
events could have occurred at the finer granularity, this is called the multiple event
assumption.
When using probability theory to capture the principles of an indeterminate in-
stant a, we need to specify a distribution for the occurrence of an event E associated
with the instant a. Under the single event assumption a distribution for Ea has the
property:
P (Ea) =
∑
t∈a
P (Ea(t)),
which follows from the two properties above. From Property (6.3) it also follows
directly that:
∀t, t′ ∈ a : t 6= t′ → P (. . . ,Ea(t), . . . ,Ea(t′), . . . ) = 0 (6.4)
and
P
( ∧
t∈a\{t′}
E¯a(t) | Ea(t′)
)
= 1.
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From this, it follows that
P
( ∧
t∈a\{t′}
E¯a(t),Ea(t′)
)
= P
( ∧
t∈a\{t′}
E¯a(t) | Ea(t′)
)
P (Ea(t
′))
= 1 · P (Ea(t′)) = P (Ea(t′)). (6.5)
However, when the multiple event assumption is adopted, only
P (Ea) = P
(∨
t∈a
Ea(t)
)
holds. This means that at the aggregated level we cannot distinguish between what
are multiple events at the precise granularity. We are interested in somehow relating
the representations at both granularities.
Further constraints result from domain specific patterns of dependence between
points in a, which will be considered later.
6.4 temporal indeterminacy in dbns
Now we focus on modelling temporal indeterminacy in dynamic Bayesian networks.
In general the problem is representing a temporal process at multiple granularities.
6.4.1 Probabilistic aggregation
A conceptually simple representation consists of separate models for the granularities.
This is shown in Figure 6.1. Basically, the lower part of the model aggregates the top
part, although here it is not specified how the aggregation takes place. A one-to-one
translation from the possible states of the finer granularity to the coarser granularity
results in:
P (Oa | Xa)P (Xa) = P (
n∧
i=1
Oi |
n∧
j=1
Xj)P (
n∧
k=1
Xk),
where basically the domain of Oa is the Cartesian product of the domains of O1, . . . ,
On; similarly, the domain ofXa is the Cartesian product of the domains ofX1, . . . ,Xn.
The result is a representation that is exponential in the size of the domains.
With the single event assumption it is easily possible to compute the aggreg-
ated probabilities. However, when represented graphically, these logical constraints
would require dropping the first-order Markov assumption yielding a factorisation
of P (X1, . . . ,Xn) without any independence information. However, in the trans-
formation it is not necessary to use a graphical representation as there is a very
specific relation between the granularities. Let Xa take on values in {0, 1, . . . ,n}
then P (Xa = i) = P (Xi = 1) and P (Xa = 0) = 1−
∑n
i=1 P (Xa = i), because by
definition for i with 1 ≤ i ≤ n:
P (Xa = i) = P (X1 = 0, . . . ,Xi = 1, . . . ,Xn = 0)
= P (Xn = 0, . . . ,Xi+1 = 0 | Xi = 1, . . . ,X1 = 0)
· P (Xi = 1,Xi−1 = 0, . . . ,X1 = 0)
= 1 · P (Xi = 1,Xi−1 = 0, . . . ,X1 = 0)
= P (Xi = 1)
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X1 · · · Xi · · · Xn
O1 Oi On
⇓
Xa
Oa
Figure 6.1: A general depiction of a model at two granularities (without the single event
assumption).
using Equation (6.5). Note that it follows that
P (Xa 6= i) = P (Xi = 0).
P (Xi = 1) =
∑
Xj ,i6=j
P (Xi = 1,
∧
j
Xj)
= P (Xi = 1,
∧
j
Xj = 0),
where the second equality follows from mutual exclusivity, as is easily seen from
Equation (6.4). Since this is true for Xi with 1 ≤ i ≤ n and P (Xa) is normalised
by setting P (Xa = 0) = 1−
∑n
i=1 P (Xa = i), we obtain the aggregation P (Xa) =
P (
∧n
i=1Xi).
To aggregate the observation variables Oi we take the domain of Oa to be binary.
Since we assumed stationarity we have only two parameters: for 1 ≤ i ≤ n P (Oi =
1 | Xi = 1) = p and P (Oi = 1 | Xi = 0) = q. Still assuming that the first-order
Markov assumption does not hold, conditioned on the Xi’s the Oi variables are
conditionally independent, allowing us to aggregate the observations by multiplying
the conditional probabilities; for 1 ≤ i ≤ n, it holds that:
P (Oa = 1 | Xa = i) = P (Oi = 1 | Xi = 1) ·
∏
j 6=i
P (Oj = 1 | Xj = 0) = pqn−1
and in addition
P (Oa = 1 | Xa = 0) =
∏
j
P (Oj = 1 | Xj = 0) = qn.
6.4.2 Structural aggregation
A different perspective on modelling indeterminacy is including the aggregate tem-
poral structure within the model. This turns out to be useful as it allows us to
model explicitly the interaction between the variables at different granularities. The
mechanism that we will employ to model multiple interactions in a systematic way
is causal independence. This is depicted in Figure 6.2. A causal independence model
allows us to model the projection by means of a particular deterministic function of
the variables at the finer granularity.
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Xa Xb
Oa Ob
X′1 X
′
2 X
′
3 X
′
4 X
′
5 X
′
6
X1 X2 X3 X4 X5 X6 · · ·
Figure 6.2: Incorporating granularity within the model. Observation variables for the
finer granularity have been omitted.
Although separating the state and observation model is common practice to model
measurement errors, we will for now assume that state variables are directly observ-
able in order to focus on modelling the indeterminacy. Hence, disregarding the O
variables in Figure 6.2 we obtain the following joint distribution for the aggregation
over a
P (Xa,
n∧
i=1
X′i,Xi) = P (Xa |
n∧
i=1
X′i)
∏
j
P (X′j | Xj)
P (X1) · · ·P (Xi | Xi−1) · · ·P (Xn | Xn−1).
(6.6)
In a causal independence model the term P (Xa |
∧n
i=1X
′
i) is represented by a
deterministic function. Equation (6.1) implies that the logical OR is a natural inter-
action function.
As the single event assumption is easily represented by the construction in the
previous section, we now focus on the multiple event assumption. The causal in-
dependence model allows us to combine the events, even when the independence
assumption on the causes is not met (as can be seen to be the case in Figure 6.2).
Although the model complexity increases, the number of parameters is still linear
in the number of variables at the fine granularity, as opposed to the exponential
increase which results when connecting the granularities directly.
The model depicted in Figure 6.2 is not the only possible aggregation. An aggreg-
ation variable can summarise arbitrary sets of state variables, which is related to the
work by [34]. The statement “symptom S occurred between 2 and 4 days ago” can
be modelled with an aggregation variable that summarises 3 variables at the granu-
larity of days. These aggregations can be made to overlap, that is Xa summarises
X1:3, Xb summarises X2:4 etcetera.
Aggregation patterns
Starting from the aggregated level we can use domain knowledge to specify a pattern
on the finer granularity. It seems worthwhile to identify patterns that have intuitive
appeal, defining which variables have more influence on the aggregated variable,
or, from the perspective of the coarser granularity, which variables are more likely
to have caused the aggregated state. Specifically, we consider four situations: the
uniformity assumption implies that we have no reason to believe that there is a
particular structure at the precise granularity, the maximum entropy choice. A
discretised normal distribution is useful to model the uncertainty around a particular
observation point. The decreasing and increasing patterns convey the idea that some
event is more likely to occur at the start or the end of the aggregated interval.
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Figure 6.3: COPD-monitoring aggregation network.
If a point in the coarser granularity Xa has corresponding points in the finer
granularity X1, . . . ,Xi, . . . ,Xn, the patterns have the following properties:
Uniform: P (X1) = P (Xi) = P (Xn)
Normal: P (Xi) = P (Xn−i+1) < P (Xn/2)
Decreasing: P (X1) ≥ P (Xi) ≥ P (Xn)
Increasing: P (X1) ≤ P (Xi) ≤ P (Xn)
Note that for the normal-pattern some care needs to be taken when aggregating an
even number of variables. For the increasing and decreasing patterns one could also
consider the strict cases, but especially for large n the current versions are more
flexible.
6.5 temporal indeterminacy in copd
The model shown in Figure 6.3 is an example of how temporal aggregation can be
used in the context of COPD-monitoring. The data has been gathered at various
hospitals and general practices in the Netherlands, with the smartphone-based mon-
itoring system as described in [96]. The model is an unrolled dynamic Bayesian
network for four symptoms: dyspnea, cough, sputum production and activity capa-
city. Each variable indicates a daily measurement over the course of a week, and
takes on binary values (False = normal, True = worse than normal). The daily symp-
tom variables are aggregated in a variable representing the whole week by means of
a generalised causal independence model [90]. Instead of a binary outcome variable,
the aggregate has values representing the number of symptom days (0 through 8).
The intermediate variables model the inhibition, or noise, parameters. Finally, we
are interested in the outcome variable Exacerbation, which provides an indication
of a clinical significant event. Here again a causal independence model is utilised to
aggregate the individual symptoms, by means of a counting function that classifies
the number of symptoms into the categories [0-7],[8-15],[16-23],[24-32], that is, it is
a deterministic function of the symptom aggregates.
The parameters of the model have been learned from the monitoring data of 8
COPD patients that participated in a pilot study. As before we assumed stationarity,
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and with a Dirichlet uninformative prior distribution with α = 1.1 we estimated the
probabilities of a symptom variable X ∈ {D,C,S,A} as:
P (Xi = k | pa(Xi) = j) =
αijk +Nijk − 1
αij +Nij − |Xi|
,
where Nijk is the number of cases that variable i takes value k and the parent
variables of i take on configuration j; αijk denotes the pseudo-counts; |Xi| is the
number of values that variable Xi can take on and Nij =
∑
k
Nijk. The parameters
of the intermediate variables were all equal with P (XIni = 1 | Xi = 1) = 0.9
and P (XIni = 1 | Xi = 0) = 0.1. All the aggregate variables have deterministic
parameters as explained above.
In the pilot study, participants were asked to fill in the Clinical COPD Question-
naire (CCQ) as a control measure for the data gathered with the monitoring system.
The questionnaire consists of 10 questions on a 7 point scale (lower scores are bet-
ter); 4 questions are about dyspnea, 1 about cough, 1 about sputum production and
4 about activity; we omitted the 2 psychological questions about dyspnea for the
current analysis; the version used asked patients to answer with respect to last week.
For our current purposes this gives us a good example to look at aggregation, since
we can compare the monitoring data from the preceding week with the results of the
CCQ. Because not all data was available at the time of writing and due to missing
data (patients not filling in the CCQ), we have data of 5 patients for comparison.
The procedure is as follows, we entered the monitoring data as evidence in the DBN
(missing values are easily taken care of by leaving them as non-evidence variables)
and noted the probabilities of the aggregate variables. For the CCQ scores we took
the mean of the scores for the same aspect, rounded to the nearest integer. The
results of the comparison are shown in Table 6.1, where the distribution over the
aggregate variables is shown, which basically means the probability of a certain
number of days of that particular symptom during the preceding week. Each value
of an aggregate variable is mapped to the same CCQ score (0 to 6), except 7 which
is mapped to CCQ score 6 (i.e. ‘(almost) always’ is taken to mean 6 or 7 days).
Using the most likely value of the variables as a simple measure to assess agreement
with the CCQ scores we see that we end up with the same value in 30% of the cases
and are one value removed in 45%. But given the currently limited amount of data
it is hard to say whether this could be improved by a better aggregation model or
whether there exists a discrepancy between the monitoring data and the CCQ scores.
The sputum value of patient 3 favours the latter explanation, as the CCQ indicates
sputum was produced almost never whereas the monitoring data provide evidence to
the contrary; clearly an aggregation model cannot solve these inconsistencies. With
respect to the outcome variable Exacerbation, visual inspection of Table 6.1 indicates
that patients 1 and 2 are stable, patients 3 and 5 are in the course of an exacerbation
and patient 4 is somewhere in between. This shows that the aggregation provides a
useful and more easily interpreted summary of the monitoring data.
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0 1 2 3 4 5 6 7
D 47.8 37.2 12.4 2.3 0.3 0 0 0
C 0.6 11.0 53.8 27.9 6.1 0.7 0 0
S 4.7 45.7 35.8 11.6 2.0 0.2 0 0
A 47.8 37.2 12.4 2.3 0.3 0 0 0
D 30.6 37.8 23.0 7.2 1.3 0.1 0 0
C 32.7 37.8 21.7 6.6 1.1 0.1 0 0
S 36.3 36.9 19.8 5.9 1.0 0.1 0 0
A 31.0 35.3 23.8 8.2 1.5 0.2 0 0
D 0 0.5 4.8 20.7 33.5 28.5 11.1 0.9
C 0 0 0.5 4.3 17.5 34.0 29.9 13.7
S 0 0 0.3 2.4 11.5 28.4 33.7 23.6
A 0 0 0.1 1.2 6.7 20.8 36.6 34.7
D 0 1.0 7.8 23.4 32.9 25.1 9.0 0.7
C 1.2 13.8 29.7 32.0 18.1 4.7 0.5 0
S 33.2 37.1 21.2 7.0 1.3 0.1 0 0
A 0 0.2 1.9 9.6 24.6 37.8 23.7 2.2
D 0 0 0.2 2.4 13.5 37.8 41.8 4.2
C 0 1.0 9.7 36.8 37.3 13.3 1.8 0.1
S 0 0 0.4 3.9 19.4 44.3 29.2 2.7
A 0 0 0 0.5 3.7 15.5 37.4 42.8
Table 6.1: Distributions (percentage) over the aggregate variables (D=dyspnea, C=cough,
S=sputum, A=activity) for 5 patients. In bold the probability of the value that
corresponds to the CCQ score.
6.6 related work
A well known representation of time is Allen’s algebra [3]. It provides a set of
relations between time intervals and operations to reason over the intervals. The re-
lations allow expressing information about the order of intervals and some different
types of overlap, for example ‘X starts or is during Y ’. In some sense this allows
indeterminacy, but in a qualitative way. Temporal indeterminacy and its relation
to representations at different granularities is a topic studied in the context of tem-
poral databases [22]; but the problem is also relevant for planning and scheduling
and information systems that deal with temporal data. For medical information
systems there has been quite some work on temporal reasoning: on multigranular
representations [55]; and on temporal abstraction [87]. The latter deals with ag-
gregating temporal data to meaningful higher level concepts, which requires taking
care of temporal representation issues like granularities. Our probabilistic graphical
model approach provides a different view on a part of these problems. Also related
are irregular-time Bayesian networks [80], which generalise DBNs to time-slices with
changing size. [11] studied granularities in temporal constraint satisfaction prob-
lems; and [19] in a more general linear time logic context, both deal extensively with
properties of multiple granularities but not with probabilistic representations.
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6.7 conclusion
Modelling temporal indeterminacy in probabilistic graphical models creates the op-
portunity to deal with different kinds of uncertainty that arises in many practical
situations and in chronic disease monitoring in particular. We think that our ini-
tial results on probabilistic multigranular models by means of causal independence
form a good starting point for further research in this direction. Particularly, the con-
sequences and applicability of the single or multiple event assumption warrant atten-
tion. Future work also includes further analysis in the context of COPD-monitoring.
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DESCRIB ING DISEASE PROCESSES US ING A
PROBABIL I ST IC LOGIC OF QUAL ITAT IVE T IME
7.1 introduction
In solving clinical problems such as diagnosis or prognosis, concerning the signs and
symptoms of a disease, one often has to take into account the time when a particular
event has occurred or is expected to occur. In many cases, the actual temporal
details about when events have occurred are not available, or at least imprecise,
whereas one is more certain about the order of the events. AI researchers have
traditionally used Allen’s interval algebra [3] to model imprecise temporal events. It
forms the foundation of a temporal logic that supports reasoning about temporal
events in a qualitative fashion [4]. Work by Shahar [87] indicates the usefulness of
Allen’s algebra for describing temporal events in medicine. However, Allen’s algebra
does not allow expressing uncertainty about the occurrence of the events or their
qualitative, temporal relationships. Yet, uncertainty is a feature of many problems
where precise temporal information is missing, such as in clinical medicine.
In the work described in this paper it is investigated in what way Allen’s interval
algebra can be extended to incorporate uncertainty reasoning. Recently developed
probabilistic logics can be used as a basis for such a more general language and
in particular we build upon the work on CP-logic [103]. The aim is to design a
framework that allows describing disease processes in a way similar to what is found
in the clinical literature, i.e. imprecise yet with uncertainty made explicit.
Developing sophisticated decision-support systems for realistic clinical problems
requires one to handle both the imprecision and uncertainty of medical knowledge
and data. The methods developed in this paper are expected to contribute to meeting
these challenges. Evidence that this is justified comes from examples taken from
important clinical problems, one of which is the management of chronic obstructive
pulmonary disease for which we have developed a smartphone-based decision-support
system [97].
We claim that to model disease progression it is often easier to start from impre-
cise notions of temporal ordering compared to directly constructing for example a
dynamic Bayesian network. That is, the kind of information readily available from
questioning a patient and from general clinical knowledge about the disease, offers
a good starting point. From there on we can add uncertainty to obtain a temporal
probabilistic model. This way of modelling clarifies the structure of the process and
makes it more explicit what kind of assumptions are made.
The topic of temporal reasoning has already received much attention, also in a
medical context, exemplified by the book of Combi et al. [20]. However the work
described there is almost completely symbolic in nature, focussing on logic proper-
ties. We argue that in a realistic clinical setting one cannot and should not ignore
the uncertainties that arise due to hidden complexity, lack of information or meas-
urement error. Whereas pure probabilistic frameworks tackle only the uncertainty,
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our qualitative time probabilistic logic seeks to model temporal uncertain processes
at a practical level of abstraction.
This paper is organised as follows. In the next section we introduce two motivating
examples, typical for the problems encountered in biomedicine, which will be used
later to validate the framework being developed. In Section 7.3 we discuss related
work and in Section 7.4 we provide some preliminaries. In Section 7.5 we describe the
probabilistic temporal framework that seems suitable for the description of disease
processes, and give some properties of the language. In Section 7.6 we return to our
examples and show that the developed framework can be usefully applied to describe
the temporal, uncertain evolution of disease processes.
7.2 motivation
7.2.1 HIV drug resistance
Our first example, from [48], is modelling HIV mutations and drug resistance. In
contrast to the COPD example which will be introduced next, HIV mutations are
uncertain temporal events without recurrence. In [48] they represent the problem
using temporal nodes Bayesian networks (TNBN), where random variables take time
intervals as values to denote time frames in which a mutation could occur. In
Section 7.6 we show that TNBNs can be represented in our framework.
7.2.2 The management of COPD
Throughout the paper we will use the management of chronic obstructive pulmonary
disease, COPD for short, to motivate the developed methods. COPD is a progressive
lung disease characterised by a mixture of chronic bronchitis and emphysema, leading
to decreased respiratory capacity and potentially to respiratory failure and death.
Although there are a number of causes, exposure to (tobacco) smoke is the most
prevalent. Because COPD is a progressive disease, its temporal development is
quite important and even more so because of the occurrence of exacerbation events
– a worsening of symptoms with possibly a large negative influence on health status.
To model exacerbations we have to take into account that patients are usually in a
home care situation which lacks precise high-frequency measurement-equipment. As
a consequence we have to rely on imprecise information. Probability theory provides
a tool to quantify our uncertainty about the state of the system, in this case the
health status of a COPD patient. We focus on a limited number of random variables
that characterise the events of the uncertain process: two main symptoms, dyspnea
and cough, a common cause infection and the outcome exacerbation. As we will be
using a probabilistic logic the relations between these variables can be specified in
terms of causal rules:
dyspnea← infection.
cough← infection.
exacerbation← dyspnea∧ cough.
Limited information also leads to temporal uncertainty, yet it is often possible
to determine qualitative temporal relations. We use time intervals to model the
duration of symptoms and other variables of interest. Allen’s algebra then provides
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a language to state ordering relations between symptoms in time. The rules above
can be extended to incorporate the temporal information:
dyspnea(I)← infection(J), allen(I, J).
cough(K)← infection(J), allen(K, J).
exacerbation(L)← dyspnea(I) ∧ cough(K) ∧ allen(L, I) ∧ allen(L,K).
where I, J ,K,L denote the intervals which we associate with the events and allen
denotes some qualitative time relation between the relevant intervals. To predict
exacerbations, we have to quantify the uncertainty of temporal relations between
symptoms. This will be the main example, and in Section 7.6 we will study the
situation introduced here in detail.
7.3 related work
Allen’s algebra has received much attention over the years and finds applications in
fields from planning to clinical medicine and many more. However there are also
numerous other temporal representation and reasoning frameworks. A comprehens-
ive overview lies outside the scope of a related work section, but we mention some
important work. For an overview of topics related to time in medicine we refer the
reader to [20].
Besides Allen’s work [3, 4], McDermott’s work on temporal logic [65] is well-known.
Interesting to note is McDermott’s observation that quite a few problems result as
a consequence of uncertainty, and that no formal framework exists that satisfact-
orily combines logic and probability. Fortunately this has changed in recent years,
leading to our current work on temporal reasoning in probabilistic logic. Combi et
al. [21] describe an extension of Allen’s logic that generalises to different temporal
granularities, which is often necessary in a clinical context.
Also important to mention is the work on temporal constraint networks by Dechter,
Meiri and Pearl [29] and on combined metric and Allen constraints by Kautz and
Ladkin [53]. Jonsson and Bäckström [52] later showed that disjunctive linear rela-
tions subsume these and a number of other temporal constraint formulations. An
application of temporal constraints in a medical context can be found in modelling
clinical guidelines, see e.g. [92].
In the probabilistic model field there has also been interest in temporal models,
and although not directly connected to qualitative time representations, dynamic
Bayesian networks [28, 69] are a well-known instance of temporal probabilistic mod-
els. Many variants and extensions exist such as the networks of probabilistic events
[39] where nodes are associated with events and the value of a node represents an
occurrence of the event at a particular time point; temporal Bayesian networks of
events [7] which are similar and use a subset of Allen relations to relate (quantified)
temporal nodes; and the work by Tawfik and Neufeld [91] on temporal reasoning in
Bayesian networks. These frameworks do not focus on representing qualitative time
as we do in this paper.
Other work on combining probabilistic and qualitative temporal reasoning includes
probabilistic temporal interval networks [82], a probabilistic extension of the interval
constraints network often used with Allen’s algebra. This is similar to our current
proposal, but our work also allows modelling uncertainty in the events. Probabil-
istic temporal networks, as defined by Santos and Young [83], are network models
that incorporate Allen’s constraints on conditional probabilities. They make the
assumption however that the intervals of interest are known beforehand and can be
specified explicitly, therefore not allowing uncertainty in what intervals are or will
be of interest.
85
describing disease processes using a probabilistic logic of qualitative time
Before IbJ ⇔ (I+ < J−)
Meets ImJ ⇔ (I+ = J−)
Overlaps IoJ ⇔ (I− < J−) ∧ (I+ < J+) ∧ (J− < I+)
Starts IsJ ⇔ (I− = J−) ∧ (I+ < J+)
During IdJ ⇔ (J− < I−) ∧ (I+ < J+)
Finishes IfJ ⇔ (J− < I−) ∧ (I+ = J+)
Equals IeqJ ⇔ (I− = J−) ∧ (I+ = J+)
Figure 7.1: Graphical representation of the seven basic relations that can hold between
two time intervals. These relations and their inverse make up Allen’s algebra.
Then, recently, probabilistic logic has been applied to represent stochastic pro-
cesses [93]. The proposed language CPT-L extends CP-logic to represent fully-
observable homogeneous Markov processes. Our work differs in focussing on using
CP-logic for qualitative time stochastic processes. Distributional clauses [43] extend
the probabilistic logic approach (based on Sato’s distribution semantics [84] like
CP-logic) to continuous distributions.
7.4 preliminaries
7.4.1 Allen’s interval algebra
Allen’s algebra builds upon qualitative relations between time intervals. An interval
implicitly refers to an event that takes place during that interval. In Figure 7.1
the relations that can hold between two intervals are shown graphically. We define
intervals as right-open I = [I−, I+) on a linearly ordered time line of points (T ,≤),
with T a subset of the set of real numbers R or, if necessary, restricted to a finite
subset of the natural numbersN. The special points I−, I+ are defined as I− = inf I
and I+ = sup I.
We can now define relations, letting I be the set of all intervals of T . A binary
temporal interval relation R is defined as R ⊆ I × I. Instead of temporal interval
relations, we shall in the following use a predicate logic representation, where the
logical atom R(I, J), having the meaning of (I, J) ∈ R in the relational form, will
be denoted in infix form as IRJ .
Allen defined a set of seven basic interval relations on two time intervals. Together
with the inverses of these seven relations we obtain a minimal set of relations that
can express any qualitative relation between two intervals. This set of relations with
respect to intervals in I will be denoted B and the thirteen relations therein are
B = {b, b¯,m, m¯, o, o¯, s, s¯, d, d¯, f , f¯ , eq}, where r¯ is the inverse relation of r, which for
intervals I, J is defined as Ir¯J ≡ JrI. Figure 7.1 gives the definition of the relations
in terms of interval endpoints, with I− denoting the start point and I+ the end
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point of interval I, and similarly for J . The basic relations in the set B are mutually
exclusive and collectively exhaustive with respect to the possible relations between
two intervals.
In the following examples we will consider events E with an interval index I,
written as EI , to denote that event E occurs in interval I, instead of pure interval
expressions, as this makes it easier to convey ideas on how to put time intervals
to use. We will also use the shorthand notation EI R E′J for the formally correct
notation EI ∧E′J ∧ (IRJ) meaning that event E occurs at time interval I and E′
at interval J and that the relationship between these intervals is expressed by the
Allen expression IRJ .
Example 7.1. A certain group of COPD patients tends to have relatively frequent
exacerbations – events of worsening of symptoms – that are usually caused by airway
infections. Using the basic temporal relations we can describe that an infection in
interval I at least partially precedes the increase in symptoms in interval J. We
then obtain the expression:
InfI o SymJ ,
which means that symptoms can outlast the infection. Since an exacerbation is
defined as an increase of the relevant symptoms in the interval we can say for an
interval K associated with the exacerbation:
ExaK eq SymJ .
With the basic relations, the full set of Allen’s relations can be constructed. Any
of these relations is defined as the disjunction of a subset of the basic relations for
the same intervals. Thus, one gets expressions such as (I N J) ≡ (I R J)∨ (I R′ J),
where N is the new relation, and R,R′ are basic relations. However, instead of
introducing new names for the resulting new relations, Allen uses set notation for
the new relations, giving rise to the following definition:
Definition 7.1. An Allen relation is defined as a disjunction of basic interval
relations, represented as a set. The power set of the basic relations contains all
Allen relations and is denoted A = ℘(B). An interval formula is then of the form
IRJ with I, J intervals and R ∈ A.
Thus, for the example above, (I N J) would be represented by (I {R,R′} J).
Because we will be using Allen’s relations as logical relations in what follows, it is
useful to notice the effects of Boolean operations on basic relations. The definition
above states that Allen’s relations are disjunctions of basic relations. From mutual
exclusiveness it follows that conjunctions of basic relations are false by definition (at
most one relation can hold between any two intervals). For the negation of a basic
relation R ∈ B we obtain ¬R = B \ {R}. Note that the negation is thus different
from the inverse R¯.
Example 7.2. COPD patients often have what is called ventilation-perfusion in-
equality – a mismatch between air flow and blood flow through the lung – which
may develop during an exacerbation due to increased airway obstruction. When
an exacerbation occurs we have a temporal event VpiI which is during, finishes
or is overlapped by ExaJ . Without any further information the relation between
ventilation-perfusion inequality and exacerbation can thus be described by:
VpiI {o¯, d, f} ExaJ .
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Given a set of interval relations, other temporal relations can be derived, using
the transitivity of time ordering. For example if IbK and KbJ , then by transitivity
it holds that IbJ . Similar rules can be constructed for all pairs of basic relations.
In many cases the result will not be a basic relation however, but a set of possible
relations, that is an element from A. Allen [3] provides a table of all the inference
rules.
More in general we can say that given a finite set of interval relations, the relations
that are entailed by this set can be derived by repeated application of the following
closure operator until a fixed point is reached [70]:
Definition 7.2. Let C be a finite set of interval relations. The closure operator
Γ maps interval formulas to interval formulas using the operations of inversion (·¯),
intersection (· ∩ ·) and composition (· ◦ ·). Γ(C) is the smallest set satisfying:
1. C ⊆ Γ(C)
2. For each I, J that appear in a formula in C : IBJ ∈ Γ(C)
3. For each IRJ ∈ Γ(C) : JR¯I ∈ Γ(C)
4. For each (IRJ), (IR′J) ∈ Γ(C) : I(R ∩R′)J ∈ Γ(C)
5. For each (IRK), (KR′J) ∈ Γ(C) : I(R ◦R′)J ∈ Γ(C)
The inversion operation is the inverse of each basic relation in R, the intersection
operation is simply the set intersection of the relations R,R′ and composition is the
result of resolving the transitivity of the basic relations. Formally, composition is
defined as ∀I, J : I(R ◦R′)J ⇔ ∃K : IRK ∧KR′J .
If there are multiple paths via which a relation between two intervals can be
derived we are interested in the strongest relation that holds. So from Γ(C) we
can derive the reduced closure Γ′(C), where for each R with IRJ ∈ Γ(C) for given
intervals I, J it holds that IR′J ∈ Γ′(C) if R′ ⊆ R. In other words, the intersection
of the relations between two intervals is contained in the reduced closure, because
the intersection is the strongest relation that follows from C. See also [70].
Example 7.3. The temporal relation between the intervals of infection and exacer-
bation is:
InfI o ExaJ
which when combined with the relation,
VpiK {o¯, d, f} ExaJ
can be used to infer the relation between ventilation-perfusion inequality and infec-
tion by application of the closure operator:
C = {InfIoExaJ , VpiK{o¯, d, f}ExaJ}
Γ′(C) = C ∪ {VpiK{b¯, m¯, o¯, d, f}InfI , InfI{b,m, o, d¯, f¯}VpiK ,
ExaJ o¯InfI , ExaJ{o, d¯, f¯}VpiK}
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7.4.2 Logical reasoning with the interval algebra
As Allen showed [4], this qualitative algebra is well suited to reason about time in
a logic context. Allen’s relations are then represented by temporal predicates. The
logic we will be using derives from the logic programming tradition of using Horn
clauses,
H ← B1, . . . ,Bn
where H is the head of the clause, B1, . . . ,Bn the body and H and the Bis are
logical atoms. Variables are denoted with upper case and are implicitly universally
quantified, conjunctions are denoted by commas ‘,’ and a semicolon ‘;’ denotes a
disjunction, as in Prolog.
Also instead of using a reified logic approach as Allen does (i.e. using meta-
predicates like HOLDS, OCCURS), we opt for the arguably simpler framework of
temporal arguments [8] (see also [105] for a discussion on the (dis)advantages of both
methods). This means that temporal predicates have a temporal argument specify-
ing the relevant time interval. Note that this implies a typed logic with temporal
and atemporal terms, which we will leave implicit as this can always be translated
to first order logic at the cost of notational convenience.
A connection between an interval relation representation and predicate logic can
be made by introducing a predicate that represents the temporal relation between
intervals. Concretely, using a Prolog like syntax, we define the predicate r/3, with
the first two arguments representing the intervals and the last argument a basic
temporal relation; and the predicate allen/3, with two intervals and a list of basic
relations as arguments such that allen(I, J ,L) holds if the disjunction over elements
X in list L,
∨
X∈L r(I, J ,X) holds.
Example 7.4. Consider again our COPD example which we can now represent
somewhat more structured:
exacerbation(P , J)← patient(P ), infection(P , I), r(I, J , o).
vpi(P , J)← patient(P ), exacerbation(P , I), allen(I, J , [o¯, d, f ]).
Here vpi stands for ventilation-perfusion inequality. As the previous example showed
the temporal relation between infection and vpi can be derived. In this case the result
is a disjunction of five possible relations:
vpi(P , J)← patient(P ), infection(P , I), allen(I, J , [b¯, m¯, o¯, d, f ]).
7.4.3 CP-logic
To represent and reason with probabilistic knowledge, we will use the probabilistic
logic language CP-logic [103]. This language is based on the theory of logic program-
ming extended with a probabilistic semantics. The main intuition is that probabil-
istic logic formulae represent causal rules, that is a logic clause gives a relation from
some cause to a set of possible outcomes (each with some probability). A CP-logic
program thus describes a causal process.
Definition 7.3. A causal probabilistic rule has the form:
(H1 : α1) ; . . . ; (Hn : αn)← B
where αi is the (non-zero) probability of outcome Hi such that
∑n
i=0 αi ≤ 1; Hi
are logical atoms and B is the body of the clause.
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In other words, a causal rule gives a probability distribution over possible effects
of some cause B. Deterministic effects can be modelled simply by a non-probabilistic
logic formula H ← B which is equivalent to H : 1← B. Unconditional probabilistic
rules can be seen as a prior distribution over logical facts. CP-logic is restricted to
finite domains, so although one can write quantified formulae, these are interpreted
as a finite set of ground instances.
The probabilistic semantics are based on the work by Shafer [86] on probability
trees. The main idea behind this is that probabilistic processes are best described
by a dynamic unfolding of events. Each node in the tree represents some state of the
domain, transitions between nodes are probabilistic events as described by the causal
probabilistic rules in the knowledge base, and each outgoing edge is some alternative
outcome labelled with its probability. The leaves of a probability tree each describe
a possible outcome of the events modelled in the knowledge base. All events are
considered to be independent and dependencies have to be modelled explicitly in
the rules. As each causal rule fires independently, it follows that the probability
of a leaf node l is the product of the labels on the edges from l to the root of the
tree. Since there may be multiple series of events that lead to the same final state
the probability of an interpretation is the sum over all the leaves in the tree that
share the same interpretation. Each rule is independent, which means that multiple
rules with the same outcome are independent causes. In CP-logic, these independent
causes are interpreted as a noisy-OR. See Vennekens et al. [103] for details and [50]
for alternative interpretations.
Example 7.5. In Figure 7.2 a CP-logic event tree is shown, representing the situ-
ation of whether a COPD patient suffers an exacerbation caused by either an infec-
tion or by breathing in a noxious substance. The tree follows from these CP-rules:
exacerbation : 0.6← infection.
exacerbation : 0.2← noxious_substance.
infection : 0.05.
noxious_substance : 0.01.
The probability of an exacerbation can be computed by summing over the leaves l
that contain E (short for exacerbation) on the path from the root to l. Note that
on some branches E occurs twice, which is allowed because there are two rules that
have E as a consequence. The probability of, for example, the leftmost path is
0.05 · 0.6 · 0.01 · 0.2 = 0.00006 and the probability of an exacerbation is:
0.00006+ 0.00024+ 0.0297+ 0.00004+ 0.0019 = 0.03194.
7.4.4 Markov processes
Markov processes are commonly used as representation of uncertainty and time.
The following definitions will be useful later on. Suppose we have a Markov process
represented by the chain
X1 → X2 → · · · → Xt → · · ·
The joint probability up to some point T is
P (X1:T ) = P (XT | XT−1,XT−2, . . . )P (XT−1,XT−2, . . . )
= P (X1)
T∏
t=2
P (Xt | X1:t),
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E 0.2 ¬ E 0.8
N 0.01 ¬ N 0.99
E 0.6
E 0.2 ¬ E 0.8
N 0.01 ¬ N 0.99
¬ E 0.4
I 0.05
E 0.2 ¬ E 0.8
N 0.01 ¬ N 0.99
¬ I 0.95
Figure 7.2: A probability tree, where I is short for the infection event, N denotes noxious
substance and E is exacerbation.
where the notation 1 : t is an abbreviation of the sequence from 1 to t. The factorised
notation is useful as we are primarily interested in Bayesian network representations.
A common independence assumption is the first order Markov property P (Xt+1 |
X1:t) = P (Xt+1 | Xt), which states that the future does not depend on the past
given the present. The joint probability then simplifies to
P (X1:T ) = P (X1)
T∏
t=2
P (Xt | Xt−1).
A generalisation of Markov chains are dynamic Bayesian networks (DBNs) that
allow modelling independences in the state space description. The state space is
then described by a graph G = 〈V ,A〉 in which vertices V represent variables X at
each time point, arcs A represent dependences either within or between time slices
and the joint probability of the process variables X factorises over the graph. The
joint probability is given by:
P (X1:T ,1:n) = P (X1,1:n)
T∏
t=2
P (Xt,1:n | Xt−1,1:n)
=
T∏
t=1
n∏
i=1
P (Xt,i | pa(Xt,i))
Note that pa(X) denotes the parents in the graph of X, which can either be in the
same time slice or in time slice t− 1, again assuming the first order Markov property.
It turns out that we can describe Markov processes in CP-logic as is shown by
the work of Thon et al. [93] on CPT-L, which represents observable homogeneous
Markov processes in CP-logic.
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7.5 a probabilistic logic of qualitative time
When modelling real world situations, qualitative time is useful for those processes
for which precise timing information is unavailable. However, it may be possible to
obtain likelihood information, telling us that some event is more likely to happen
at a particular time, even when the timing information is imprecise. This leads to
temporal process descriptions – as represented with Allen’s logic – extended with
probabilistic information. The expressive power of CP-logic will appear sufficient to
act as a basis for such an extended, qualitative temporal and uncertain logic.
7.5.1 A framework for uncertain temporal reasoning
To model uncertain processes we are primarily interested in the occurrence of events.
In our context we consider events that are uniquely associated with intervals, and
this association is expressed by means of a time-interval index. We interpret events
as taking place throughout their associated intervals.
Now to define temporal events, we index facts with time intervals from the set of
all time intervals I.
Definition 7.4. Let E denote the event space containing all probabilistic events of
interest. A temporal uncertain event EI is defined as a probabilistic event E ⊆ E
that occurs in time interval I ∈ I.
The Boolean algebra of temporal events B(EI), where EI is defined as EI = {EI |
E ⊆ E, I ∈ I}, should obey certain rules, taking into account the time interval indices
of the events. The elements of the Boolean algebra are obtained by constructing
conjunctions of events (EI ∧E′J ), disjunctions (EI ∨E′J ) and negations ¬EI , with
events EI ,E′J ∈ EI .
With all the basic ingredients defined above, it is now possible to define a frame-
work for uncertain temporal reasoning.
Definition 7.5. A probabilistic qualitative time algebra PQT is defined as a 4-
tuple PQT = 〈 I, EI ,B,P 〉, where
• I is the set of all time intervals;
• EI is the set of temporal uncertain events;
• B is the set of basic Allen relations;
• P is an associated joint probability distribution.
Below, we will use CP-logic as a practical language to implement the framework.
7.5.2 On events and intervals
There are certain properties of temporal events which require further attention, and
which will be considered subsequently.
For E = E′ with temporal events EI and E′J , there is an interaction between the
Boolean operations on temporal events and the Allen relationships of the time inter-
vals. For example, when IbJ holds, then (EI ∧EJ ) cannot be simplified; however,
if IeqJ holds, then (EI ∧EJ ) = EI = EJ . In addition, when two intervals I and J
meet, i.e. ImJ holds, then (EI ∧EJ ) = EK with K = I ∪ J . This expresses that
event E actually occurred during interval K.
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Proposition 7.1. For intervals I, J ∈ I and a relation IRJ it holds that
(EI ∧EJ ) = EI∪J (7.1)
if R ∈ B \ {b, b¯}.
In other words, it holds for all cases except when I and J are disconnected intervals.
Proof. The proposition can be understood by splitting the intervals into the inter-
section K = I ∩ J , and the remainders I′ = I \K and J ′ = J \K. Note that
{b, b¯,m, m¯} are the only relations for which the intersection K is empty, but that for
{m, m¯} we have that sup I = inf J and hence I, J are connected. Then by realising
that (I′ ∪K)∪ (K ∪J ′) = I′ ∪K ∪J ′ and that the same event in connected intervals
cannot be distinguished, we obtain EI∪J .
Note that Equation (7.1) is true for any temporal relation R if we define the time-
interval index I of a temporal event EI as a set of time intervals, rather than as a
single time interval, with the singleton set as a special case. This would generalise
Allen’s algebra of temporal relations to relations between sets of time intervals. As
it is not our intention in this paper to change the algebraic basis of Allen’s algebra,
we will not pursue this idea further.
For a disjunction EI ∨EJ , we can apply the results from the proof of Proposition
7.1 to obtain that
(EI ∨EJ ) = EK ∧ (EI′ ∨EJ′ ) (7.2)
where K, I′ and J ′ are defined as in the proof above, for IRJ , with R ∈ B \ {b, b¯}.
7.5.3 Uncertainty
There are various ways in which uncertainty can be incorporated into the language:
• Uncertainty can be expressed with respect to the temporal events EI .
• Uncertainty can be expressed with regard to the relation between time intervals
IRJ .
When combined for two temporal events EI and E′J , these assumptions give rise to
a joint probability distribution of the form
P (EI ,E′J , IRJ),
with R an Allen relation. Note that this could also be the special case where we
have a single event E associated with both interval I and interval J .
Often one is interested in more than two events, which can be modelled with a
joint probability over all the events and pairwise temporal relations between the
events. For example for three events we have the joint probability
P (EI ,E′J ,E
′′
K , IRJ , IR
′K, JR′′K).
Sometimes this joint probability will simplify due to independences between the
events. In the following we focus on situations with two events, yet similar arguments
can also be made for multiple events.
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Certain Allen relations
By conditioning on IRJ , one removes part of the uncertainty, yielding:
P (EI ,E′J | IRJ).
In this case, only events are uncertain, and relations between interval are considered
to be part of the (deterministic) logic specification. We can now define a distribution
over temporal events.
Definition 7.6. The probability of a Boolean expression of events is given by the
probability function P : B(EI) → [0, 1], where B(EI) denotes the Boolean algebra
over the set of temporal events EI .
Here uncertainty is introduced at the level of events attached to particular intervals,
which means we are looking at what happens at a greater level of detail than the
qualitative relations describe. However, the nature of Allen’s qualitative algebra
dictates that relationships between the intervals are more important than the exact
intervals. Consequently, the following parameter invariance appears appropriate to
restrict arbitrary models to those models where the qualitative relations are the key
primitives for temporal uncertainty:
∀R, I, J ,K,L : P (EI ,E′J | IRJ) = P (EK ,E′L | KRL), (7.3)
i.e. when the Allen relation R between (potentially) different intervals is the same,
the probability of joint occurrence of the associated temporal events is also the
same. This invariance ensures that the influence of time on probabilities of events is
governed by the temporal relations.
This invariance is actually related to a common assumption for dynamic Bayesian
networks, where one assumes parameter invariance over time to limit the number
of parameters. There is however a subtle difference. The invariance that is com-
monly assumed for DBNs is that P (Xt | Xt−1) is equal for all t. The invariance
in Equation (7.3) however states that as long as two events are related through the
same temporal relation their probabilities are equal, which is not about repetition
invariance. Yet the relation with Markov processes is interesting and we will now
show that the qualitative time framework can be used to model Markov processes.
The important properties of a Markov process as described in Section 7.4.4 for
a representation in terms of Allen’s relations are the ordering of events and the
factorisation over time slices. Hence a chain of events, connected with the relations
Ri ∈ {b,m} represents the correct ordering:
EI R1 E
′
J R2 E
′′
K R3 · · ·
Since this results in disjoint time slices, the factorisation property also holds under
the first order Markov assumption.
To generalise to representing a DBN with Allen relations we have to somehow map
events to time slices depending on the relations between them. A division in classes
of relations turns out to be useful here:
B = P ∪ P¯ ∪ C ∪O
where the subsets are the precedence relations P = {b,m}, the inverse precedence
relations P¯ = {b¯, m¯}, the concurrent relations C = {s, s¯, d, d¯, f , f¯ , eq} and the overlap
relations O = {o, o¯}.
Definition 7.7. A temporal partition Π of a set of temporal events EI is a partition
such that for all sets L ∈ Π it holds that: EI R E′J with R ∈ C iff EI ,E′J ∈ L; and
EI R E
′
J with R ∈ P ∪ P¯ iff EI ∈ L, E′J ∈M , M ∈ Π and L 6= M .
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First, we need to show that the uncertain temporal events can be linearly ordered.
Recall that a linear order ≤ is transitive, antisymmetric and total.
Lemma 7.1. Let EI be a set of temporal events and Π a temporal partition of EI ,
then, the temporal events can be linearly ordered.
Proof. The sets L ∈ Π are linearly ordered by the fact that the precedence relation
induces a linear order ≤. Hence, temporal events in different sets are also linearly
ordered. Events in each set L are equivalent as they are neither < nor >, showing
antisymmetry. Between any two temporal events in a temporal partition a relation
in B \O holds, so totality follows.
From the linear order that can be imposed on the temporal events it follows that
one can map temporal events to a DBN.
Proposition 7.2. A set of temporal events EI with a temporal partition Π can be
mapped to a DBN with the first order Markov assumption.
Proof. A DBN with the first order Markov assumption has arcs either within a time
slice or from time slice t to t+ 1. The temporal partition results in a linear order
by Lemma 7.1. Now let each L ∈ Π correspond to a time slice. Two time slices are
connected by arcs in the DBN graph if L < M with L,M ∈ Π, E′J R EI holds with
R ∈ P¯, E′J ∈M and EI ∈ L, and there is no set N ∈ Π such that L < N < M .
In other words, we can construct a first order Markov DBN for those temporal
networks that only contain relations in C and P, resulting in intra and inter time-slice
arcs respectively. If we also want to take into account the overlap relations I O J
the construction is less straightforward. The overlapping events can be considered
an indivisible unit, which allows us to assign the combined interval I ∪ J to a single
time slice. An undesirable consequence is that a chain of overlapping events would
result in a single time slice for the complete chain. However we can give a restriction
that allows us to deal with some overlapping events.
Proposition 7.3. Let EI O E′J , EI ,E′J ∈ EI . EI corresponds to a DBN if for all
E′′K ∈ EI we have E′′K R EI and E′′K R′ E′J with R,R′ ∈ C; or R,R′ either both in
P or both in P¯.
Proof. If R,R′ ∈ C the joined interval I ∪ J is also only related via C, which by
Proposition 7.2 results in a single time slice. If R,R′ ∈ P or R,R′ ∈ P¯ the joined
interval will by the same proposition result in a separate time slice for the events.
Uncertain Allen relations
The joint probability P (EI ,EJ , IRJ) represents the combined uncertainty in events
and their temporal relations. Quantifying uncertainty in the relations by means
of probability generalises the use of disjunctions in Allen’s algebra to model for
example uncertainty in the ordering of events. Conditioning the joint probability on
the temporal relation, we obtain:
P (EI ,EJ , IRJ) = P (EI ,EJ | IRJ)P (IRJ).
For fixed intervals I, J , the following holds:
P (IBJ) = P (
∨
r∈B
IrJ) =
∑
r∈B
P (IrJ) = 1,
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which is due to the mutual exclusivity of the basic relations. Thus, for any subset
R ⊆ B it holds that:
P (IRJ) = P (
∨
r∈R
IrJ) =
∑
r∈R
P (IrJ).
So although the set A is large (|A| = 213) the probability of a relation R ∈ A is
simply the sum over the basic relations in R.
Closure operations
When using probabilistic relations it is natural to think about whether the prop-
erties of Allen’s algebra can be generalised. Returning for a moment to relations
instead of a logic representation, we should reconsider the operations from Defini-
tion 7.2: inverse, intersection and composition. In [82] some methods were proposed,
explained below. However, in our opinion the motivation is lacking and we propose
an alternative for the probabilistic equivalent of the intersection operation.
We first introduce the notation P [IBJ ] to define a distribution over the elements of
B. So for example if for IRJ we have P (IeqJ) = 0.3, P (IbJ) = 0.7 and P (IrJ) = 0
for all r ∈ B \ {eq, b}; we write
P [IBJ ] = [eq : 0.3, b : 0.7].
Now, let the following probability distribution for JR′K be given:
P [JBK] = [d : 0.5, o : 0.5].
We can now define the probabilistic operations.
inverse The inverse of P [IBJ ] is found by elementwise inversion P [JBI ] = [eq :
0.3, b¯ : 0.7].
composition If we compute the composition I(R ◦R′)K we obtain I{bmosd}K,
for which we can compute the probabilities via the procedure in [82]
P (d) = eq ◦ d = 0.3 · 0.5 = 0.15
P (o) = eq ◦ o = 0.3 · 0.5 = 0.15
P (b) = b ◦ d = 0.7 · 0.5 = 0.35
P (bmosd) = b ◦ o = 0.7 · 0.5 = 0.35
Note that P (Ir′′K) = P (IrJ)P (Jr′K) with r′′ = r ◦ r′. The composition b ◦ o
results in multiple relations, which means that the probability 0.35 has to be divided
over {bmosd}. A non-informative choice would be a uniform assignment, but in
general we have
P (I{b, o, d, (b∨m∨ o∨ s∨ d)}K) = 1
0.15 ≤ P (IdK) ≤ 0.15+ a
0.15 ≤ P (IoK) ≤ 0.15+ b
0.35 ≤ P (IbK) ≤ 0.35+ c
P (ImK) + P (IsK) + a+ b+ c = 0.35
which implies a, c, b ∈ [0, 0.35].
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R1 R2
I1 I2
R
g
Figure 7.3: Causal independence model to combine the distributions over the relations
R1,R2 via the interaction function g.
intersection For the intersection operation we first consider conditioning. As-
sume that we have the following probability distribution:
P [IBK] = [m : 0.3, o : 0.7]
When we now also learn that I{m, s}K holds this means that according to Allen’s
algebra only ImK can hold as {m} = {m, o} ∩ {m, s}. Probabilistically, this can
be viewed as a conditioning event which leads to the conclusion that meets holds
almost surely, as follows:
P (ImK | I{m, s}K) = P (ImK)
P (I{m, s}K) =
P (ImK)
P (ImK) + P (IsK)
= 1
as P (IsK) = 0, and
P (IoK | I{m, s}K) = P (⊥)
P (I{m, s}K) = 0
Here we assume that we know the initial distribution and obtain additional in-
formation on which we can condition. In this particular situation we can solve the
problem and compute the probabilities as in the example. This is different from
the approach taken in [82], where two distributions PR′ (IR′J) and PR′′ (IR′′J) are
combined into a single distribution P (IRJ):
∀x ∈ R : PR(IxJ) = 1
Z
PR′ (IxJ)PR′′ (IxJ)
PR′ (IxJ) + PR′′ (IxJ)
,
where Z is the normalisation Z =
∑
z∈R PR(IzJ). There appears to be little theor-
etical justification for this approach however. Instead, we opt to use the framework
of causal independence, which offers a principled approach to model interactions
between probabilistic events. Modelling the intersection operation then results in
the graphical model shown in Figure 7.3.
The behaviour of the causal independence model depends on the choice of in-
teraction function, g in the figure. Using some variant of the noisy-AND appears
appropriate, due to the similarity to the logical case. Since the relations are not bin-
ary valued the standard approach does not apply, but the generalisation by Srinivas
[90] offers an alternative. The probability of R given R1 and R2 is given by:
P (R | R1,R2) =
∑
{I1,I2|g(I1,I2)=R}
∏
i
P (Ii | Ri)
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where the probabilities P (Ii | Ri) are given by:
P (Ii = x | Ri = y) =
{
P (pass(Ii)) + P (fail(Ii = x)) if x = y
P (fail(Ii = x)) otherwise
where fail(Ii = x) indicates that Ii takes on the value x irrespective of the value of
Ri, whereas pass(Ii) indicates that no failure occurs and hence
P (pass(Ii)) = 1−
∑
z∈val(Ri)
P (fail(Ii = z)).
For the interaction function g an analogue to the conjunction used in Allen’s algebra
is the componentwise AND-function
R = g(I1, I2) with R(i) = I1(i) ∧ I2(i),
where the components correspond to the basic relations B and R(i) denotes the ith
component of R and similarly for I. This then results in the probabilities
P (R = r) = P (g(I1, I2) = r) = P (I1 = r)P (I2 = r),
which is not a normalised distribution, so after normalisation we obtain
P (R = r) =
1
Z
P (g(I1, I2) = r) =
1
Z
P (I1 = r)P (I2 = r),
where Z =
∑
z
P (I1 = z)P (I2 = z).
7.5.4 The framework in CP-logic
Probabilistic logic, and specifically CP-logic, offers a way to implement the frame-
work described above. In CP-logic events are represented by facts, which are inter-
preted as independent events. Relations between facts are stated by logical expres-
sions and through these expressions, dependences between events embedded in the
facts can be introduced.
We can now define our language which we call Qualitative Time CP-logic as a
restriction of CP-logic. The language consists of CP-rules (Definition 7.3), where
the predicates model temporal probabilistic events (Definition 7.4). Furthermore,
the special predicates r/3 and allen/3 (defined in Section 7.4.2), are used to denote
the temporal relations between the events in each rule. We allow abbreviations
where the omission of an interval means that the event is static over the time of
interest and the omission of a relation in a rule indicates that allen(·, ·, [B]) holds.
These abbreviations allow us to incorporate specific static rules in standard CP-logic
syntax. The probabilistic semantics are inherited from CP-logic, which leads to the
result in the following subsection.
7.5.5 Reasoning with temporal events
Now that we have defined uncertainty with respect to temporal events we can exam-
ine reasoning with uncertainty and time. To capture the qualitative nature of the
time representation in logic, we represent intervals as atoms, foregoing the need to
reason about the underlying time points.
The probability of temporally related events is of interest, which is, as we have
seen, the probability P (EI ,E′J , IRJ). The following proposition shows how we can
compute this probability via the CP-logic semantics, given that IRJ is a logical
relation between the intervals associated with the events.
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Proposition 7.4. Let R be a relation R ∈ A, and EI ,E′J ∈ EI events; the probab-
ility P (EI ,E′J , IRJ) is then obtained as follows:
P (EI ,E′J , IRJ) = P (EI | E′J , IRJ)P (E′J | IRJ)P (IRJ)
=
∑
`
I`(EI ,E′J , IRJ)
∏
e`
P (e`)
where ` denotes a leaf node in the tree, e` is an edge on the path from ` to the root
of the tree; and I`(x) is an indicator function that is 1 if x is true in `.
Proof. (sketch) The proposition follows from the probability tree semantics of CP-
logic. An event EI is either true with a priori probability p, or is the consequent
of a rule EI : p ← B, with B the body of the clause. A rule decomposes the
joint probability P (H,B) into P (H | B)P (B). The probability of a particular event
can hence be computed via a series of rule applications, which can be represented
as a event tree. As CP-rules fire independently, we obtain the product from the
proposition as a path in the tree. As there are multiple series of rules (logic proofs)
that can lead to the same events, the total probability P (EI ,E′J , IRJ) is the sum
over those leaves ` in which the events are true.
The proof relies on properties of CP-logic, the details of which can be found in
[103]. Note that the temporal relations can be seen as a special kind of event. We use
them only as constraints in the body of rules, but this is not a technical requirement.
Example 7.6. We are again interested in modelling the relation between an infec-
tion and the occurrence of an exacerbation. Given the temporal relations overlaps
and equals we now obtain the CP-logic rules:
exacerbation(j) : 0.7; ¬exacerbation(j) : 0.3← infection(i), allen(i, j, [o, eq]).
r(i, j, o) : 0.8; r(i, j, eq) : 0.2.
infection(i) : 0.01.
It follows that the probability of an exacerbation is a priori 7 · 10−3, and if we would
have (definite) evidence for an infection the probability would be 0.7.
The distribution over possible temporal relations in this case has the same result
as when r(i, j, o) or r(i, j, eq) holds with probability 1, since the same rule for exacer-
bation fires in both cases. It does show however that by specifying a distribution
in this way the relations are mutually exclusive also in the reasoning process, which
ensures that the right probabilities are computed, as given in Proposition 7.4.
7.5.6 Metric relations
A number of extensions to Allen’s algebra have been proposed (e.g. [29, 53]) based
on various kinds of constraint reasoning. The added value lies mostly in metric
constraints, which allow numerical constraints in addition to the pure qualitative
relations in Allen’s algebra. Jonsson and Bäckström [52] proposed the framework of
disjunctive linear relations, which supports tractable reasoning with metric relations,
while being at least as expressive as a number of earlier proposals (see also [58] on
tractability results).
For practical medical applications metric constraints seem a useful addition to qual-
itative relations, enabling a more precise model of the temporal relation in those cases
where the necessary level of quantitative detail is attainable. The essence of adding
metric information is that additional constraints between interval endpoints should
99
describing disease processes using a probabilistic logic of qualitative time
be satisfied, which can be modelled in the logic part of our specification. That is,
special instances of temporal relations can be defined containing a metric constraint.
The metric extension is useful to model relations that cannot be expressed within
the original algebra, for instance a physical constraint that some effect occurs only
after a certain amount of time.
Formally, for a qualitative temporal relation R ∈ B, a quantified version Rm(x, y)
of this relation has numerical parameters x, y that bound the distance between in-
terval endpoints. Depending on the temporal relation, this definition can still be
implemented in different ways. For instance a constraint like ‘I is at least two time
points before J ’ can be specified with a single quantitative parameter, leading to an
alternative definition of before:
bm(I, J ,X,Y )← I+ +X < J−,
meaning that I is at leastX time points before J . Here we did not need the parameter
Y , in practice different types of metric constraints might be useful that do require
two parameters, like ‘I between 2 and 4 time points before J ’:
bm(I, J ,X,Y )← X ≤ J− − I+ ≤ Y .
With this parametrisation we can construct a quantified set of temporal relations on
a level of detail that is appropriate for the domain.
To specify a distribution over relations, notice that the metric versions of the
qualitative relations define a subset of the intervals, i.e. in terms of relations as sets
bm ⊆ b, hence the probability assigned to before can be distributed over the metric
relations under the condition that they are disjoint. For example, if in the original
distribution the probability of before was p and we want to introduce the relation
‘at least two time points before’, b>2, with probability 12p, it suffices to define b>2
and add the rule
Ib>2J : 0.5← IbJ .
7.6 validation of the qualitative probabilistic framework
In this section, we return to the two typical biomedical cases described in Section 7.2
and we use them here to validate the framework. We investigate whether the frame-
work has sufficient expressive power to capture the biomedical knowledge concerning
those cases. As the same framework is used to handle different cases, this shows that
the framework is generic and has potential for dealing with a wide variety of other
biomedical problems as well.
7.6.1 Temporal Nodes Bayesian Networks
We first study a particular class of temporal models called temporal nodes Bayesian
networks (TNBN) [6], which represent event intervals as values of variables in a
Bayesian network. This allows reasoning about events in those situations where one
is not interested in dynamic changes over time but in single occurrences that are
temporally uncertain. This class of models describes a worthwhile subset of the
situations that we want to be able to represent.
In a recent paper [48] a TNBN was used to model interactions between antiretro-
viral drugs and mutations of the Human Immunodeficiency Virus, HIV, that result
in drug resistance. The temporally uncertain aspect is here the occurrence of the
mutations given other mutations and an antiretroviral drug or a cocktail of those
drugs (which present an evolutionary pressure for particular mutations to succeed).
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IDV TPV
L63P I93L
∅ : P0
[24, 136] : P1
[137, 217] : P2
[218, 302] : P3
[303, 454] : P4
∅ : P00
[16, 110] : P01
[111, 203] : P02
[204, 309] : P03
Figure 7.4: Submodel of the TNBN from [48].
The presence of drugs is modelled atemporally, while each mutation has a probability
of occurrence in each of a set of consecutive intervals.
To represent this in our logic we first need to represent the atemporal information,
which consists of a set of ground clauses of the type:
anti_viral(X) : P .
indicating that a particular drug X occurs with probability P , although when study-
ing a particular situation it will typically be known which drugs are present, allowing
us to instantiate these clauses to either true of false. Each mutation is influenced by
other mutations and drugs resulting in rules of the type:
mutation(X, ∅) : P0; mutation(X, i1) : P1; mutation(X, i2) : P2;
. . . ;mutation(X, in) : Pn ← mutation(Y , j), . . . , anti_viral(Z), . . .
where i1, i2, . . . , in, j are ground intervals, ∅ indicates the event did not occur and∑n
k=0 Pk = 1 holds as usual. In terms of Allen’s relations we have the constraint
i1 m i2 m · · ·m in,
for all temporal variables. However, because each variable is allowed to take on
different interval values, interactions between mutations result in other temporal
relations. In TNBNs these relations are modelled implicitly in the probability distri-
butions. That is, if mutation(X, I)← mutation(Y , J), the n · (m+ 1) parameters for
ik, jl with k ∈ {0, . . . ,n}, l ∈ {0, . . . ,m} encode the Cartesian product of possible
combinations of I and J .
Concretely, we model the two most common mutations, L63P and I93L, and two
drugs, IDV and TPV, that influence them. This is a submodel of one of the networks
described in [48], reproduced in Figure 7.4. This results in the following rules:
anti_viral(IDV).
anti_viral(TPV).
mutation(L63P, ∅) : P0; mutation(L63P, [24, 136]) : P1;
mutation(L63P, [137, 217]) : P2; mutation(L63P, [218, 302]) : P3;
mutation(L63P, [303, 454]) : P4 ← anti_viral(IDV).
mutation(I93L, ∅) : P00; mutation(I93L, [16, 110]) : P01;
mutation(I93L, [111, 203]) : P02; mutation(I93L, [204, 309]) : P03;
← anti_viral(TPV), mutation(L63P, ∅).
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where for brevity we have omitted the rules for the other parent configurations of
I93L which are analogous to the one shown. It is easy to see that the probability of
for example mutation(I93L, ∅) can be computed as:
P (mutation(I93L, ∅))
=
∑
I
P (mutation(L63P, I))P (mutation(I93L, ∅) | mutation(L63P, I))
=
4∑
i=0
PiPi0.
This is the expected result of the CP-logic semantics and of TNBNs, and indeed our
rule representation is equivalent to the TNBN.
With our representation we can also quite simply introduce extensions with little
additional work, as the framework takes care of the probabilistic reasoning. For
example it may be interesting to make the temporal representation more qualitative,
instead of the concrete intervals used now. To do so we can model the interaction
between mutations by means of a temporal relation, and especially before is a natural
candidate. For instance, the influence of L63P on I93L can be modelled as two rules,
for the case that L63P does not occur (not shown) and for the case that L63P occurs
before I93L:
mutation(I93L, ∅) : P10; mutation(I93L, J) : P11;
← anti_viral(TPV), mutation(L63P, I), r(I, J , b).
Another possible extension would be to also take into account time for the antiviral
drugs. It appears plausible that the influence of a drug is concentrated in the interval
in which it is present, with possibly limited influence some time longer due to the
fact that it changed the population of viruses. We can capture this idea in the rules:
anti_viral(IDV, I).
mutation(L63P, ∅) : P0; mutation(L63P, J) : P1;
← anti_viral(IDV, I), r(I, J , eq).
mutation(L63P, ∅) : P ′0; mutation(L63P, J) : P ′1;
← anti_viral(IDV, I), r(I, J ,mx).
where the relation mx is a metric version of the meets relation, defined as ImxJ ←
I+ = J− ∧ J+ − J− ≤ x, allowing us to limit the time of influence of the drug after
it is no longer administered.
The ease with which we can incorporate ideas for extensions in the language shows
the versatility of our framework. The logic offers a readable language to represent
relations both atemporal and temporal which together with the probabilistic se-
mantics results in a compelling framework to represent many clinical situations. We
now return to the problem of modelling the disease process of COPD.
7.6.2 Describing the evolution of COPD
Our framework is particularly well-suited to the clinical task of monitoring patients
with chronic obstructive pulmonary disease. As the previous examples have shown
both the time and uncertainty aspects play a role in COPD management. In this
section we develop a model of COPD disease progression in more detail.
We start with a clinical description of influence between the relevant variables
and their qualitative temporal relations. Relevant events to construct a process
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description of COPD progression are the outcome variable exacerbation its usual
cause infection and the observable symptoms, signs and lab data. In the context of
monitoring patients at home, access to signs or lab data is limited and we focus on
symptoms, specifically dyspnea (difficulty in breathing), sputum colour and volume,
cough and reduced activity. The patients from whom the data have been acquired
typically have around two exacerbations per year, and consequently exacerbation
symptoms will be largely absent most of the time. The situations we are interested
in are the episodes in which an exacerbation occurs. When an exacerbation develops,
different symptoms will increase over time until either through medication or through
natural recovery the symptoms return to normal levels.
After having identified the variables our logic representation makes it is easy to
model explicitly the structural relations in the domain. That is, we construct rules
of the type:
symptom(P ,S)← infection(P ,Y ), symptom(S), patient(P ).
symptom(dyspnea).
symptom(cough).
symptom(sputum).
symptom(activity).
This indicates that a patient P with an infection Y (which would allows us to specify
different kinds of infections, e.g. bacterial or viral; or even more detailed by identi-
fying specific bacteria that often cause airway infections like H. Influenzae, or S.
Pneumoniae, but here we limit ourselves to just modelling the presence of an infec-
tion), has symptoms from the set {dyspnea, cough, sputum, activity}. In addition
we should take into account interdependencies of the symptoms, for example, that
an increase in dyspnea can cause a decrease of activity (the fact that some symptoms
indicate an increase and others a decrease can easily be represented explicitly in the
logic but is omitted for simplicity):
symptom(P , activity)← symptom(P , dyspnea), patient(P ).
The resulting rules are quite readable, and both obtaining and verifying the domain
knowledge with help from an expert is a realistic option.
Given the structural properties the next step is modelling the temporal character-
istics. It is unrealistic to have precise timing information as this depends on many
patient specific and environmental factors. Allen’s algebra is a useful compromise
between unattainable precise temporal knowledge and disregarding the temporal
dimension of the problem completely. Concretely, we can describe the temporal
structure of the process by assigning relations between infection events, exacerba-
tion events and symptoms, for example in a substantial number of cases the first
symptom to increase is dyspnea, which often stays present until the exacerbation
ends. So the most likely temporal relation would be:
infection {d¯o} dyspnea {f¯o} exacerbation.
Similarly we can use domain knowledge to define relations for the other symptoms
with respect to infection and exacerbation events. Analogous to the structural rela-
tions, we can also take into account the temporal relations between symptoms. It
should be noted however that if the desired information is hard to obtain, this just
means that we have no explicit constraint on the temporal relation between events,
which means that all basic relations are possible.
In general it will often not be easy to specify structural and temporal character-
istics exactly, requiring the inclusion of uncertain information. The advantage of
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starting with logic (without probabilities) is that the main structure of the process
can be determined more easily. The choice for a probabilistic logic like CP-logic
allows us to subsequently refine the representation within the same framework to
include uncertainty. If clinical data is available, it can be applied in this stage to
estimate probabilities.
The temporal relations may also be underspecified which can be modelled with
a distribution over the basic temporal relations. For example derived from relative
frequencies in the data and a knowledge-based prior distribution. We then might
obtain for example the following distribution for the relation between an exacerba-
tion and dyspnea – which in CP-logic notation consists of a set of statements like
r(I, J ,X) : P , where X is a temporal relation and P a probability – shown here more
compactly:
b 0 m 0 o 0 s 0.01 d 0.05 f 0.35 eq 0.18
b¯ 0 m¯ 0 o¯ 0.2 s¯ 0.05 d¯ 0.1 f¯ 0.05 (7.4)
The relation before and meets have been assigned probability zero, because we are
only interested in symptoms that actually co-occur with an exacerbation. And over-
laps has zero probability since it makes little sense to consider exacerbations that
start before their symptoms.
Putting it all together we end up with a representation that includes structural,
temporal and uncertainty information. To give an example of the reasoning in our
COPD model we restrict ourselves to the symptoms dyspnea and cough, their cause
infection and the effect exacerbation. We assume the temporal relation equals for
the relation between the symptoms and infection. Then using the predicates we
introduced in Section 7.4.2 and somewhat more compact notation for readability
(omitting the specification of the patient P , writing symptoms as predicates and
some set-notation in 7.8), the rules to model this process are the following:
dyspnea(I) : 0.8← infection(J), r(I, J , eq). (7.5)
cough(I) : 0.6← infection(J), r(I, J , d¯). (7.6)
exacerbation(I) : 0.95← dyspnea(J), allen(I, J , [o¯, f ]), cough(K), r(I,K,X).
(7.7)
exacerbation(I) : 0.7← dyspnea(J), allen(I, J , [C \ {f}]), cough(K), r(I,K,X).
(7.8)
infection(I) : 0.05← infection(J), r(I, J , b¯). (7.9)
infection(i1) : 0.05. (7.10)
Both exacerbations and individual symptoms are recurring events but the start
event of a series of occurrences is the only event for which we need to model the repeti-
tion. This is expressed by rule 7.9. To predict the probability of an exacerbation in a
particular interval, we need probabilities for the dependencies between exacerbations
and symptoms given a temporal relation. Instead of exhaustively enumerating all
relations, we identify the dominant pattern: exacerbation is overlapped-by or finishes
dyspnea. The only probabilities that have to be specified are those for the dominant
temporal pattern (rule 7.7) and for the case summarising the other situations (rule
7.8). Instantiations of the relation predicates for specific intervals are omitted for
conciseness.
With this representation we can now query probabilities of interest given evid-
ence (observations). For example, let us assume the relations between infection
and the symptoms, r(dyspnea, infection, eq) and r(cough, infection, d¯) hold. The dis-
tribution for r(exacerbation, cough,X) can be derived from r(dyspnea, infection, eq),
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Time (days)
Prob. without / with evidence
Exacerbation0.840.001
Dyspnea10.04
Cough10.03
Infection-0.05
Figure 7.5: Graphical representation of the example time-course and probabilities. The
proportion of the circle that is shaded indicates the probability.
r(infection, cough, d) and allen(dyspnea, exacerbation, [C ∪ {o¯}]) leading to the relation
allen(exacerbation, cough, [C ∪O]), with the distribution:
o 0.009 s 0.006 d 0.006 f 0.006 eq 0.006
o¯ 0.189 s¯ 0.189 d¯ 0.572 f¯ 0.009 (7.11)
resulting from the procedure described in 7.5.3 and using the uniform distribution
to split up probabilities when the composition resulted in multiple basic relations.
To compute P (exacerbation) the relation is marginalised, but it nonetheless provides
the insight that the probability that an exacerbation contains an episode of coughing
is high.
Computing P (exacerbation) from the rules and distributions above, we obtain
P (exacerbation) = .001, which is dominated by the small prior probability of an
infection. Then, if we have evidence (from the patient) that dyspnea and cough are
present, we obtain P (exacerbation) = 0.84. See also Figure 7.5.
Dynamic Bayesian network
To show the different aspects of the language we can compare the situation above
to a model based on a dynamic Bayesian network. As we have seen we can convert
a model based on Allen’s algebra to a DBN using the procedure in Section 7.5.3.
First we notice that possible infections are the repeating events (with relation be-
fore) that define the time slices of the DBN. Inspecting the rules above we see that
the symptoms are contemporary with the infection event, resulting in connections
within the time slice. Both observations are a direct consequence of Proposition 7.2.
However, we also have that the relation between dyspnea and exacerbation is over-
laps with probability 0.2. In Proposition 7.3 we gave a characterisation of situations
for which we can construct a DBN. In the current situation it means that the ex-
acerbation and its symptoms would have to be modelled as interacting in the same
time slice. This seems a reasonable solution, resulting in the DBN structure shown
in Figure 7.6. Note that a consequence of this choice is that we lose the possibility
to make a distinction between the start of the symptoms (dyspnea, cough) and the
exacerbation. This shows that although a DBN can be constructed for this situation,
the representation with Allen’s algebra is more expressive.
With respect to the probabilistic parameters we can reuse the parameters from
the logic representation. We did not display the rules that govern the probability
of symptoms without an infection, which are needed to complete a conditional prob-
ability table, but they have a similar pattern as the rules shown. The uncertainty
on the relations is however less easy to represent: since we aggregate all concurrent
relations, an obvious solution would be to marginalise out the relations. Taking as
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I0
D0 C0
E0
It
Dt Ct
Et
Figure 7.6: Structure of the COPD-monitoring DBN. Dashed arcs represent inter time-
slice connections. I=infection, C=cough, D=dyspnea, E=exacerbation.
an example the probability of exacerbation given that dyspnea and cough are true,
this results in the parameter estimate (omitting the conditioning on D,C on the
right for readability):
P (E | D,C) =
∑
RED ,REC
P (E,RED,REC )
=
∑
RED ,REC
P (E,RED | REC )P (REC )
=
∑
RED={o¯,f}
P (E,RED) +
∑
RED={C\f}
P (E,RED)
=
∑
RED={o¯,f}
P (E | RED)P (RED) +
∑
RED={C\f}
P (E | RED)P (RED)
= 0.95 · 0.55+ 0.7 · 0.45
The parameter estimates for the other cases are similar.
Alternatively we can explicitly model the relations within the time slice by intro-
ducing extra variables that take the relations as values. To maintain the temporal
semantics of the DBN we again only consider relations in C within a time slice. The
network from Figure 7.6 can then be extended to the one in Figure 7.7. Since we
assumed earlier that the distribution over temporal relations is independent of the
values of the (event) variables involved, the relation variables do not have parents
in the graph. The parameters of the relation variables are equal to the distribution
in (7.4). For exacerbation, in this particular example REC has no influence and we
can encode the joint distribution of dyspnea, cough and RED easily in the CPT. We
obtain P (E | D = 1,C = 1,RED = r) = p where p = 0.95 when r ∈ {o¯, f} and
p = 0.7 when r ∈ {C \ f}. This follows directly from the rules we gave earlier.
Summarising, we can see that comparing the two representations the DBN has
a straightforward interpretation in terms of events that happen at the same time
and those that do not. Allen’s algebra allows a richer temporal structure without
enforcing too much temporal detail. The logic representation can be used when only
ordering information is available and allows us to model both structural and temporal
information. Furthermore, since it is easy to define new relations for a particular
domain situation, much more complex relations can also be specified easily. In
order to gain the same level of detail in a DBN representation one has to introduce
additional variables, losing some of the convenience of the compact representation
of DBNs.
The best choice of temporal model is a balancing act where it depends on the
importance and availability of temporal information whether a DBN or a logic rep-
106
7.7 conclusion
I0
D0 C0
E0RED REC
It
Dt Ct
EtRED REC
Figure 7.7: Structure of the COPD-monitoring DBN with variables for the temporal
relations. Dashed arcs represent inter time-slice connections. I=infection,
C=cough, D=dyspnea, E=exacerbation.
resentation has more value. In the case of COPD monitoring, a DBN is useful as
a simple classifier that takes some temporal information into account. However, to
gain a better understanding of the nature of the disease process it is worthwhile to
use a richer representation that models different kinds of temporal relations between
symptoms and between a symptom and an exacerbation. Using qualitative rela-
tions we can model the additional temporal structure, without requiring unrealistic
temporal detail.
7.7 conclusion
In this paper we reformulated and extended Allen’s algebra in a probabilistic logic,
leading to a framework calledQualitative Time CP-logic. Medical processes are often
well suited to be represented in a qualitative time framework, and the representation
explored in this paper appears to capture knowledge that fits clinical reasoning well.
Specifically, the framework allows us to construct models stepwise, starting with
structural properties represented by logic, adding qualitative temporal information
and finally representing uncertainty with probabilities. Compared to directly con-
structing a dynamic Bayesian network, we gain the expressiveness of probabilistic
logics in general and a more intuitive time representation. If desired, the model can
still be converted to a DBN, but this requires some assumptions on how to simplify
the temporal information represented with Allen’s algebra. Our COPD model indic-
ates that we can specify clinically relevant processes in an intuitive fashion within
our framework, while the generic nature of the framework implies that we can also
deal with many other biomedical situations.
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8
DISCUSS ION AND CONCLUS ION
In this thesis we have studied both practical and theoretical aspects of dealing with
uncertain temporal processes and data in a clinical context. We focussed on chronic
disease management in which the combination of uncertainty and time occurs natur-
ally, although similar situations can also be identified in other fields of medicine. The
application domain of chronic disease care lead to the development of a monitoring
system for COPD-exacerbation detection. The system has the potential to improve
patient well-being and reduce health-care costs while at the same time provided a
relevant context for the development and application of modelling techniques.
In this final chapter we place our contributions in a broader context and provide
some views on directions for future research.
8.1 smart mobile health
As was mentioned in the introduction, eHealth and more recently mHealth are a res-
ult of technological advances that allow us to automate some aspects of health care.
Making information available is one of the main contributions of this automation.
Our system also contributes to this aspect by making it possible for both the patient
and the physician to be kept apprised of a patient’s health status. However, as a
result of monitoring too much information may become available, so that filtering
becomes a necessity. We think that this is where our smart mobile health approach
is an improvement over previous monitoring systems. Producing data is in itself not
a useful activity unless it can be used to improve health care, either through bet-
ter patient care or efficiency gains. For the former, it is important to give patients
feedback on their health in a timely manner, for which our system is well suited. In
addition feedback needs to be understandable and appropriate, a topic that in this
stage of the development of our system has received fairly limited attention. To give
proper feedback further cooperation with physicians is necessary to establish the
appropriate course of action in a given situation, which is nowadays facilitated by
clinical guidelines that summarise current best practices. With respect to efficiency
we think that because early detection of exacerbations may prevent hospital admis-
sion and our system is better equipped to make timely detection possible than the
methods that are now usual care, the potential for cost reduction is considerable.
Design
The design of the monitoring architecture was an important aspect to consider.
While at the start of the project in 2008 it seemed reasonable to base the system on
a notebook computer it quickly became apparent that a more future-proof solution
would be implementing the system on a smartphone. The release of the Android
operating system – or to be precise the availability of phones running Android in
2008 – provided the open-source platform that allowed us to easily develop our own
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application. An advantage of using smartphones is the increased mobility and the
fact that many people are already accustomed to carrying a phone on their person.
A consequence of this choice was that we had to find sensors that could communicate
with our application, which turned out to be difficult to find as medical sensors are
usually only available as a monolithic package of hardware and software. Although
we finally found a solution for spirometry and pulse-oximetry with Bluetooth com-
munication, it is currently a rather custom and costly option. As an alternative we
have also looked into developing our own hardware (in cooperation with the Radboud
University Techno Centre). This has lead to a prototype of a new sensor interface,
but more work is required before this can be used in practice. To enable large scale
employment it is clear that both the hardware and software should be improved and
tested further to ensure stable operation.
Model development
To implement smart mobile health care we have turned to probabilistic models to
represent uncertain disease processes. The advantages of such models are that they
can describe patient monitoring in a way that is easily interpretable; can be construc-
ted both manually and from data; can be given a causal interpretation; are robust
to missing values and are versatile in the sense that they can be used as a classifier
as well as to provide insight in the domain by computing arbitrary probabilities of
interest in the domain. These are all desirable properties which support the choice
for Bayesian networks. This does not mean however, that a Bayesian network is the
only possible solution, and indeed also for the COPD-exacerbation prediction task
it is conceivable that other methods would be effective. Especially if we drop the
requirement of interpretability, many statistical machine learning methods (see e.g.
[46]) could be applied to classify monitoring data as either an exacerbation or not
an exacerbation. With increasing model complexity however, including environment
factors and therapy plans such that we can support patient self-management with
mobile decision support, interpretability is of great importance to maintain account-
ability of the system. Bayesian networks are therefore in our opinion a good choice
for automatic data interpretation.
The development of a disease model can be based on expert knowledge, on data
or a combination of the two. Unfortunately, even though COPD is a common dis-
ease there is little data available. Clearly, particular data is available in patient
records, but detailed day by day information is scarce and generally not accessible.
Although patient data is privacy sensitive, one could argue here for open access of an-
onymised data for scientific purposes. The scarcity of data meant that hand-crafting
a model was our only initial option, which does have the advantage of obtaining
insightful knowledge from experts in the field. Knowledge elicitation is however a
time-consuming and difficult task often hard to fit into the busy schedule of clinical
specialists.
After the pilot study we had a limited amount of data, gathered with our system,
which could then be exploited to learn models, leading to the work in Chapter 5
on model learning from small data samples. A possible shortcoming of structure
learning temporal Bayesian networks from small data samples is that we may learn
models that have too much variance. Although the first validation indicates that per-
formance is quite good, a more extensive evaluation is necessary. Further limitations
lie in the variables that are taken into account to predict exacerbations. To increase
the practical clinical relevance the model needs to be extended from purely interpret-
ing the monitoring data to taking into account patient history, therapy plans and
environmental factors. For decision support purposes, especially therapy plans will
be an important addition to the model.
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Evaluation
The system as a whole and the model in particular needs to be evaluated to establish
first whether it works as expected and second whether it has added value in health
care. The pilot study served to start answering the first question, indicating that
monitoring can be effective and that the model is capable of predicting exacerbations.
The performance of the prediction degrades when we try to make predictions further
ahead in time, which is to be expected, but gives us a kind of graceful degradation.
For sudden onset exacerbations this is not the case however, as these cannot be
detected before the actual onset. Although promising, the pilot study is not sufficient
to fully establish these findings due to the small number of enrolled patients, so the
generalisability is limited. Further clinical validation of the probabilistic model is
necessary to make the step to actual decision support based on the predictions.
The prototype does inspire confidence in the underlying ideas and consolidating the
system to be practically clinically usable appears worthwhile. In the next section,
on future research, we will outline further evaluation steps.
Further considerations
The nature of monitoring also has an ethical aspect as it encroaches on patients’
private life. Ethics play a role in all medical procedures, but gathering data over a
prolonged period of time at home is a particular kind of situation. Data security is
an important issue that should be considered and furthermore, besides the purely
technical perspective, it should be regulated who owns the data and who has access.
We would argue here that patient empowerment should also mean that the patient
is in control of the data and has to actively grant access rights (also for anonymised
data for scientific purposes). Nonetheless from a clinical efficacy point of view it
appears useful to integrate our system with existing health care information systems
used by physicians and nurses. This is the usual trade off between security and
convenience. In practice a middle ground will have to be found.
Embedding smart monitoring in actual clinical practice is not trivial. The road
from a working prototype to a system that is implemented within existing health care
procedures is full of pitfalls of a diverse nature related to responsibility, (technical)
support, regulatory requirements, financing, etcetera. We should therefore be careful
to keep the needs of the patient in mind and try to minimise procedural overhead. Fo-
cussing on supporting self-management can play a role in ensuring we really improve
disease management from a patient perspective, as it is in principle possible for our
system to function independently. Nonetheless integration with existing health care
structures may have added value by improving information provision. This means
an appropriate way has to be found to integrate our system, which in some sense
is yet another information system, within the workflow of clinicians. Finally, for a
practically useful system both patients and physicians need to be convinced of its
use and usability, but we think that the potential benefits are sufficient to attempt
to overcome the problems of implementation.
8.2 future research
The work described in this thesis leaves various opportunities for further research.
From a clinical perspective it is clear that the current system is promising but lacks
a rigorous validation in the form of a randomised clinical trial designed to evaluate
the benefits of the home monitoring system compared to usual care. At the time of
writing, realising this validation is in progress, starting with a data gathering study
with a larger group of patients to validate the probabilistic model. The availability
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of additional data will also give us the opportunity to further investigate the pre-
diction task and revisit the machine learning approach to find models and estimate
parameters. One of the interesting questions that we will try to answer is whether
longer term temporal trends can be found that improve prediction performance.
A possible improvement to the models used to capture the COPD monitoring
process is including more general risk factors in the model to augment the pure
monitoring data. Especially modelling in some detail the different therapies and
their effect is of interest to capture the possible influence on future exacerbations.
This has the added benefit of allowing the model to generate what-if scenarios for
therapy change to compare their effect according to the model, which is useful for
decision support. Clearly it is not feasible to model in detail the effect of the many
drugs in use, but it does appear useful to model effects at the level of classes of drugs
like short or long acting bronchodilators, corticosteroids and antibiotics.
The extension to decision support requires integration of patient advice in the
model. Although related, this does not necessarily depend on modelling therapy
effects, as we could also view therapy as a black box that relies on clinical guidelines
and input from a physician. Various techniques have been developed over the years
for decision making under uncertainty, notably Markov decision processes (MDPs)
and influence diagrams, where the former has a focus on finding optimal policies for
making many decisions while the latter usually deals with a more structured domain
and can be viewed as an extension of Bayesian networks with decisions. Research in
the integration of MDPs and dynamic Bayesian networks [13] is of interest as a way
to extend our dynamic Bayesian network models to include decision making under
uncertainty.
The characteristics of monitoring data described in Section 1.4 inspire further
ideas for future work. We have studied some aspects of temporal indeterminacy in
Chapter 6, but the problem is not yet solved. Studying more general ways to deal
with indeterminacy, without relying on predetermined granularity bounds is still a
challenge in terms of modelling, inference and learning. A generalisation to multiple
granularities would also be of interest. The language we developed in Chapter 7 is
a different approach to modelling temporal uncertainty but is limited to reasoning
about the relations between events and not the actual interval instances, in the sense
that it remains a qualitative representation. In many situations this turns out to
be sufficient, but it may be possible to further extend the language. Irregular data
acquisition [80] and non-stationary models [81] have received some attention but a
general approach to tackle the combination of problems associated with representing
uncertain temporal data is still of interest. It appears that probabilistic models or
perhaps a generalisation to probabilistic logic are a useful starting point for this
research.
Another topic that justifies further research is personalisation. To properly sup-
port each individual patient the system should be able to adapt to the patient’s
personal characteristics. Part of the value lies in the departure from group level
models that are common in medicine. Especially for COPD that exhibits different
disease types (number of exacerbations, bronchitic or emphysemic characteristics),
personalisation may be able to improve decision support. Practically, personalisa-
tion may be achieved by using the monitoring data to update the parameters of the
model. What the best way is to do so, taking into account that exacerbations are
rare events, is an open research question.
Finally, a note on generalisability. We have developed a monitoring platform
consisting of a smartphone application that includes a disease model, sensors and
a web-application for administration purposes. To use this for a monitoring system
targeted at a different disease some parts can be reused as the general architecture
will be the same. However if different sensors are required new interfaces will have to
be developed. The most important aspect for decision support is the disease model,
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which is also the main bottleneck in terms of development. It usually requires a
substantial investment of time from a domain expert and availability of data. So
although the principles behind the system are generalisable, expansion to a different
domain still entails a considerable amount of work. Nevertheless, mHealth solutions
with disease models remain an interesting direction for research with great potential
to improve healthcare.
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SUMMARY
Uncertainty is one of the difficulties one has to deal with in complex decision making
situations. In this thesis we have studied this problem using probabilistic models in
the clinical context of chronic disease management. Chronic obstructive pulmonary
disease (COPD) is one of the major chronic diseases worldwide. COPD-patients
suffer from a progressive lung disease with episodes of acute worsening of symptoms
called exacerbations. Exacerbations have great impact on patient well-being and on
health-care costs due to hospital admission. We have developed a system which aims
to reduce exacerbation impact by monitoring patients at home and automatically
interpreting the data to detect exacerbations. The system consists of a smartphone
application that registers symptoms via a questionnaire and sensors to assess lung
function. To predict the occurrence of exacerbations taking into account the uncer-
tainty in the measurements, we used probabilistic models constructed in coopera-
tion with pulmonologists and from patient data. We studied different versions of
the model, using methods suitable for limited amounts of data, explicitly taking the
time aspect of patient monitoring into account. A pilot study in which ten patients
used our system suggests that we are able to predict the onset of an exacerbation
a day in advance for gradual onset exacerbations and detect sudden onset exacer-
bations on the first day. After further testing our system could be used to support
COPD patients by providing direct feedback based on the automatic interpretation
of their monitoring data, which hopefully prevents hospital admission due to COPD.
In this thesis we have further studied some theoretical properties of reasoning about
uncertain time processes, of which patient monitoring is an example. We have de-
veloped a framework based on probabilistic logic that allows reasoning about time
in a qualitative way using relations like ‘hospital admission occurred during an ex-
acerbation’. This kind of reasoning is fairly natural when precise timing information
is unavailable but ordering is of interest. In this thesis we have made some progress
both theoretically and practically in modelling uncertain temporal processes, how-
ever numerous options for future research in knowledge representation and clinical
applications remain.
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SAMENVATTING
Onzekerheid is een van de problemen waar we mee om moeten gaan wanneer we com-
plexe beslissingen nemen. In dit proefschrift hebben we dit probleem onderzocht, met
behulp van probabilistische modellen, in de klinische context van chronische ziekten.
Chronisch obstructief longlijden (Engelse afkorting: COPD) is een van de meest
voorkomende chronische ziekten ter wereld. COPD-patiënten lijden aan een voort-
schrijdende longziekte met episodes van acuut toenemende symptomen, exacerbaties
genoemd. Exacerbaties hebben grote invloed op patiëntwelzijn en op zorgkosten
veroorzaakt door ziekenhuisopname. Wij hebben een systeem ontwikkeld met als
doel de impact van exacerbaties te verminderen door patiënten thuis te monitoren
en automatisch de verzamelde data te interpreteren om exacerbaties te detecteren.
Het systeem bestaat uit een smartphone-applicatie die symptomen registreert met
behulp van een vragenlijst en sensoren om longfunctie te meten. Om exacerbaties
te voorspellen, waarbij rekening wordt gehouden met de onzekerheid in de metingen,
gebruiken we kansmodellen ontwikkeld in samenwerking met longartsen en gebruik-
makend van patiëntdata. Verschillende versies van de modellen zijn bestudeerd met
methoden geschikt voor het maken van modellen met weinig data, waarbij expliciet
rekening wordt gehouden met het tijdsaspect van patiëntmonitoring. Een pilotstu-
die met tien patiënten suggereert dat we in staat zijn om de start van exacerbaties
een dag van tevoren te voorspellen in het geval van geleidelijk ontwikkelende exa-
cerbaties en te detecteren op de eerste dag in het geval van een plotselinge start.
Na verdere evaluatie zou ons systeem gebruikt kunnen worden om COPD-patiënten
te ondersteunen door directe terugkoppeling te geven gebaseerd op de automatische
interpretatie van de monitoringdata om hopelijk daarmee ziekenhuisopname door
COPD te voorkomen. In dit proefschrift bestudeerden we verder theoretische eigen-
schappen van het redeneren over onzekere tijdsprocesses, waarvan patiëntmonitoring
een voorbeeld is. We hebben een raamwerk ontwikkeld gebaseerd op probabilistische
logica waarmee we op een kwalitatieve manier kunnen redeneren over tijd met be-
hulp van relaties zoals ‘opname vond plaats gedurende een exacerbatie’. Deze vorm
van redeneren is redelijk natuurlijk als precieze tijdsinformatie niet voorhanden is
maar de ordening van gebeurtenissen van belang is. In dit proefschrift hebben we
zowel theoretisch als praktisch enige progressie gemaakt in het modelleren van on-
zekere tijdsprocessen, maar er bestaan nog talrijke mogelijkheden voor toekomstig
onderzoek naar kennisrepresentatie en klinische toepassingen.
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“Breath in a second, wait, wait, you’ll be okay.”

